Associations between hypothalamic-pituitary-adrenal axis system gene variants and cortisol reactivity in preschoolers: Main effects and gene-environment interactions by Sheikh, Haroon I
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
6-6-2014 12:00 AM 
Associations between hypothalamic-pituitary-adrenal axis system 
gene variants and cortisol reactivity in preschoolers: Main effects 
and gene-environment interactions 
Haroon I. Sheikh 
The University of Western Ontario 
Supervisor 
Dr. Shiva M. Singh 
The University of Western Ontario 
Graduate Program in Biology 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Haroon I. Sheikh 2014 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Behavioral Neurobiology Commons, Biological Psychology Commons, Biology Commons, 
and the Molecular Genetics Commons 
Recommended Citation 
Sheikh, Haroon I., "Associations between hypothalamic-pituitary-adrenal axis system gene variants and 
cortisol reactivity in preschoolers: Main effects and gene-environment interactions" (2014). Electronic 
Thesis and Dissertation Repository. 2136. 
https://ir.lib.uwo.ca/etd/2136 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
  
 
Associations between hypothalamic-pituitary-adrenal axis 
system gene variants and cortisol reactivity in preschoolers: 
Main effects and gene-environment interactions 
 
(Thesis Format: Integrated article) 
 
 
 
 
by 
 
 
 
Haroon I. Sheikh 
 
 
Graduate Program in Department of Biology 
 
 
 
Submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
The School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario, Canada 
April, 2014 
 
 
 
 
© Haroon I. Sheikh 2014  
  ii
Abstract 
 Exposure to stressful events during early development has consistently 
been shown to produce long lasting effects on the hypothalamic-pituitary-adrenal 
(HPA) axis, which may increase vulnerability to mood and anxiety disorders. 
Recently reported genetic association studies indicate that these disorders may 
be influenced, in part, by gene-environment interactions (GxE) involving 
polymorphisms within the corticotrophin-releasing hormone and monoaminergic 
system genes. However, little is known about how genetic variants and life stress 
work to shape children’s neuroendocrine reactivity and emerging symptoms. 
Therefore, the aim of this thesis is to examine main effects of candidate genes 
and GxE on the neuroendocrine stress response and internalizing symptoms in a 
community sample of 409 preschoolers. 
In Chapter 2 analyses show associations between variants of the CRHR1 
and CRHBP genes and children’s cortisol responses to a standardized laboratory 
stress task. I also found evidence for GxE, where variants of the CRH system 
genes moderated the impact of childhood stress on early-emerging symptoms of 
depression and anxiety.  
A functional polymorphism of the catechol-O-methyltransferase (COMT) 
gene, the val158met, has been implicated in the etiology of stress-related mood 
disorders. Therefore, in Chapter 3, I examined links between the val158met 
polymorphism, cortisol reactivity to stress, and internalizing symptoms. I found 
evidence for association between the val158met genotype and cortisol reactivity 
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to stress. Additionally, the val158met genotype moderated the link between 
childhood stress and emerging symptoms of anxiety.  
Due to the proposed role of dopamine and serotonin gene polymorphisms 
in research on GxE in internalizing disorders, in Chapters 4 and 5, I examined 
whether associations between dopaminergic and serotonin candidate gene 
polymorphisms and childhood cortisol reactivity and internalizing symptoms were 
moderated by childhood life stress. Analyses showed evidence for GxE 
predicting children’s symptoms. Specifically, polymorphisms of DRD2 and DAT1 
genes moderated the effect of childhood stress on emerging symptoms of 
anxiety. With regard to serotonin pathway polymorphisms, I found associations 
between the serotonin transporter promoter polymorphism (5-HTTLPR) and 
children’s anxious symptoms. Additionally, consistent with previously reported 
findings, the interaction between MAOA 30bp VNTR and childhood stress 
predicted child anxiety symptoms. Limitations of this work include a relatively 
small sample size for genetic analyses, as well as the examination of a limited 
number of markers at each gene. Additionally, I did not correct for multiple 
statistical tests in some analyses due to the hypothesis-driven nature of the work.  
Taken together, the analyses show the complex underpinnings of 
individual differences in stress regulation, and highlight specific genetic 
vulnerabilities that influence early psychophysiological reactivity, that may in turn 
contribute to the development of stress-related disorders later in development. 
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Keywords: HPA axis, childhood stress, cortisol, haplotype, polymorphism, early 
development, serotonin, dopamine, gene-environment interactions, depression, 
anxiety. 
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1  Introduction – Hypothalamus-pituitary-adrenal axis stress reactivity: 
The role of genetics, environment and implications for emerging risk for 
depression and anxiety 
 
1.1 The hypothalamic-pituitary-adrenal axis  
The hypothalamic-pituitary-adrenal (HPA) axis is the primary physiological 
regulator of environmental stress in humans (Selye, 1973). In his seminal work, 
Selye defined stress as the result of an organism’s failed attempt to respond 
appropriately to a physical challenge (Selye, 1936). Since then, this definition has 
been further elaborated to include psychological threats, including both 
anticipation and ideation of impending stressors, not just those actually present in 
the current environment (Schulkin et al., 1994). Expanding on this work, an 
alternative view of stress is encapsulated in the concept of allostasis and 
allostatic load (McEwen, 1998; Sterling & Eyer, 1998). Allostatic responses are 
those physiological changes that occur in response to environmental 
disturbances. These responses are not inherently negative, but instead play an 
important positive role in helping an individual adapt to a changing environment. 
Importantly, the concept of allostasis focuses on the mediators of adaptation, 
such that the HPA axis not only promotes adaptation to stressors, but also 
contributes to pathophysiology when it is overused or dysregulated (McEwen, 
2006). For instance, inflammatory cytokines can stimulate the production of 
corticosteroids, which in turn can suppress inflammatory cytokine production. 
Similarly, the sympathetic and parasympathetic systems exert differential effects 
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on inflammatory cytokines, with the former stimulating their production and the 
latter inhibiting them (Sapolsky et al., 2000). However, under allostatic load when 
cortisol is too high, these systems become unbalanced leading to inhibition of an 
appropriate inflammatory response during immune challenge. Conversely, if 
corticosteroid levels are too low, a ‘normal’ immune response can become 
overactive and result in excessive inflammation (Karatsoreos & McEwen, 2011). 
As described by McEwen and Wingfield (2003), when environmental 
stress is encountered, the HPA neuroendocrine cascade (Figure 1.1) initiates the 
release of corticotrophin-releasing hormone (CRH) in the hypothalamus into the 
hypothalamic-pituitary portal. CRH triggers the release of adrenocorticotrophic 
hormone (ACTH) in the anterior pituitary by binding to its receptor, the 
corticotrophin-releasing hormone receptor-1 (CRHR1). The cascade culminates 
at the adrenal cortex with the release of cortisol in primates and corticosterone in 
other mammals (e.g., rodents). Glucocorticoids in turn act on the hypothalamus 
and pituitary to suppress CRH and ACTH production in a negative feedback 
cycle, thus downregulating these hormones once the stressor has terminated. 
Cortisol is a potent glucocorticoid hormone and a key biomarker of HPA axis 
activity in mammals (McEwen, 2007) and its broad role in physiology and 
psychology are briefly reviewed in the following sections.  
1.1.1 Cortisol and its importance in physiological metabolism 
Cortisol is one of the few hormones essential for life; for example, 
adrenalectomy in humans is fatal unless glucocorticoids are administered 
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(Karatsoreos & McEwen, 2011). Cortisol exerts an anabolic effect, such as 
conversion of glucose to glycogen in the liver, and catabolic effects such as 
proteolysis and lipolysis in other tissues including skeletal muscle, adipose 
tissues and lymphoid tissues (Spiga et al., 2007). Further, cortisol also facilitates 
the function of other hormones. For example, cortisol must be present in order for 
glucagon to exert its calorigenic action, and for catecholamines such as 
dopamine, epinephrine and adrenaline to exert their lipolytic effects (Spiga et al., 
2007). Cortisol also acts as an inhibitor of CRH and ACTH secretion by the 
hypothalamus and pituitary glands.  
In addition to its effects on the organs and tissues directly involved in 
metabolic homeostasis, cortisol influences a number of other organs and 
systems. For example, cortisol maintains the responsiveness of vascular smooth 
muscle to catecholamines and therefore participates in blood pressure regulation 
(Danhof-Pont MB, van Veen & Zitman, 2011). When blood pressure is low, 
decreased muscle responsiveness, together with the associated hypovolemia 
caused by mineralocorticoid deficiency, can result in severe hypotension 
(Veldhuis et al., 1987).  
Excessive cortisol production has been etiologically implicated in many 
medical conditions such as inflammatory diseases, musculoskeletal disorders, 
asthma, and heart disease (Negrao et al., 2000; Sharpley, 1998; Sternberg et al., 
1990; Wright et al., 1998). Our understanding of the deleterious effects of 
excessive cortisol production (hypercortisolemia) comes from studies of people 
with Cushing’s disease (for an in-depth review, see Prague, May & Whitelaw, 
  
2013). Individuals with hypercortisolemia in Cushing’s syndrome present with 
excessive abdominal fat, obesity and significantly higher 
cardiovascular disease, Type
2002). Further, along with 
health, maladaptive cortisol responses to stress have also been linked to 
psychiatric disorders such as depression, anxiety and panic disorders (McEwen, 
2004, 2008).   
Figure 1.1. The hypothalamic
negative feedback loop of the signalling cascade.
risk factor for 
-II diabetes, and stroke (Miller & O’Callaghan, 
the effects of excessive cortisol exposure on physical 
 
-pituitary-adrenal axis. The red line indicates the 
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1.1.2 Cortisol function and depression 
HPA axis dysregulation has been a well-documented neuroendocrine 
feature in individuals with depression and anxiety. Abnormal levels of cortisol in 
saliva, plasma, urine, and cerebrospinal fluid have long been known to be 
present during episodes of depression (Carroll, Curtis, & Mendels, 1976; 
Charney, 2004; Heim & Binder, 2012). Cortisol responses are also exaggerated 
after CRH and ACTH administration in patients with depression compared to 
healthy controls (Amsterdam et al., 1986; Nelson & Davis, 1997). Aberrant 
patterns of HPA axis activity is not only found in many adults with depression, but 
has also been reported in depressed children and adolescents. For example, 
compared to healthy controls, depressed children were found to exhibit a 
stronger ACTH response to CRH administration (Kaufman et al., 1997). Similarly, 
an increased cortisol response to psychosocial stress was observed in 
depressed children aged 3 through 6 compared to their healthy counterparts 
(Luby et al., 2003). A recent meta-analysis has confirmed these findings in 
patients with depression (Stetler & Miller, 2011). Literature also suggests that 
normalization of the HPA system may be necessary for stable remission of 
depression and successful antidepressant treatment has been shown to 
attenuate and normalize HPA axis abnormalities (De Bellis et al., 1993; Kling et 
al., 1994; Nemeroff et al., 1991; Ising et al., 2005).  
1.1.3 Salivary cortisol as a biomarker for HPA axis reactivity 
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The primary biomarkers of the HPA axis include CRH, ACTH, and cortisol. 
In studies of human participants, CRH is measured in cerebrospinal fluid, which 
means that this biomarker must be measured in controlled clinical settings. In 
contrast, ACTH and cortisol can be assessed in blood, and unbound levels of 
cortisol can be measured in saliva. Unbound cortisol diffuses from the blood 
stream into salivary glands and is highly correlated with serum cortisol levels 
(McEwen, 2004). As cortisol is transferred from plasma to saliva within a few 
minutes, the short time lag makes it useful in research investigating HPA axis 
responses (Harmon et al., 2007). There are many advantages to using salivary 
biomarkers in stress research. First, sampling is non-invasive and eliminates the 
possibility of needle puncture injuries. Stress related to blood draws during 
collection, which may bias the results, is also minimized, making it useful in 
studies of children. Salivary biomarkers are also useful for research involving 
children as it avoids ethical concerns associated with invasive measures. 
Furthermore, saliva collection can be performed at participants’ homes and does 
not require skilled healthcare professionals, making it highly useful in 
assessments in the subjects’ natural environment, such as at a child’s home. 
Cortisol is also relatively stable in saliva; thus, saliva samples can be stored at 
room temperatures for at least for a couple of weeks (Kirschbaum & Hellhammer, 
2000). For these reasons, salivary cortisol has been widely used in HPA axis 
research and is considered a well-established biomarker of HPA axis function.  
1.2 Correlates of the HPA axis response 
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As previously discussed, literature suggests that HPA axis dysregulation 
measured via cortisol reactivity is a prominent neuroendocrine feature in 
psychiatric disorders such as depression (Charney & Manji, 2004). However, the 
developmental correlates of the cortisol stress response are poorly understood 
(Krishnan & Nestler, 2008). Extant research points to the role of environment and 
individual diatheses in contributing to cortisol reactivity to stress. Therefore, the 
following sections will briefly review current knowledge of the environmental and 
genetic determinants of the HPA axis reactivity to stress.    
1.2.1  Life stress during early childhood and the HPA axis 
Early caregiving has been shown to contribute to the lifelong 
responsiveness of the HPA axis to stressors (Meaney et al., 1988, 1991). 
Perhaps the strongest evidence for the environmental regulation of the 
development of responses to stress comes from postnatal handling research with 
rodents. Handling involves a brief (i.e., 3–15 min), daily period of separation of 
the pup from the mother for the first few weeks of life, and results in hyper-
reactivity to stress in adulthood (Levine et al., 1967; Zarrow et al., 1972; Meaney 
et al., 1989; Viau et al., 1993; Bhatnagar et al., 1995). As adults, rats exposed to 
extended positive maternal care show decreased fearfulness and more modest 
HPA responses to stress; such effects are apparent in animals tested as old as 
26 months of age (Meaney et al 1988, 1992). The handling effects on the 
development of HPA responses to stress have important consequences for 
health. Glucocorticoid levels often rise with age in rats and are associated with 
hippocampal degeneration and the emergence of learning and memory deficits 
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(Landfield et al., 1981, Landfield & Pitler 1984, Sapolsky et al., 1984, Issa et al., 
1990). Such age-related increases in basal and stress-induced pituitary-adrenal 
activity is significantly less apparent in the control or non-handled animals; thus, 
these animals show little evidence of hippocampal aging (Meaney et al., 1988, 
1991). 
Research with rodents has been complemented by work with nonhuman 
primates where maternal separation during early childhood leads to higher 
plasma cortisol levels (Bayart, et al., 1990; Levine, 1993; Sanchez et al., 2005). 
Primate infants separated from their mothers and raised with peers have greater 
HPA axis reactivity in adulthood (Heim & Nemeroff, 1999). In addition to maternal 
separation stress, poor early caregiving can be observed in non-human primates 
as well, where a small number of primate mothers are actively abusive to their 
offspring, subjecting them to behaviours that include dragging, crushing, hitting, 
and biting the infant (Maestripieri, 1998). The infants of abusive and nonabusive 
mothers were administered CRH and their basal cortisol and cortisol reactivity 
tested every 6 months for up to 3 years of age. The authors found no effects of 
abuse on basal cortisol levels but offspring of abusive mothers had greater 
cortisol reactivity to stress contexts (such as facing aggressive males of higher 
social rank) when compared to their nonabused counterparts (Sanchez et al., 
2010).  
In addition to research on links between poor early caregiving and 
abnormal cortisol response in rodents and non-human primates, similar findings 
have been reported in humans as well. For example, Heim and colleagues 
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(2002) and in a later study by Rao and colleagues (2008) showed that a history 
of childhood adversity was associated with increased neuroendocrine stress 
responses in adolescents and adult women. Elevated cortisol reactivity has also 
been documented in children in daycare centers with lower quality of care (Tout 
et al., 1998) and children with poor care in foster homes (Dettling et al., 2000). 
However, the literature also yields contradictory findings as well. For example 
Carpenter and colleagues (2007) and MacMillan and colleagues (2009) failed to 
replicate earlier findings of increased neuroendocrine reactivity to stress and 
found attenuated neuroendocrine stress responses in maltreated adolescents 
and adults, suggesting that the effect of exposure to adversity and caregiving on 
stress reactivity is not straightforward (Ellis & Boyce, 2008; Del Giudice, Ellis & 
Shirtcliff, 2011). However, it is of note that the literature has focused largely on 
extreme forms of negative early care such as physical and sexual abuse, 
although more normative aspects of early care are also likely relevant, and would 
have implications for a larger number of children. For example, a recent study by 
Hackman and colleagues (2013) explored the role of common parenting 
behaviours on adolescents’ stress responses, demonstrating that positive early 
childhood parental care directly predicted adolescent cortisol reactivity to 
psychosocial stress.  
1.2.2 Genetic bases of cortisol responses to stress 
In addition to the influence of early care, genetic factors have been linked 
to cortisol response to stress. Literature from twin studies suggests that salivary 
cortisol responses to acute challenge are significantly influenced by genetic 
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factors. For example, in a seminal pilot study, the heritability of salivary cortisol 
responses was investigated in a sample of 124 monozygotic and 155 dizygotic 
twins who were exposed to laboratory stressors such public speaking, a complex 
arithmetic task, and exhausting physical exercise (Kirschbaum et al., 1992). The 
proportion of variance in cortisol reactivity attributable to heritable factors was 
estimated at 48%. Research over the past decade has supported these findings 
via replications in large independent samples (Bartels et al., 2003; Steptoe et al., 
2009). Therefore, these heritability studies suggest a moderate genetic 
component of cortisol reactivity, and in addition to environmental influences on 
cortisol reactivity. However, only a small number of studies have examined 
associations between polymorphisms of the HPA axis genes and childhood 
cortisol reactivity.  
Due to the genetic underpinnings of HPA axis function, and its links to 
complex traits such as internalizing symptoms, in psychiatric research, cortisol 
reactivity is considered an endophenotype of mood and anxiety disorders. 
Endophenotypes such as cortisol reactivity are quantifiable components in the 
genes-to-behaviors pathways, distinct from psychiatric symptoms, which make 
genetic and biological studies of etiologies for disease categories more 
manageable. Endophenotypes provided a means for identifying the 
“downstream” traits or facets of clinical phenotypes, as well as the “upstream” 
consequences of genes and, in principle, could assist in the identification of 
candidate genes in the hypothesized polygenic systems conferring vulnerabilities 
to disorders (Gottesman & Gould, 2003). Therefore, research is needed to 
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document specific genetic variants linked to individual differences in childhood 
cortisol reactivity to stress, the endophenotype of depression and anxiety.  
1.2.3  Gene-environment interactions influence HPA axis response to stress: 
Implications for etiology of depression and anxiety 
Although so far the extant literature suggests that genes and 
environmental factors influence early cortisol reactivity to stress, a large body of 
molecular genetics research has documented that the impact of genes on 
phenotypes is dependent on environmental exposure (e.g., Kendler et al., 2007). 
Therefore, it is the joint consideration of interactions between genetic diathesis 
and environmental exposure that can help unfold the complex biological 
pathways that contribute to psychological risk. However, limited research in 
adults has examined the role of gene-environment interactions as predictors of 
cortisol responses to stress. For example, Tyrka and colleagues (2009) have 
reported that an interaction between childhood trauma and CRHR1 genotype 
predicted cortisol reactivity in a sample of adults. Expanding on this study, Heim 
and colleagues (2009) reported that interactions between the CRHR1 genotype 
and history of childhood physical abuse predicted significantly higher increases in 
cortisol responses to stress stimuli in a standardized laboratory task in depressed 
patients when compared to healthy controls. Additionally, a study by Alexander 
and colleagues (2009) reported interactions between a functional polymorphism 
of the serotonin transporter gene (also known as 5-HTTLPR) and stressful life 
events predicted cortisol reactivity in a non-clinical sample. To my knowledge, 
the studies of adults briefly reviewed here are the only examples of GxE 
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predicting cortisol reactivity. However, no prior research has examined the role of 
GxE as a predictor of cortisol reactivity in young children; thus, this topic will be 
one focus of this dissertation.  
Even though only a few studies have reported on the role of GxE in 
shaping cortisol responses to stress, a large literature has reported on GxE 
predicting stress-related psychopathologies such as depression and anxiety. 
Specifically, gene polymorphisms of the CRH system and the aminergic 
pathways (serotonin and dopamine) have been shown to interact with early 
childhood adversity to predict later risk for mood and anxiety disorders (for an in 
depth review see Mandelli & Serrtti, 2013).  For example, the effect of early 
caregiving on risk for depression and anxiety was moderated by gene 
polymorphisms of serotonin (Eley et al., 2004; Huang et al., 2004; Karg et al., 
2011), dopamine (Hayden et al., 2010), norandrenergic (Sun et al., 2008; Xu et 
al., 2009) and glutamate pathways (Sokolowski et al., 2013). In sum, based on 
these studies in addition to GxE role on intermediate phenotypes that may 
contribute risk for mood and anxiety problems, I also intend to examine whether 
GxE predict emerging symptoms.     
1.2.4 Rationale for conducting study in preschoolers  
As described above, studies of GxE (see reviews by Heim et al., 2009; 
Uher, 2007) indicate that variation in CRH and monoaminergic system genes 
may influence risk for depressive and anxious symptoms based on early 
childhood environment. One possible explanation for these findings is that a 
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critical period exists for the normative development of an emotional regulatory 
system. A few studies suggest that there might be timing-dependent effects of 
early stress on depression risk. For example, Agid and colleagues (1999) report 
that parental loss before 9 years of age was associated with higher depression 
risk compared to parental loss between 9 and 17 years of age. Although there 
are very few studies that have systematically evaluated neurobiological 
outcomes of childhood stress experienced at different developmental stages, 
studies of rodents and non-human primates suggest that the direction of the 
effects of early life stress on the CRH/HPA system depend on timing of the early 
life stress (Coplan et al., 2006). For example, early weaning of 21-day old rats 
causes faster myelination in the amygdala, decreased brain-derived neurotrophic 
factor protein levels in the hippocampus and prefrontal cortex, and reduced 
neurogenesis in the dentate gyrus (Kikusui & Mori, 2009). Although limited 
evidence from human studies for age-dependent effects of early caregiving have 
been reported, a study by Rogeness and McClure, (1996) showed abnormal 
dopamine metabolism in children who were maltreated in the first 3 years of life, 
but not in children maltreated later in childhood. Carpenter and colleagues (2004) 
reported that preschool life stress, but not later childhood stress, modulates 
adulthood cerebrospinal fluid CRH levels. The same group reported that cortisol 
response to stress in adults decreases with increasing onset age of emotional 
abuse (Carpenter et al., 2009). Taken together, the data described here suggest 
that early childhood is a critical period with consequences for later mental health 
outcomes. 
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In addition to the role of biological mechanisms underlying the phenotype 
in question (internalizing problems) and the environmental factors that may 
contribute to the expression of said phenotype, the study of emerging symptoms 
in preschoolers is an informative tool in the understanding of the etiology of 
depression and anxiety. For example, evidence exists that early symptoms, even 
subthreshold ones of anxiety and depression such as the ones found in 
preschoolers have heterotypic and homotypic continuity for later disorders. 
Specifically literature from our group and others has shown that early emerging 
symptoms of depression and anxiety predict internalizing symptoms later in life 
(Costello et al., 2003; Klein et al., 2008; Luby et al., 2009). Therefore findings in 
this study would help inform early prevention and intervention. 
1.3 Neurotransmitters as mediators of links between early life stress and 
HPA axis response 
The search for candidate genes that shape cortisol responses to stress 
must be informed by an understanding of the neurobiological systems that 
regulate the function of the HPA axis. The hypothalamus and pituitary glands are 
heavily innervated by aminergic neuronal inputs from the limbic system region 
including the prefrontal cortex, hippocampus, and amygdala (Herman et al., 
1996). The two major aminergic neurotransmitter systems linked to HPA axis 
regulation are the dopaminergic and serotonergic systems: these are briefly 
reviewed here. 
1.3.1 The dopaminergic system 
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Dopamine (DA) is released predominantly from the ventral tegmental area 
of the brain and is involved in the control of locomotion, cognition, affect, and 
neuroendocrine secretion (Bunney et al., 1980; Jaber et al., 1996; Smythe, 
1977). At the synaptic level, DA exerts its effects through its interaction with the 
DA receptors. Molecular biology and pharmacology studies have identified two 
classes of receptors consisting of at least five DA receptor subtypes: D1, D2, D3, 
D4, and D5, with the most widely expressed subtypes in the prefrontal regions of 
the brain being the D2 and D4 receptors (LaHoste et al., 2000). On binding an 
agonist, DA receptors activate the adenylate cyclase second messenger system, 
elevating intracellular cyclic adenosine monophosphate concentrations. Cyclic 
adenosine monophosphate increases protein kinase-A activity with resulting 
changes in expression levels of a wide range of proteins within the cell (Dunlop & 
Nemeroff, 2007). DA signalling is terminated via either its reuptake by the 
dopamine transporter (DAT) into the presynaptic neurons or DA inactivation by 
two catabolic enzymes, namely, the catechol-O-methyltransferase (COMT) and 
the monoamine oxidase-A (MAOA).  
DA innervation of the medial prefrontal cortex (mPFC) appears to be 
particularly sensitive to mild and brief stress (Deutch et al., 1985). In addition to 
genetic influences, animal studies of rodents and non-human primates show that 
both acute and chronic stress influence the functioning of the DA system. For 
example, rodents exposed to brief stressors such as low intensity foot shock and 
short periods of restraints show DA release and metabolism in the prefrontal 
cortex (Deutch & Roth, 1990; Thierry et al., 1998; Kalivas & Duffy, 1989). In 
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contrast, chronic stress over time may enhances DA degradation in areas that 
receive DA innervations, such as the hypothalamus and hippocampus, leading to 
overall DA depletion and DA mediated signalling in these important stress 
regulating brain regions (Roth et al., 1988). Thus, mPFC DA metabolism and 
release is related to the occurrence of stress, and suggests the importance of DA 
in stress regulation (Abercrombie et al., 1989; Deutch et al., 1985; Deutch & 
Roth, 1990; Mantz et al., 1989).  
1.3.2 The serotonergic system  
Serotonin (5-HT) is involved in a wide variety of processes including 
anxiety, arousal, vigilance, aggression, mood, impulsivity, and regulation of 
appetite (Charney & Manji, 2004). There is both anatomical and functional 
evidence for a regulatory role of 5-HT on stress-induced HPA activity (Dinan, 
1996; Phelix et al., 1992). Animals exposed to a variety of stressors, including 
restraint and maternal separation, show an increase in 5-HT turnover in limbic 
regions, such as the medial prefrontal cortex (Adell et al., 1988; Inoue et al., 
1994; Pei et al., 1990; Petty & Sherman, 1983), amygdala, and hypothalamus 
(Kaehler et al., 2000). Animals exposed to social stress such as maternal 
separation during early life, also had an increase in activation of 5-HT receptors 
in the hippocampus and dentate gyrus, two regions widely implicated in 
regulation of stress stimuli (McKittrick et al., 1995). Studies of non-human 
primates have provided evidence that increased 5-HT metabolism during 
exposure to inescapable stress prevents anhedonic behaviours, evinced by lack 
of caloric intake (loss of appetite), decrease in sexual activity and withdrawal 
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from social exploration (Ronan et al., 2000), behaviours usually associated with 
depression in humans. 5-HT antagonists also produce behavioural deficits while 
drugs that enhance 5-HT neurotransmission (SSRI) are effective in reversing 
anhedonia-like symptoms (Martin et al., 1990; Sherman & Petty, 1980). 
Additionally, injection of 5-HT into the frontal cortex after stress exposure in adult 
rats reverses stress-related behavioural deficits, such as anhedonia-like 
symptoms described above (Sherman & Petty, 1982).  
There are two key regulators of serotonin levels in the limbic system. First, 
is the 5-HT transporter (5-HTT), which regulates serotonin neurotransmission 
through precise control of extracellular 5-HT levels (Lesch et al., 1996). This 
process is driven by the 5-HTT, which belongs to the sodium ion dependent 
transporter family (Nelson, 1998; Rudnick & Clark, 1993). 5-HTT assumes the 
uptake of extracellular 5-HT across the cell membrane of neuronal and non-
neuronal cells, such as serotonergic neurons of raphe nuclei, basal nuclei and 
platelets. Dysregulation of the tightly controlled external concentration of 5-HT is 
linked to a host of metabolic and psychiatric disorders, including depressive, 
anxious, and obsessive-compulsive disorders (Charney & Manji, 2004). The 
second regulator of synaptic 5-HT levels is the MAOA enzyme, which catabolizes 
serotonin in the neuronal synapse (Martin et al., 1990). In brains of MAOA 
knockout mice, 5-HT concentrations were increased up to nine-fold compared 
with wild-type mice. Additionally, adrenergic concentrations in the prefrontal 
cortex and basal nuclei were increased up to two-fold; however, relative to 5-HT, 
only a small increase in DA levels was observed in infant mice brains (Cases et 
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al., 1995), suggesting that MAOA has a greater affinity for degrading serotonin 
when compared to DA. MAOA deficient mice show a significant increase in brain 
serotonin levels and attenuated reactivity to stress, suggesting a link between 
serotonergic metabolism and HPA axis function (Shih et al., 1999). Due to its 
ability to regulate serotonin availability in the brain, MAOA inhibitors have been 
widely used in psychiatric populations for the treatment of depression, anxiety 
and posttraumatic stress disorder (Liebowitz et al., 1990). Doyle and colleagues 
(1996) reported that an increase in salivary MAOA activity was also correlated 
with levels of life stress. Additionally, MAOA inhibitor therapy in adult patients 
diagnosed with posttraumatic stress disorder leads to normalization of diurnal 
cortisol rhythm (Liebowitz et al., 1990). Taken together, these studies suggest a 
role of serotonin and DA pathways in HPA responses to stress and stress-related 
psychopathologies such as mood and anxiety disorders. 
1.4 Candidate genes examined in the current study 
Based on current literature implicating the dopamine and serotonin 
systems in HPA axis responses to stress (Figure 1.2), a logical starting point for 
examining the underpinnings of psychological risk is to focus on gene variants 
implicated in aminergic signalling. This method (also known as the gene-pathway 
approach; Mormede et al., 2002) of candidate gene identification utilizes a priori 
knowledge of the metabolic pathway involved taking advantage of data from 
previous cellular, biochemical, molecular, or pathological experiments. Candidate 
genes and their variants investigated in this study are listed in Table 1.1. DA 
signalling is widely documented in regulating HPA axis response to stress and 
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stress-related disorders such as depression and anxiety. Therefore, the current 
study will explore common variants of the DA pathway, specifically the D2 and 
D4 receptors (Chapter 4). Additionally, as both COMT and DAT directly affect the 
availability of synaptic DA, thereby controlling the intensity of DA 
neurotransmission in response to stress, genetic variants of the COMT and DAT 
genes will be investigated (Chapters 3 & 4). Similarly, as the serotonin 
transporter gene (commonly known as 5-HTT) and MAOA also regulate the 
availability of the limbic systems extracellular serotonin, the current thesis will 
also examine the role of the variants of the two genes in stress response and 
emerging risk for psychopathology in Chapter 5. 
As discussed in previous sections, the intensity of the cortisol response at 
the adrenal level is based on the release of CRH in the hypothalamus (McEwen, 
2007). The availability of CRH in the brain is directly regulated by the CRHBP 
protein, which sequesters and inactivates CRH and its receptor in the pituitary 
gland (CRHR1) that initiates the release of ACTH. However, the common genetic 
variants that may be associated with cortisol stress reactivity in young children 
are unknown. Therefore, the current study aims to examine the genetic variation 
of the entire coding and regulatory regions of the CRH system genes. These 
associations will be based on constructing haplotypes based on linkage 
disequilibrium. Haplotypes refer to combinations of marker alleles which are 
located closely together on the same chromosome and which tend to be inherited 
together (van West et al., 2004). Methods based on haplotypes can be more 
powerful than those based on single markers in association studies of mapping 
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complex disease genes. The power of single marker-based methods depends on 
the linkage disequilibrium (LD) between the tested marker locus and the disease-
susceptibility locus (Akey et al., 2001). LD information contained in flanking 
markers is not incorporated into such methods, which can result in potential 
reduction of power. In addition, even if the tested marker locus is in strong LD 
with the disease locus, power can be quite low if the frequencies of the marker 
and disease alleles are different (e.g., Kaplan & Morris, 2001). Therefore, 
haplotype-based association methods are generally regarded as being more 
powerful than methods based on single markers (Akey et al., 2001; Morris and 
Kaplan, 2002) as these analyses can detect the combined effects of multiple 
sequence variants on promoter activity or protein structure and/or function 
(Devlin & Roeder 1999; Drysdale et al. 2000; Joosten et al. 2001). The work of 
the International HapMap Project (International HapMap Consortium 2003; 
International HapMap Consortium 2005), dedicated to describing the patterns of 
human genetic variation by developing a map of the linkage maps in the human 
genome, provides a valuable resource for efficient SNP selection in haplotype-
based association studies and forms the basis of Chapter 2 of this thesis. 
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Table 1.1. List of genes investigated for associations with childhood cortisol reactivity to stress and emerging internalizing 
symptoms.  
Gene1 Chromosome Functional mutation Behavioural associations 
CRH 8q13 None reported ↑behavioural inhibition in children at risk for panic disorder (Smoller et al., 2005) 
CRHR1 17q12 None reported Increased risk for internalizing problems (Bradley et al, 2008) 
CRHBP 5q11 18 amino acid exon 7 deletion leads to truncated messenger RNA Suicidal ideation (Roy, 2012) 
COMT 22q11 
Exon 4 Val→Met substitution at 
position 158 leads to changes in 
enzyme activity 
Linked to multiple internalizing disorders  
MAOA X 
30bp VNTR polymorphism in gene 
promoter region leads to decreased 
function 
Polymorphism linked to externalizing 
behaviours such as aggression  
SLC6A4  
(5-HTTLPR) 17q11 
44-48bp VNTR polymorphism in gene 
promoter region leads to decreased 
transporter protein 
↑ depression and anxiety incidence 
among short allele carriers (Wust et al., 
2009) 
SLC6A3 
(DAT-1) 5p13 
30bp VNTR in exon 4 leads to 
differential dopamine binding 
Associated with major depression and 
bipolar disorder (Szczepankiewicz et al., 
2011) 
DRD2 11q23 Single nucleotide polymorphism in the promoter region  
Associated with cortisol reactivity in mice 
and non-primate humans  
DRD4 11p15 48bp VNTR polymorphism in exon 3 leads to altered receptor function 
Interaction between this variant and early 
life stress predict anxiety problems 
Note: BDNF: Brain derived neurotrophic factor; SLC6A3: Solute carrier family member-3 (dopamine transporter); SLC6A4: Solute 
carrier family member-4 (serotonin transporter); CRH: Corticotrophin releasing hormone; CRHR1: Corticotrophin releasing hormone 
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receptor-1; CRHBP: Corticotrophin releasing hormone binding protein; COMT: Catechol-O-Methyltransferase; MAOA: Monoamine 
oxidase-A; DRD2: Dopamine receptor D2; DRD4: Dopamine receptor D4; bp: base pairs; VNTR: Variable number tandem repeat. 
Val: valine; Met: methionine; Leu: leucine; Phe: phenylalanine; Gly: glycine; Ile: isoleucine. 
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Figure 1.2. Overview of the limbic regulation of the HPA axis via central nervous 
system neurotransmitters. Activation and inhibition of the signalling cascade is denoted 
by the “+” and “-“ signs. Note:  CRH: Corticotrophin releasing hormone; ACTH: 
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Adrenocorticotrophic hormone; COMT: Catechol-O-Methyltransferase; MAOA: 
Monoamine oxidase; DA: Dopamine. 
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1.5 Hypotheses and thesis objectives  
The main focus of this thesis is to investigate the link between genetic 
variants of the dopamine, serotonin and CRH pathway genes and cortisol 
responses to stress in a community sample of preschoolers. I hypothesize that 
the genetic variants of the monoaminergic (DA and 5-HT) and CRH pathway 
genes will be associated with individual differences in children’s cortisol 
reactivity to stress. Further, GxE between candidate gene polymorphisms 
and life stress will predict risk for emerging symptoms of depression and 
anxiety in preschool-aged children.  
Given the role of the HPA axis response to stress in the etiology of 
internalizing problems, I will also examine associations between monoaminergic 
and CRH pathway gene variants and emerging risk for psychopathology. 
Specifically, the following chapters of this dissertation focus on three objectives 
(see conceptual model in Figure 1.3): 
1. Examine the main-effects of CRH system, serotonin and 
dopaminergic system gene variants on early age cortisol 
reactivity to stress. 
2. Examine the main-effects of CRH system, serotonin and 
dopaminergic system gene variants on early age emerging 
symptoms of depression and anxiety. 
3. Investigate whether gene-environment interactions between 
candidate gene variants and childhood stress predict cortisol 
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response to stress and/or emerging symptoms in a community 
sample of preschoolers. 
 
 
 
Figure 1.3. A conceptual model of life stress and genetics interacting through 
HPA axis physiological response to influence emerging symptoms.  
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2   – Genetic variation of the CRH pathway genes and childhood cortisol 
response to stress: The role of early life stress and implications for 
emerging risk  
2.1  Introduction 
As discussed in Chapter 1, dysregulation of the HPA axis in patients with 
major depressive disorder (MDD), demonstrated by abnormal plasma ACTH and 
cortisol concentrations, is one of the most consistent biological markers identified 
in the literature (Gillespie & Nemeroff, 2005; Holsboer et al., 1984). HPA axis 
dysfunction is also often found among patients with anxiety, including panic 
disorder (Abelson et al., 2007), social anxiety disorder (Condren et al., 2002) and 
generalized anxiety disorder (reviewed in Martin et al., 2009). However, a 
significant gap in knowledge remains in research on human participants 
regarding the genetic mechanisms underlying cortisol reactivity to stress, which 
may be an important mediator of genetic risk for depression and anxiety. 
Research using murine and primate models has explored this question in greater 
detail (McEwen, 1998), with extant literature implicating genes expressing the 
cascade initiation molecule, the corticotrophin-releasing hormone (CRH), and its 
components, the CRH receptors and CRH binding protein (CRHBP) in regulating 
glucocorticoid reactivity in response to stress (Behan et al., 1995; Roy et al., 
2012). In this cascade, CRHBP is a passive ligand trap that neutralizes active 
CRH by binding to it, thereby regulating bioavailability of free CRH and 
influencing downstream release of glucocorticoids (Jahn et al., 2005). Null 
mutants of the murine Crh gene (Crh -/-) have markedly impaired production of 
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both ACTH and corticosterone under conditions of stress compared to wild-type 
mice (Muglia, 1995). Other pituitary neuropeptides, such as oxytocin and 
vasopressin, do not compensate for the loss of corticosterone reactivity under 
stress (Schmidt et al., 2003; Venihaki & Majzoub, 2002), highlighting the 
importance of CRH gene expression in normal HPA axis function. Consistent 
with this, murine Crhr1 (Crhr1 -/-) knockouts lack a typical corticosterone 
response to stress. Furthermore, conditional knockouts of Crhr1 in the 
hypothalamus and pituitary lack a stress-induced corticosterone response 
(Schmidt et al., 2003, 2006). Translational research on the effects of stress in 
CRHBP knockout mice is limited, but these knockouts do exhibit higher free CRH 
in their serum and increased anxious behaviours compared to wild-type animals, 
supporting the role of CRHBP gene in the HPA axis function (Gammie et al., 
2008). These findings implicate the importance of CRH system genes in 
maintaining HPA axis function and regulating glucocorticoid reactivity to stress.  
Based on findings from animal studies, and the role CRH system genes 
play in cortisol response in animals, a parallel line of research in humans has 
increasingly focused on the GxE between CRH system genes and the early 
environment in patients with internalizing disorders. For example, variants of both 
CRHR1 and CRHBP genes have been shown to interact with early adversity, 
such as child abuse or maltreatment, to predict risk of depression and even 
suicidality later in life (Bradley et al., 2008; Heim et al., 2009; Grabbe et al., 2010; 
Roy et al., 2012). Additionally, genetic variation in the CRHR1 gene has also 
been linked to consolidation of aversive memories in adults and is thought to 
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mediate the pathway from childhood maltreatment to adulthood depression 
(Polanczyk et al., 2009). Similarly, variation in the DNA region containing the 
CRH gene has also been linked to behavioural inhibition, a personality trait 
associated with increased risk for internalizing disorders (Smoller et al., 2003, 
2006). Taken together, these studies suggest that CRH system genes may play 
a role in moderating the effect of childhood adversity on behaviour outcomes. 
Little is known about whether links between CRH system gene variation 
and cortisol reactivity or emerging risk for psychopathology exist in early 
childhood. Therefore, the aim of this chapter is to examine the links between 
common variation of the CRH system genes and early life cortisol reactivity and 
emerging symptoms. The second aim of this chapter is to extend the adult 
literature on CRH pathway gene variants as moderators of the effect of childhood 
adversity on later psychiatric problems (Bradley, 2008; Ciccetti, 2011). 
Specifically, we examined whether interactions between the CRH system gene 
variants and childhood adversity predicted either cortisol response to stress or 
emerging symptoms of anxiety or depression in young children.  
2.2  METHODS 
2.2.1  Participants 
Participants were an unselected community sample of 409 children (201 
boys; 49.1%) between 36 and 47 months of age (M = 40.72, SD = 3.51) from 
southwestern Ontario, recruited for a study of child emotional development (see 
Table 2.1 for further demographic details). Informed consent was obtained from 
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children’s parents before data were collected. Children with significant medical or 
psychological problems were excluded from participation via a screening 
procedure administered by trained study personnel at the recruitment stage. The 
sample was mostly Caucasian (90.5%) and of average cognitive ability (M = 
111.94, SD = 14.32) as assessed by the Peabody Picture Vocabulary Test–
Fourth Edition (Dunn & Dunn, 1997; PPVT-4). The study protocols were 
reviewed and approved by the University of Western Ontario Human Research 
Ethics Review panel. Finally, as allele frequencies and correlation structures 
between SNPs in a gene differ across populations, we limited all analyses to the 
subsample of 371 Caucasian children in the sample.  
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Table 2.1. Study sample demographics 
 
Characteristic Participants No. (%) 
Sex   
Male 201 (49.1) 
Female 208 (50.9) 
Caregiver-identified Race/Ethnicity   
Caucasian 371 (90.5) 
Asian American  6(2.3) 
Other 28 (68) 
Parent Education   
Some high school  7(1.8) 
High school graduate or some 
college 
212 (52.8) 
College graduate or beyond 181 (45.4) 
Household Income   
<$20K 22 (5.5) 
$20-40K 45 (11.0) 
$40-100K  219 (53.5) 
>$101K  120 (29.5) 
 
2.2.2 DNA preparation 
DNA samples were collected from all participants using buccal swabs 
(Epicentre, Madison, WI, USA) and stored according to the manufacturer’s 
instructions. Qiagen DNA MicroKit (Mississauga, ON, Canada) was used to 
extract DNA from epithelial cells and stored according to the manufacturer’s 
instructions. DNA was successfully extracted from the buccal swab samples of all 
participants.  
2.2.3 SNP selection and genotyping 
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A SNP marker panel (Table 2.1) was used to tag the full-length CRH 
(RefSeq NM_006180, 1.27 kilobases [kb]), CRHR1 (RefSeq NM_001145146, 
27.3 kb) and CRHBP (RefSeq NM_001882, 16.6 kb) according to Human 
HapMap Project phase II data for the central European population. The Tagger 
program (http://www.broad.mit.edu/mpg/tagger/; de Bakker et al., 2005) was 
used to determine the minimum set of SNPs necessary to capture or ‘‘tag’’ all 
HapMap SNPs (through linkage disequilibrium) with minor allele frequencies >5% 
among Caucasians. Tag-SNPs (tSNP) validated in Caucasian populations were 
selected from public databases (dbSNP, 
http://www.ncbi.nlm.nih.gov/projects/SNP/; HapMap, http://www.hapmap.org) 
flanking ±10 kb of the respective gene coding regions. This strategy allowed us 
to genotype variants in the gene promoter regions, which could be functionally 
important in gene transcription. Specifically, this tagging approach allowed us to 
select a limited number of SNPs that account for the entire genetic variation 
across a sequence of DNA by taking into account SNPs that are highly correlated 
with each other. SNPs tagged had a minimum r2 of 0.80 with the tagging SNP 
(mean r2 was 0.98). The suggested number of tSNPs was four for CRH, seven 
for CRHR1 and seven for CRHBP.  
All SNPs were genotyped using a TaqMan allelic discrimination assay 
(Livak, 1999), developed for use on the StepOne® instrument (Applied 
Biosystems, Foster City, California). Assay identification numbers and primer 
sequences for all of the TaqMan probes are provided in Table 2.2. Polymerase 
chain reactions were performed in 10-µL reaction volumes in 48-well plates and 
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contained 10 ng of DNA. Thermal cycler conditions were 95°C for 10 min and 
then 40 cycles of 95°C for 15 s and 60°C for 1 min. The SDS 2.2 software 
(Applied Biosystems) was used for allelic discrimination. For quality control, 10.0 
% of the samples were randomly chosen and genotyped as duplicates across 
and within a 48-well plate. The genotyping success rate for the CRHBP and 
CRHR1 genes was 99.1 % or 369 participants, and 98.1 % or 364 participants for 
the CRH gene. The final number of participants genotyped is provided in Table 
2.1 for each gene region.  
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Table 2.2. The CRH system genes: description of tSNPs. 
SNPs Chromosome location Nucleotide 
variant 
MAF in study 
sample 
MAF in HapMap, 
CEU populationsa 
HWE 
p-values 
CRH  Chr 8 Gene     
rs9694082 67066780 3' region C > G 0.18 0.19 0.51 
rs6999100 67082732 Intronic T > C 0.32 0.37 0.70 
rs1870394 67102818 5' region C > T 0.34 0.37 0.72 
rs11996294 67114738 5' region G > T 0.26 0.28 0.49 
N =364       
CRHBP  Chr 5      
rs1715751 76239704 Intergenic C > T 0.36 0.34 0.15 
rs1715747 76250378 5' region T > C 0.45 0.48 0.44 
rs32897b 76250972 Intronic T > C 0.22 0.20 0.26 
rs7728378 76259350 Intronic T > C 0.41 0.47 0.91 
rs10062367 76264354 Intronic G > A 0.24 0.24 0.42 
rs10473984b 76264982 3' UTR G > T 0.12 0.10 0.49 
rs10514082 76266447 Intergenic A > G 0.17 0.14 0.33 
N = 369       
CRHR1  Chr 17      
rs12944712 43871147 3' region G > A 0.28 0.31 0.25 
rs16969853 43880159 Intronic A > C 0.13 0.13 0.83 
rs242924 43885367 Intronic G > T 0.42 0.46 0.13 
rs171441 43893345 Intronic A > G 0.15 0.13 0.26 
rs1396862 43902997 Intronic G > A 0.12 0.12 0.24 
rs17763104b 43905795 Intronic G > A 0.13 0.15 0.65 
rs17689966 43910455 5' region G > A 0.40 0.39 0.54 
N = 369       
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Note: CRH, Corticotrophin releasing hormone; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin 
releasing hormone binding protein; Chr, Chromosome; MAF, Minor allele frequency; SNP, Single Nucleotide Polymorphism; HWE, 
Hardy-Weinberg equilibrium. 
a
 Frequency in HapMap European (CEU) populations of the minor allele. 
b
 SNPs associated with cortisol reactivity (See Figure 2.1).  
  
  50
Table 2.3: List of tag-SNP-specific primers and their annealing temperatures.  
 
Gene 
 
Allele-specific primer [5' to 3'] Annealing temp. (°C) 
CRH 
   
 
rs9694082 AACAAAACAAATTTGAGTTCACTCT[C/G]CTGGTGCATGGTGACCTCACACCTG 60 
 
rs6999100 ATGTATGCATGACATTTTGTTTATC[C/T]GCTTCTCCAAGGATGGACTCTTGGG 60 
 
rs1870394 TAAGGTCAGGGTAATAGAAAAGAAT[C/T]ATTCATCATAAGTTTTAAAACTCCC 62 
 
rs11996294 AGAGCCAATCCTTCAGTAAGATGTC[G/T]ATATAAATGCACTGCCCTGAGGTTA 59 
CRHR1 
   
 
rs12944712 TAAAGCTGACAGGGCAGGAGACCTG[A/G]GGTTGGAGCTGACTCAGCCACTTCT 62 
 
rs16969853 AAGGGAAGACTAGCCCTTTGCCTGG[A/C]ATTTGGCTTCATTTTCTGACGAATC 60 
 
rs242924 GCATGGCTGCTGCTGGGCAAAAATG[G/T]AGAGGGTCCCTGCACCTGAGTGTCT 60 
 
rs171441 AAGGAGGGCCAACTTCATTTAGCTG[A/G]TTCTTCCCTGCAGGGCCAGGGTAGA 62 
 
rs1396862 GTTGGACCAGGGCTTCTGAACTGCA[A/G]AGGTGCTTTTTCCTAAAACCAAGCT 63 
 
rs17763104 CGGGGTTGCCCTGATGGTTTAAGAC[A/G]ATAACAGATATGAAAATCCTCTGTA 62 
 
rs17689966 AAGCACTGTCCCTCCCCATGCCATC[A/G]AGGTGGACGCAGATGACCCTTCCTC 60 
CRHBP 
   
 
rs1715751 CACATGCAGAAACCAGAATGGGGCC[C/T]GAGGCAAAAGGAAAAGTCACTGACA 62 
 
rs1715747 ACTTTAAGGGATGAGGAGTTACTTC[C/T]TTTGAATGAGCAAAGAAAGCGGTTT 60 
 
rs32897 GTTCTTGACATTTTAAAGTAATATG[C/T]GATGATATTTTTAAAAAATGAGAAA 60 
 
rs7728378 GATTAAAAAAAAATAAGCACTCCCC[C/T]AATATTTTCTACATTGGAAGGTGAG 61 
 
rs10062367 ATGAGGAGAAAGACTGAATTCAATT[A/G]CACTATTCTATAACTAATTATAAGT 60 
 
rs10473984 AATTTACAGTACCTTTACAGAAGGA[G/T]AAAGGTGCCTTCTTCAAAAGGTTTT 60 
 
rs10514082 CTTCATTTCATAGAAACTAAATTCT[A/G]TGAAGCAGGAGGTTGAACCCTTTTC 60 
Note: CRH, Corticotrophin releasing hormone; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin 
releasing hormone binding protein.  
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2.2.4  Linkage Disequilibrium 
The linkage disequilibrium (LD) pattern and haplotype block delineation 
were determined using Haploview software version 4.0.51. Blocks were defined 
using the confidence interval method described by Gabriel et al. (2002) as 
implemented in Haploview software. Our sample showed a modest LD in the 
CRH, CRHBP and CRHR1 gene coding regions represented by one LD block in 
of 26 kb, 8 kb and 22 kb respectively (Figure 2.1). 
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Figure 2.1. The 5' to 3' gene structures, respective chromosome tracks and r2-
based linkage disequilibrium (LD) structures of CRH system genes included in 
this study. A, CRH; B, CRHR1 and C, CRHBP LD structures, spanning across 31 
kb, 25 kb and 47 kb respectively. Boxes and lines represent exons and introns. 
Arrows represent location of tSNPs in relation to the gene coding region. 
Average distance between SNPs was 7.75 kb for CRH, 3.57 kb for CRHBP and 
4.10 kb for CRHR1. Inset shows expected haplotype frequencies for each block 
based on HapMap CEU populations. dbSNP information for each SNP is 
presented in Table 2.2. SNPs associated with cortisol reactivity are marked by an 
asterisk. 
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2.2.5 Stress task and cortisol sampling procedure 
The stress task and cortisol sampling procedures for this study are 
described in greater detail previously (Kryski et al., 2011) and are outlined in brief 
here. Several steps were taken to increase the accuracy with which children’s 
baseline cortisol levels were indexed. First, to eliminate the influence of a novel 
laboratory setting, which has been shown to increase children’s cortisol (Donzella 
et al., 2008), cortisol data were collected during a visit to the family’s home by a 
female experimenter whom the child had met previously during a laboratory visit 
unrelated to the present study.  All visits began between 12:00 pm and 3:30 pm 
to minimize the effects of diurnal variation on cortisol samples (de Weerth, Zijl & 
Buitelaar, 2003; Donzella et al., 2008). Caregivers were asked to prevent 
children from eating or drinking for a half hour prior to the visit to minimize the 
influence of food/drink on cortisol assays (Magnano, Diamond & Gardner, 1989; 
Schwartz et al., 1998). None of the children were taking corticosteroids. Finally, 
the visit began with the child and a familiar experimenter playing quietly with a 
set of unexciting toys to allow any effect of the experimenter’s arrival on 
children’s cortisol to dissipate. After 30 minutes of quiet play, a baseline salivary 
cortisol sample was collected, followed by the stress task described below.   
The stress task was designed to emphasize social evaluation under 
motivated and uncontrollable circumstances, which has been shown to elicit 
large cortisol responses in both adults (Magnano, Diamond & Gardner, 1989) 
and preschool-aged children (Dickerson & Kemeny, 2004; Gunnar, Talge & 
Harrera, 2009). Briefly, each child attempted to complete a matching task by 
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matching coloured game pieces to animal icons based on an answer key. A large 
toy replica of a traffic light was placed adjacent to the board, and the child was 
instructed that the traffic light would show how much time they had to complete 
the task and win a prize, with “green” indicating that they had time to work, and 
“red” indicating that they were out of time. The experimenter surreptitiously 
controlled the traffic light via remote control to that no child could complete the 
task on time during any of the three trials conducted. The mean duration of the 
task for children who completed all three trials was 15.01 min (SD = 1.5), 
including the instruction period. Supporting the validity of this task as a means of 
inducing stress, our group has previously shown that it successfully elicited a 
mean increase in children’s cortisol, and that child negative affect increased as a 
result of participating in this task (Kryski et al., 2011). Following the stress task, 
the child and experimenter resumed quiet play while the remaining cortisol 
samples were collected every 10, 20, 30, 40, and 50 minutes.  
To obtain cortisol, children chewed on a 2-inch absorbent cotton dental roll 
until it was wet with saliva, which was expunged into a micro tube and frozen at -
20°C.  Studies consistently report high correlations in saliva to serum cortisol 
concentrations (Daniel et al., 2006; Dorn et al., 2009; Eatough et al., 2009). 
Saliva samples were assayed in duplicate using salivary cortisol enzyme 
immunoassay kit (Salimetrics, PA, USA). Optical density was read on a standard 
plate reader at 450 nm and corrected at 650 nm (Molecular Devices, Sunnyvale, 
CA, USA). All samples from the same child were assayed in the same batch with 
no duplicates varying more than 5%. The average intra- and interassay 
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coefficients were 3.5 and 5.1%. Standard curve and concentration of unknown 
samples were generated according to manufacturer’s instructions using a 4-
parameter sigmoid minus curve fit. Cortisol data were skewed and were therefore 
log10 transformed prior to all analyses, a standard procedure with human cortisol 
data (Schwartz et al., 1998).  
Three aspects of cortisol stress reactivity were examined. I calculated 
individual cortisol response for each participant by calculating post-stress-task 
cortisol change scores [baseline cortisol – peak cortisol post stress task], 
hereafter referred to as “baseline to peak change.” I also calculated the area 
under the curve (AUC) as a measure of cortisol response. The AUC is comprised 
two types of information; first, the intensity of the response or AUCi, and second, 
the total response as a function of time or AUCg (Figure 2.2). With 
endocrinological data, AUCg is assumed to be a measure more related to total 
hormonal output, whereas AUCI is a parameter that emphasizes the changes 
over time and is more related to sensitivity of the system (Fekedulegn et al., 
2007; Pruessner et al., 2010).  
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Figure 2.2. Cortisol response over 3 time points in an arbitrary dataset. AUCI is 
the area under the curve above the referent baseline measurement (shaded 
region). (Adapted from Fekedulegn et al., 2007). 
2.2.6 Behaviour measures 
 The child’s primary caregiver completed the Child Behavior Checklist 
(CBCL; Achenbach, 2001), a standardized parent report measure of the 
frequency and intensity of child behavioural and emotional problems exhibited in 
the last 6 months. Since I was primarily interested in the presence and severity of 
children’s specific internalizing disorder symptoms, alternative scale scores 
derived to be consistent with DSM-IV diagnostic criteria for disorders were used 
(Lengua et al., 2001) including empirically-derived scales indexing depression (α 
= 0.81) and anxiety (α = 0.77).   
2.2.7 Assessment of life stress 
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Several factors known to contribute to children’s early development were 
examined: familial chronic stress (Burge & Hammen, 1991); marital discord 
(Hammen, Brennan, & Shih, 2004); and socioeconomic status (SES; Lupien et 
al., 2000). The UCLA Life Stress Interview was used to assess chronic stress as 
reported by the primary caregiver. Trained Ph.D. students in clinical psychology 
gathered information from each child’s primary caregiver related to their intimate 
relationships, close friendships, social life, family relationships, childcare hassles, 
work, finances, health of the primary caregivers, and health of close family 
members (Adrian & Hammen, 1993; Hammen, 1991). The interviewer then 
assigned Likert style ratings to the level of stress present in each domain from 
low (1) to high (5). Reliability was assessed by having a second coder rerate the 
chronic stress descriptions for 12 of the interviews (average ICC = 0.78). Life 
stress ratings for each domain were averaged to create an average life stress 
variable.  
Primary caregiver reports of relationship adjustment were collected using 
the Dyadic Adjustment Scale (DAS; Spanier, 1976). The DAS is a 32-item 
questionnaire of marital adjustment designed for use with either married or 
unmarried cohabiting couples (Spanier, 1976). The instrument provides a global 
score of dyadic adjustment which can range from 0 to 151, with higher scores 
reflecting higher level of dyadic adjustment. For the purposes of this study, the 
global score were reverse-coded so that higher scores reflect greater marital 
discord. Previous research has demonstrated good psychometric properties 
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(Baillargeon, Dubois, & Marineau, 1986). The internal consistency for global 
dyadic adjustment was good (α = 0.83). 
 Family income was reported by one of the child’s caregivers as an index 
of family socio-economic status. This data was collected on a generic 
demographic form along with other basic demographic characteristics. Family 
income scores were generated that ranged from < $20,000 coded as 1 to income 
> $100,000 coded as 5. For the purposes of this study family income was reverse 
coded so that higher scores reflect lower family income and greater 
socioeconomic stress. Following Evans and colleagues (2013), an aggregate 
index of children’s cumulative stress exposure was created by first standardizing 
and then averaging these variables. This overall life stress aggregate, which isI 
referred to as “childhood stress” or CS, was used in all subsequent analyses. 
2.2.8 Data Analyses 
Descriptive statistics for children’s genotypes, gender, age, cortisol 
reactivity, CS and symptoms are presented in Table 2.1. Next, bivariate 
correlations between the main outcome measures were tested using Pearson 
correlation analysis (Table 2.1). I used linear regression to assess whether SNPs 
in the CRH, CRHR1 and CRHBP genes predicted child cortisol reactivity scores. 
I first considered single-SNP analyses that regressed cortisol reactivity on tSNP 
genotype (coded under  additive, recessive & dominant models). I also 
investigated whether epistatic interactions between CRH system polymorphisms 
predicted cortisol reactivity using regression models. I established the 
significance of genotype–mean cortisol reactivity using permutation-based 
  62
procedures (Schmidt et al., 2002, 2003a) that randomly assigned the sample 
cortisol reactivity scores to subjects (sampled without replacement) while holding 
each subject’s genotype fixed. This permutation method is preferred as it 
accounts for LD among SNPs in a haplotype block therefore conserving power 
compared to commonly used correction techniques such as the Bonferroni 
method (Schmidt et al., 2003b). For each analysis, the empirical P value was 
based on 10,000 permutations. I conducted these analyses using appropriate 
components of PLINK (Purcell et al., 2007). 
To examine whether CRH gene pathway tSNPs moderated associations 
between CS and child internalizing symptoms, multiple regression was used as 
implemented in the macro developed by Hayes (2012). This macro uses a 
regression-based path analytical framework for estimating direct and indirect 
effects in simple and multiple moderation models, two- and three-way 
interactions in moderation models along with simple slopes and regions of 
significance for probing interactions. Bootstrap methods are implemented for 
inference about indirect effects in both unmoderated as well as mediated 
moderation models. All predictor values were centered as needed.   
2.3  RESULTS 
2.3.1  Associations between study variables and CRH system gene 
polymorphisms  
We first looked at whether links existed between study demographics and 
cortisol reactivity measures. Table 2.4 presents correlations between all major 
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study variables. Cortisol response measures (i.e., AUCi, AUCg and baseline to 
peak cortisol change scores) were highly positively correlated with each other. As 
baseline to peak cortisol change and AUCi are highly correlated and capture the 
intensity of cortisol response, we chose to present only the AUCi as a dependent 
variable in subsequent sections. As is frequently found in the literature on cortisol 
reactivity, higher family income was associated with lower cortisol reactivity 
(Chen et al., 2010; Lupien et al., 2001) and with fewer depressive and anxious 
symptoms. Child sex was associated with symptoms such that girls had more 
anxious and depressive symptoms compared to boys in the sample. No 
significant associations between child sex and the three measures of cortisol 
response were found, as expected based on the literature (Mackinaw-Koons & 
Vasey, 2000; Stroud et al., 2004). Anxious symptoms were positively correlated 
with all measures of cortisol reactivity (AUCi, AUCg and baseline to peak cortisol 
change). All symptom measures were positively correlated. Finally, the CS 
measure was positively associated with all measures of cortisol response and 
internalizing symptoms, but negatively correlated with family income.   
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Table 2.4. Correlations among study variables 
  1 2 3 4 5 6 7 8 9 
1. baseline to peak change 
[peak – baseline] -- 
2. AUCi .881*** -- 
3. AUCg .686** .724*** -- 
4. PPVT -.026 .006 .003 -- 
5. Family Income -.074 -.090 -.123* .092 -- 
6. Child Sex .002 .030 -.008 .064 .009 -- 
7. Anxious Symptoms .116* .114* .117* .041 -.125* .133* -- 
8. Depressive Symptoms -.018 -.002 .006 -.032 -.120 .144** .313** -- 
9. Childhood stress .146** .141* .176** -.118* -.624** .017 .161** .264** -- 
Mean 0.065 .050 .180 111.98 3.76 1.498 1.258 1.273 0.096 
(SD) (0.053) (.090) (.123) (14.11) (1.10) (.500) (1.442) (1.533) (.645) 
Note: Child gender was coded as males = 0 and females = 1; Family income was coded as 1 = < $20,000; 2= $20,000-
$40,000; 3= $40,001-$70,000; 4 = $70,001-$100,000; 5 = > $100,001. AUCi = area under curve with respect to baseline; 
AUCg  = area under curve with respect to ground; PPVT = Picture Vocabulary Test–Fourth Edition (Dunn & Dunn, 1997). 
*p < 0.05; **p < 0.01; ***p < 0.001. 
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Regression analyses showed no significant associations between 
demographic variables and the 18 tSNPs genotypes in this study (ps > 0.11). Of 
the 18 tSNPs genotyped, only two tSNPs were significantly associated with 
cortisol reactivity or AUCi after correcting for multiple tests, CRHR1 tSNP 
rs17763104 and CRHBP tSNP rs10473984. The CRHR1 tSNP rs17763104 
genotypes predicted child AUCi under an ancestral recessive model, with the 
CRHR1 tSNP rs17763104 GG homozygote children having significantly lower 
cortisol reactivity (AUCi) relative to heterozygotes and AA homozygotes (β = 
0.13, se = 0.05, t = 1.98, p = 0.01) (Figure 2.3A). Similarly, an association also 
existed between children’s AUCi and CRHBP tSNP rs10473984 when coded 
under a recessive model (β = 0.05, se = 0.03, t =1.14, p = 0.02), such that the 
GG homozygote children had significantly higher AUCi than their counterparts 
who have at least one copy of the T allele (Figure 2.3B). 
An association also existed between children’s total cortisol response or 
AUCg and CRHBP tSNP rs10062367 and cortisol reactivity when coded under a 
recessive model (β = -0.04, se = 0.01, t = -2.74, p < 0.01), such that the GG 
homozygous children had significantly higher AUCg than children with at least 
one copy of the A allele (Figure 2.3C).
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2.3.2  CRHR1 haplotypes are associated with cortisol reactivity to stress  
One haplotype block extended distally across the gene and included four 
tSNPs from rs16969853 to rs1396862 (Figure 2.1B). There were five haplotypes 
with a frequency > 0.05 accounting for 94% of haplotype diversity. Figure 2.4 
shows the relationship between CRHR1 haplotype carriers inferred from the 22kb 
LD block and children’s cortisol reactivity measured via AUCi. Children with the 
GGTC and AAGC haplotypes had significantly lower cortisol reactivity than the 
GAGT, GGGC and GAGC haplotype groups (all ps < 0.05) but these two 
haplotypes were not significantly different in cortisol reactivity (all ps > 0.05). All 
four tSNPs were in strong LD for the 26kb CRH gene region. There were four 
haplotypes with a frequency of > 0.05 that accounted for 99% of haplotype 
diversity. Similarly two tSNPs were in strong LD in a 8kb CRHBP gene region (all 
ps > 0.23). There were two haplotypes with a frequency of > 0.05. The CRHBP 
haplotypes were also not associated with measures of cortisol reactivity (all ps > 
0.14).  
No links were found between the CRHR1 haplotypes and cortisol 
response measured via AUCg (all ps > 0.05). 
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Figure 2.4. Mean salivary AUCi as a function of CRHR1 haplotypes in linkage block 1 (Figure 2.1). Two haplotype groups 
showed significantly lower cortisol reactivity compared to the rest of the haplotype groups. 
Note: Inset represents pairwise comparisons between haplotype groups.   
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2.3.3 Gene–gene interactions and cortisol reactivity  
I also investigated pairwise interactions between tSNPs genotypes in 
predicting cortisol reactivity, finding effects of three tSNP pairs, illustrated in 
Figure 2.5. Regression analyses showed a significant interaction between two 
tSNP pairs on chromosome 8 and 17. The first significant interaction was 
between CRH rs9694082 and CRHR1 rs171441 (β = -1.10, se = 0.52, corrected 
p < 0.01; Figure 2.5A), such that CRHR1 rs171441 heterozygotes had 
significantly lower cortisol reactivity than their homozygous counterparts (all ps < 
0.01). Figure 2.5B illustrates the second significant interaction that was found 
between CRH rs11996294 and CRHR1 tSNP rs12944712 (β = -2.97, se = 0.50, 
corrected p < 0.01) such that carriers who were heterozygous for the CRH 
rs11996294 tSNP but homozygous for the rs12944712 G or A alleles had 
significantly higher cortisol reactivity than their rs12944712 GA heterozygous 
counterparts (all ps < 0.001). Figure 2.5C illustrates the interaction between the 
CRHR1 rs171441 and CRHBP rs32897 predicting child cortisol reactivity (β 
=1.41, se = 0.25, corrected p = 0.01). Carriers homozygous for the rs32897 G 
allele substitution had significantly higher cortisol reactivity compared to carriers 
with at least one copy of the rs32897 A allele (all ps < 0.01).  
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Gene-gene interactions also predicted overall cortisol response or AUCg. 
Figure 2.6A illustrates the interaction effect between CRHR1 tSNP rs242924 and 
CRHR1 tSNP rs12944712 genotypes predicting AUCg (β =2.81, se = 0.25, 
corrected p = 0.001) such that children heterozygous for the two tSNPs had 
lower cortisol response than children who were not heterozygous for these 
tSNPs. Figure 2.6B illustrates the interaction between CRHR1 tSNP rs16969853 
and CRH tSNP rs17689966 genotypes predicting child AUCg (β =2.07, se = 0.18, 
corrected p < 0.01) such that children homozygous for the G allele had lower 
cortisol response when compared to children who were either heterozygous or 
homozygous for the A allele.  
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Note: AUCg, area under curve with respect to ground; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin 
releasing hormone binding protein; Chr, Chromosome; tSNP, tagging-Single Nucleotide Polymorphism. *p < 0.05, ** p < 0.01, ***p < 
0.001.  
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2.3.4 CRH pathway tSNPs are associated with emerging symptoms of 
depression and anxiety 
Based on the hypotheses that the CRH system gene variants may 
contribute to depressive and anxious symptoms, I examined such links in this 
sample of preschoolers. Results of these analyses are presented in Table 2.5. I 
found significant main effects of the tSNPs and genotype on children’s symptoms 
of depression and anxiety. First, the CRH gene tSNP, rs9694082, was 
associated with child anxious symptoms (Figure 2.7A), such that the carriers for 
at least one copy of the G allele had significantly higher anxious symptoms than 
their counterparts homozygous for the C allele (t = 2.30, df = 368, p = 0.02).  
Similarly, the CRHR1 tSNP, rs242924, was also associated with 
symptoms of depression and anxiety in preschoolers (results presented in 
Figures 2.7B and 2.7C). Children who carried at least one copy of the G allele 
had significantly higher depressive (t = -2.48, df = 368, p = 0.01) and anxious 
symptoms (t = -2.27, df = 368, p = 0.02) compared to children homozygous for 
the T allele. 
One tSNP in the CRHBP gene region was also associated with child 
anxious symptoms (Figure 2.7D), such that children who were carriers of the 
major allele or A allele had significantly higher anxious symptoms than children 
carrying the minor allele or G allele (t = 3.67, df = 360, p < 0.01).  
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Table 2.5. Main effects of CRH system gene variants on emerging depressive and anxious symptoms. 
Depressive symptoms 
 
Anxious symptoms 
Gene (N=369) tSNP Additive model Allelic model Additive model Allelic model 
CRH p-value p-value 
rs9694082* 0.58 0.41 0.06 0.02 
rs6999100 0.92 0.85 0.65 0.71 
rs1870394 0.60 0.51 0.73 0.66 
rs11996294 0.16 0.06 0.75 0.25 
CRHR1 
rs12944712 0.19 0.20 0.80 0.55 
rs16969853 0.55 - 0.81 - 
rs242924** 0.26 0.01 0.05 0.05 
rs171441 0.81 0.14 0.97 0.31 
rs1396862 0.53 0.94 0.13 0.66 
rs17763104 0.22 0.27 0.47 0.68 
rs17689966 0.18 0.15 0.60 0.49 
CRHBP 
rs1715751** 0.32 0.08 0.15 0.01 
rs1715747 0.41 0.26 0.86 0.73 
rs32897 0.98 0.88 0.99 0.94 
rs7728378 0.48 0.31 0.29 0.31 
rs10062367 0.71 0.56 0.94 0.82 
rs10473984 0.08 0.11 0.37 0.22 
rs10514082 0.55 0.31 0.36 0.58 
Note: CRH, Corticotrophin releasing hormone; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin 
releasing hormone binding protein.  
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C.          D. 
 
Figure 2.7. CRH pathway gene tSNPs are associated with emerging symptoms of depression and anxiety. Results 
derived from the best genetic model are reported. Symptoms are plotted as a function of genotype for A) CRH tSNP, 
rs9694082, and anxiety symptoms; B, C) CRHR1 tSNP, rs242924, and depressive and anxious symptoms; D) CRHBP 
tSNP rs1715751 and depressive symptoms in preschoolers. *p < 0.05; **p < 0.01.  
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2.3.5 Interactions between CRH system gene variants and childhood stress 
predict cortisol response to stress in preschoolers 
In the next set of analyses, I examined whether the interactions between 
CRH system tSNPs and CS were associated with children’s cortisol AUCi (Table 
2.6). I found two tSNPs in the CRHBP coding region which acted as moderators 
of the association between CS and children’s AUCi. The first significant 
interaction term included CRHBP rs1715747 tSNP and CS. To understand the 
moderation effect, I plotted the association between cortisol and CS for the two 
allelic groups (Figure 2.8A). My analysis showed that children with at least one 
copy of the G allele showed higher AUCi, as CS levels increased (β = 0.09, se = 
0.02, p < 0.001, 95% CI: 0.04 – 0.13, N = 71); in contrast, the association 
between AUCi and CS in children homozygous for the T allele was not fully 
significant (β = 0.02, se = 0.01, p = 0.07, 95% CI: -0.00 – 0.03, N = 300).1 
I also found a similar evidence for moderation in the CRHBP gene variant 
as well. The interaction term for CRHBP rs32897 tSNP and CS was also 
significant (Table 2.6). I plotted the levels of CS for the two allelic groups (Figure 
2.8B). My analysis showed that children with at least one copy of the G allele 
showed higher AUCi as CS levels increased (β = 0.21, se = 0.04, p < 0.001, 95% 
CI: 0.13 – 0.29, N = 219); in contrast, the association between AUCi and CS in 
                                                        
1
 The gene-environment interaction term did not predict AUCg, p > 0.66.  
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children homozygous for the T allele was not significant (β = 0.01, se = 0.01, p = 
0.31, 95% CI: -0.01 – 0.03, N = 148).2 
  
                                                        
2
 Similar to rs1715747 tSNP, the interaction between the rs32897 tSNP and CS did not 
predict AUCg, p > 0.23.  
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Table 2.6. Interaction between CRH system tSNPs and childhood stress (CS) 
effect on stress response measured via cortisol AUCi. 
Gene SNP x CS model β se p-value 
CRH 
rs9694082 REC -0.01 0.02 0.59 
rs6999100 REC 0.00 0.02 0.99 
rs1870394 ADD -0.02 0.02 0.25 
rs11996294 REC -0.02 0.02 0.17 
CRHR1 
rs12944712 ADD 0.00 0.01 0.96 
rs16969853 ADD 0.01 0.02 0.73 
rs242924 ADD 0.01 0.01 0.95 
rs171441 REC -0.02 0.03 0.37 
rs1396862 ADD 0.01 0.02 0.69 
rs17763104 ADD 0.03 0.02 0.18 
rs17689966 REC 0.02 0.02 0.33 
CRHBP 
rs1715751 ADD -0.02 0.02 0.26 
rs1715747* DOM 0.24 0.01 0.04 
rs32897*** REC 0.19 0.04 0.00 
rs7728378 ADD 0.01 0.01 0.70 
rs10062367 REC -0.13 0.02 0.07 
rs10473984 ADD 0.00 0.02 0.91 
  rs10514082 ADD 0.02 0.02 0.41 
Note: SNP, single nucleotide polymorphism; AUC, area under curve; ADD, additive 
model; REC, recessive model; DOM, dominant model; CRH, Corticotrophin releasing 
hormone; CRHR1, Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin 
releasing hormone binding protein. 
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2.3.6 GxE between CRH system genetic variation and childhood stress predict 
emerging symptoms of depression and anxiety  
Based on recent findings (Heim et al., 2009), I investigated whether CRH 
pathway gene variation would moderate the link between CS and internalizing 
symptoms in preschoolers. I found three tSNPs which acted as moderators of the 
association between CS and children’s depressive or anxious symptoms. The 
interaction terms for CRHR1 rs242924 tSNP and CS were significant for both 
depressive and anxious symptoms (Table 2.7). I plotted levels of child depressive 
and anxious symptoms as a function of CS and CRHR1 rs242924 tSNP 
genotype (Figure 2.9A). My analysis showed that children with at least one copy 
of the G allele showed an increasing levels of depressive symptoms as the levels 
of CS increased (β = 0.20, se = 0.07, p < 0.001, 95% CI: 0.06 – 0.34, N = 275); in 
contrast, the link between depressive symptoms and CS in children homozygous 
for the T allele was not significant (β = 0.06, se = 0.13, p = 0.38, 95% CI: -0.07 – 
0.14, N = 96). Similarly, my analysis showed that children with at least one copy 
of the G allele showed increasing levels of anxious symptoms as CS increased 
(β = 0.58, se = 0.16, p < 0.001, 95% CI: 0.26 – 0.90, N = 275); in contrast, the 
link between anxious symptoms and CS in children homozygous for the T allele 
was not significant (β = 0.08, se = 0.18, p = 0.65, 95% CI: -0.28 – 0.44, N = 96; 
Figure 2.9B). 
I also found similar evidence for moderation in the CRHBP gene variant as 
well. The interaction term for CRHBP rs7728378 tSNP and CS was also 
significant (Table 2.8). I plotted levels of child depressive symptoms and CS for 
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the two allelic groups (Figure 2.9C). My analysis showed that children with at 
least one copy of the A allele showed an increasing levels of depressive 
symptoms as the life stress increased (β = 0.26, se = 0.29, p = 0.35, 95% CI: -
0.30 – 0.82, N = 217); in contrast, the link between depressive symptoms and CS 
in children homozygous for the G allele was not significant (β = - 1.16, se = 0.33, 
p < 0.001, 95% CI: 0.51 – 1.79, N = 145). 
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Table 2.7. Summary of interactions between CRH system tSNPs and childhood 
stress (CS) predicting emerging anxiety symptoms. Significant model p-values 
are in bolded text. 
Gene SNP x CS model β se p-value 
CRH 
rs9694082 REC 0.23 0.35 0.51 
rs6999100 REC 0.40 0.29 0.17 
rs1870394 ADD 0.32 0.30 0.28 
rs11996294 REC 0.16 0.26 0.54 
CRHR1 
rs12944712 ADD 0.20 0.23 0.38 
rs16969853 ADD -0.27 0.35 0.44 
rs242924* REC 0.38 0.18 0.03 
rs171441 REC -0.45 0.40 0.26 
rs1396862 ADD 0.02 0.27 0.93 
rs17763104 ADD 0.28 0.31 0.48 
rs17689966 REC 0.30 0.23 0.21 
CRHBP 
rs1715751 ADD -0.18 0.27 0.50 
rs1715747 DOM -0.13 0.27 0.62 
rs32897 REC 0.31 0.26 0.25 
rs7728378 ADD 0.08 0.19 0.66 
rs10062367 ADD 0.19 0.17 0.28 
rs10473984 ADD 0.32 0.37 0.17 
  rs10514082 ADD -0.06 0.30 0.85 
Note: SNP, single nucleotide polymorphism; ADD, additive model; REC, recessive 
model; DOM, dominant model; CRH, Corticotrophin releasing hormone; CRHR1, 
Corticotrophin releasing hormone receptor-1; CRHBP, Corticotrophin releasing hormone 
binding protein. *p < 0.05; †p < 0.10. 
 
 
 87 
 
Table 2.8. Summary of interactions between CRH system tSNPs and childhood 
stress (CS) predicting emerging depressive symptoms. Significant model p-
values are in bolded text. 
Gene SNP x CS model β se p-value 
CRH 
rs9694082† REC 0.43 0.25 0.09 
rs6999100 REC 0.20 0.28 0.48 
rs1870394† ADD 0.51 0.29 0.08 
rs11996294 REC 0.38 0.34 0.26 
CRHR1 
rs12944712 ADD 0.12 0.20 0.54 
rs16969853 ADD -0.36 0.34 0.29 
rs242924* ADD 0.47 0.18 0.01 
rs171441† REC -0.66 0.39 0.09 
rs1396862 ADD -0.13 0.26 0.62 
rs17763104 ADD 0.18 0.29 0.54 
rs17689966 REC 0.11 0.17 0.64 
CRHBP 
rs1715751 ADD 0.26 0.25 0.30 
rs1715747 DOM -0.20 0.18 0.25 
rs32897 REC -0.13 0.22 0.55 
rs7728378* ADD -0.42 0.18 0.02 
rs10062367 REC 0.58 0.26 0.58 
rs10473984 ADD -0.55 0.36 0.13 
  rs10514082 ADD 0.30 0.31 0.34 
Note: SNP, single nucleotide polymorphism; ADD, additive; REC, recessive; DOM, 
dominant; CRH, Corticotrophin releasing hormone; CRHR1, Corticotrophin releasing 
hormone receptor-1; CRHBP, Corticotrophin releasing hormone binding protein. *p < 
0.05; †p < 0.10.  
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C. 
 
Figure 2.9.  Relationship between levels of childhood stress and emerging 
symptoms by CRHR1 tSNP rs242924 (A, B) and CRHBP tSNP rs7728378 (C) 
genotypes.  
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2.4  DISCUSSION 
The first aim of this study was to explore links between genetic variation of 
the CRH system genes and children’s cortisol responses to stress. Analyses 
found evidence for associations between CRH pathway gene variations and both 
the intensity (measured via AUCi) and total hormonal response measured via 
AUCg. Specifically, tSNPs of the CRHR1 and CRHBP gene-coding regions were 
associated with preschoolers’ cortisol responses to stress. The CRHR1 tSNP, 
rs17736104 was associated with childhood AUCi. Even though the CRHR1 tSNP 
rs17763104 is intronic, it is likely that this SNP is flanked by nonsynonymous 
SNPs in CRHR1 gene exons 6 through 8. Although speculative, it is possible that 
one of these SNPs may have functional effects on CRHR1 gene transcription, 
thus influencing the number of functional CRH receptors on the pituitary gland 
leading to changes in the release of ACTH, and ultimately affecting cortisol 
release from the adrenal gland. Recent research indicates that most CRHR1 
isoforms are a result of splicing variation within the exon 6 through 10-coding 
regions (van Pett et al., 2000). Furthermore, intronic SNPs have also been 
shown to exert functional effects on gene expression when the intron is part of 
the gene’s regulatory region. It is likely that this tSNP may be linked to such a 
variant, which may be regulating the CRHR1 gene expression. Future research is 
needed to investigate the functional effects this SNP and either the regulatory 
nature or the alternatively spliced variants from this coding region on ACTH 
release from the pituitary and stress sensitivity.  
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I also found associations between CRHR1 haplotypes and cortisol 
reactivity. Children with the GGTC and AAGC haplotypes showed significantly 
lower cortisol reactivity than those with the GAGT, GGGC and GAGC 
haplotypes. The linkage block that encompasses these haplotypes contain exons 
code for the transmembrane parts of the mature CRHR1 protein. It is plausible 
that the genetic variation in this region may lead to changes in the 
transmembrane protein structure, which initiates downstream signaling of this g-
protein couple receptor. Differences in downstream activation could lead to 
altered release of ACTH and eventually cortisol release from the adrenal 
medulla. Animal knockout research lends some support to this hypothesis by 
showing that the CRHR1 gene is critical for normative cortisol reactivity to stress. 
To my knowledge, my study is the first to show that common genetic variation of 
the CRHR1 gene loci is also associated with differences in cortisol reactivity in 
children.  
Association also existed between CRH system gene variants and 
emerging symptoms of depression and anxiety. Specifically, the CRH rs9494082 
and CRHBP rs1715751 were associated with anxious symptoms, whereas the 
CRHR1 tSNP, rs242924, was associated with depressive symptoms. I also found 
evidence for gene-environment interaction between CRH pathway genes and CS 
on emerging symptoms of depression, with the interaction between CRHR1 tSNP 
rs242924 and CS predicting symptoms of depression. Although no main effect of 
these variants on depression or anxiety has been reported, a few studies have 
implicated these variants in gene-environment interactions REFS. For example, 
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polymorphisms within this region of the CRHR1 gene, and rs110402 and 
rs242924 SNP genotypes in particular, have been shown to moderate the link 
between early childhood maltreatment and the development of depressive 
symptoms later in life (Bradley et al., 2008; Heim et al., 2009; Polanczyk et al., 
2009; Wasserman et al., 2009; Grabe et al., 2010), suggesting genetic 
differences are shaped by the environment in CRH-dependent 
neurotransmission. Similarly, Tyrka and colleagues (2009) report that variation in 
the CRHR1 gene, and rs242924 GG homozygotes in particular, moderated the 
effect of childhood maltreatment on cortisol responses to the 
dexamethasone/corticotrophin-releasing hormone test. Thus, pathways between 
CRH system genes and negative outcomes are clearly complex, with evidence 
for both moderation and main effects. These findings contribute to this literature, 
showing that the CRH system genetic variation is associated with early stress 
reactivity and could act as a moderator of CS’ effects on emerging risk for 
psychopathology.  
My analysis also showed that a tSNP in the CRHBP-coding region, 
rs10473984 was associated with intensity of cortisol reactivity, and that CRHBP 
rs10062367 genotype was associated with total cortisol response or AUCg. 
Additionally, the interaction between CRHBP tSNP rs7728378 and CS also 
predicted childhood symptoms of depression. Once again, children homozygous 
for the major allele (A allele) showed greater depressive symptoms as a function 
of life stress; however, this relationship was nonsignificant for children with at 
least one copy of the minor allele or the G allele. Since 65–90% of total CRH is 
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bound to CRHBP (Jahn et al., 2005), the effectiveness of CRH in stimulating 
ACTH to release cortisol may be influenced by a variation in CRHBP expression.  
A number of recent studies have focused on the CRHBP gene as a 
candidate gene for stress-related disorders such as major depression and 
suicidality (De Luca et al., 2010). A study by Binder and colleagues (2010) report 
that allelic variants of rs10473984 are associated with higher ACTH 
concentrations, and these data extend this finding by showing this SNP is 
associated with early childhood cortisol reactivity as well. Although this SNP is 
30kb upstream of the gene-coding region, it is likely that it is in linkage with 
SNP(s) with functional consequences, resulting in decreased affinity for free 
CRH, thus increasing the bioavailability of CRH to activate its receptor, the 
CRHR1. Such a functional change could lead to an increase in subsequent 
ACTH release from the pituitary gland and downstream cortisol release from the 
adrenal glands. Recent work by Enoch et al. (2008) provides some support for 
this speculation, identifying a second CRHBP isoform in the brain in which the 
terminal exon (exon 7) is spliced out, resulting in a truncation of the messenger 
RNA, such that the C-terminus of ancestral 52 amino acids is truncated to only 
18 amino acids. This change in peptide sequence might affect protein folding and 
stability, which might alter CRH binding affinity. Further research including ultra-
deep sequencing of this region and molecular analyses are needed to explain the 
role of the genetic variation in this region and HPA axis function.  
I also found evidence for gene-gene interactions predicting both AUCi 
cortisol reactivity and total cortisol response. The interactions between CRH 
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rs9698042 and CRHR1 rs171441 were such that children heterozygous for the 
CRHR1 rs171441 showed lower cortisol reactivity than the homozygotes for 
these loci. The second interaction, between CRH rs11996294 and CRHR1 
rs12944712 also predicted lower cortisol reactivity for heterozygotes at both gene 
loci. Although I did not find any main effects of genetic variation in the CRH gene 
on cortisol reactivity, the interaction between the CRH and CRHR1 tSNPs 
indicates that CRH gene variants are important in HPA axis function, but only by 
virtue of epistatic effects. An interaction between CRHR1 rs171441 and CRHBP 
rs32897 also predicted cortisol reactivity such that children homozygous for the 
rs32897 GG genotype showed significantly higher cortisol reactivity than the A 
allele carriers. The rs32897 tSNP has been implicated in other studies examining 
the genetic bases of alcoholism (Enoch et al., 2008) and inflammation (Velez et 
al., 2008). However, the interaction I found between the loci on the CRHR1 and 
CRHBP genes and cortisol reactivity is novel. Taken together, the presence of 
multiple interactions between genes that shape different levels of the HPA 
signaling cascade highlights the complex nature of the genetic bases of HPA 
function in humans. 
Overall, these findings illustrate an important relationship between genetic 
variation of the various CRH system genes and early cortisol reactivity and the 
role of these variants in emerging risk for internalizing symptoms. Additionally, 
these findings support and extend recent adult literature where CRH system 
genes were found to moderate the early environment on psychopathological risk. 
These findings have the potential to shed light on the mechanisms involved in the 
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transmission of risk and the origins of stress sensitivity and resilience observed in 
disorders such as major depression and post-traumatic stress disorder. I 
demonstrated that cortisol reactivity to stress in humans has complex polygenic 
underpinnings.   
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Chapter 3 - Catechol-O-Methyltransferase gene (val158met) polymorphisms 
and anxious symptoms in early childhood: The roles of hypothalamus-
pituitary-adrenal axis reactivity and life stress 
 
3.1 Introduction 
Catechol-O-methyltransferase (COMT), a catabolic enzyme that degrades 
cortical catecholamines including dopamine and epinephrine, plays a vital role in 
regulating prefrontal cortex catecholamine levels (Meyer-Lindenberg & 
Weinberger, 2006). The gene encoding COMT (Gene ID: 1312) is mapped to 
chromosome 22p11, and contains four exons (Brahe et al., 1986). Further, a 
non-synonymous G→A single nucleotide polymorphism (rs4680) in exon four 
leads to a valine (val) to methionine (met) peptide change in the mature protein, 
and is called the val158met polymorphism. This substitution impacts the 
thermostability of the COMT protein and reduces the enzyme’s catabolic 
function, thereby reducing dopamine degradation in carriers with at least one 
copy of the met allele by more than one-third compared to carriers homozygous 
for the val allele (Lotta et al. 1995; Chen et al. 2004). Thus, functional differences 
in catecholinergic activity due to this genetic variation appear to lead to individual 
differences in cortical dopamine availability, which may account for associations 
between this gene and various forms of psychopathology (Dickinson & Elvevag, 
2009). For example, Hamilton and colleagues (2002) reported an association 
between the COMT val158met polymorphism and panic disorder in a family-
based sample of 83 parent-offspring triads. Additionally, the val allele has been 
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associated with early-onset major depression (Massat et al., 2005), and other 
studies have shown that this variant may increase risk for panic disorders and 
anxiety in adults (Rothe et al., 2006; Domschke et al., 2007; Hosak, 2007). A 
recent study from our group reported associations between the val158met 
polymorphism and emerging symptoms of depression and anxiety in two large, 
independent community samples of preschoolers (Sheikh et al., 2013). 
Specifically, in both samples, val homozygous children exhibited significantly 
higher symptoms of depression and anxiety compared to children with at least 
one copy of the met allele.  
In addition to main effects on the development of symptoms, a few studies 
have implicated this gene in gene-environment interactions. For example, 
Baumann and colleagues (2013) reported that an interaction between childhood 
adversity and the COMT gene locus predicted anxiety sensitivity and anxious 
apprehension. Similarly, an interaction between COMT genotype and childhood 
trauma predicted risk for psychotic symptoms in adolescents; specifically, val 
homozygotes who were also exposed to childhood trauma also reported more 
psychotic experiences compared to met allele carriers (Ramsay et al., 2013). 
Other studies have linked interactions between the val158met polymorphism and 
childhood maltreatment in shaping cognitive performance, neuroticism, and risk 
for alcohol dependence (Goldberg et al., 2013; Hoth et al., 2006; Schellekens et 
al., 2013). Taken together, recent literature suggests that the val158met 
polymorphism may moderate the effect of childhood adversity on a broad 
spectrum of psychological outcomes later in life, and could hold etiological 
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significance for internalizing disorders. However, research is still lacking on 
whether an interaction between COMT genotype and life stress predicts early 
symptoms of internalizing disorders. 
In addition to gene-environment interactions, a parallel line of research 
has also focused on identifying the mechanistic processes (i.e., mediators) 
through which COMT functional variance may contribute to maladaptive 
outcomes. The hypothalamic–pituitary–adrenal (HPA) axis is widely posited to be 
one such mediator of links between neurotransmitter gene function and risk for 
future psychopathology (Charney, 2004; Krishnan & Nestler, 2008; McEwen, 
1998; Mokrani et al., 1997; Pitchot et al., 2003). Dopaminergic metabolism is 
known to regulate endocrine stress reactivity primarily by affecting extra-
hypothalamic brain structures that regulate HPA axis functioning, such as the 
prefrontal cortex, hippocampus and the amygdala (for in depth reviews see 
Locatelli et al., 2010; Vermetten & Bremner, 2002). For example, distribution of 
dopamine was found to alter HPA axis reactivity in rodents and non-human 
primates exposed to early life stressors paradigms such as maternal separation 
and glucocorticoid administration (Kofman, 2002; Macri et al., 2009; Posener et 
al., 1994, 1999). Additionally, the altered HPA axis functioning was linked to 
anhedonia-like symptoms and high anxiety-like traits. Taken together, the extant 
literature suggests a link between catecholamine metabolism and HPA axis 
function (Moghaddam, 2002), and it is plausible that genetic variations leading to 
functional differences within the catecholamine system, such as the COMT 
val158met polymorphism, may also be linked to HPA axis reactivity.  
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In a complementary line of research, studies have implicated COMT 
val158met variation in stress sensitivity. For example, in a community sample of 
adults, Jabbi and colleagues (2007) showed that the COMT met/met genotype 
was associated with increased adrenocorticotropic hormone responses, although 
the authors did not test cortisol function. Similarly, a recent study conducted in a 
large community sample of adolescents demonstrated an association between 
the COMT val158met polymorphism and cortisol reactivity to stress (Bouma et 
al., 2012). However, the link between genotype and stress reactivity was gender-
specific, such that boys with the met homozygous genotype had higher cortisol 
levels than boys with the val homozygous genotype. Conversely, girls with the 
val homozygous genotype had stronger cortisol responses than the met allele 
carrier girls (Bouma et al., 2012). Recently, in a sample of 8-year-olds, met 
homozygotes were reported to have a higher cortisol response to psychosocial 
stress task when compared to heterozygotes and val homozygotes (Armbruster 
et al., 2011). A brief review of these studies suggests a link between the COMT 
val158met polymorphism and HPA axis function, but the literature is inconsistent 
on the allele associated with cortisol reactivity. Considering the importance of 
cortisol reactivity in the etiology of various mood disorders (McEwen, 2008), 
further research is needed to clarify the link between the val158met 
polymorphism and HPA axis response. 
In sum, separate lines of research show links between COMT val158met 
polymorphism and emotional problems. Literature also suggests that interactions 
between the COMT functional polymorphism and early life stressors may predict 
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psychological outcomes later in life. Additionally, research suggests that the link 
between catecholamine signaling and risk for emerging internalizing symptoms 
may be influenced by psychophysiological response of the HPA axis (Bouma et 
al., 2012). However, whether these processes are at play during early childhood 
and contribute to early symptoms of internalizing disorders has not yet been 
explored. To address these gaps in knowledge, we investigated whether the 
COMT val158met polymorphism would be associated with cortisol responses to 
stress in a community sample of preschoolers. We also explored whether early 
cortisol function mediated links between COMT and emerging symptoms. Finally, 
in an effort to understand the process through which the gene-environment 
interactions may influence early behaviour, we developed an integrated pathway 
(Figure 3.1) where we tested the role of these variables on emerging symptoms 
using path analysis.  
3.2 Methods 
Detailed sample demographic are provided in Chapter 2, pg. 42. Sample 
demographics by COMT genotype are presented in Table 3.1. Children's mean 
age was 36.2 months (SD = 0.16). As in the previous chapter, population 
stratification was minimized by restricting all analyses to include Caucasian 
participants (N = 371) only. 
3.2.1 Genotyping 
Genomic DNA was purified from buccal swab cellular extracts and stored 
according to manufacturer instructions (Qiagen, Valencia, CA, USA). The rs4680 
(val158met) SNP was genotyped using a TaqMan allelic discrimination assay 
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(Assay ID: C_25746809_50), developed for use on the StepOne® instrument 
(Applied Biosystems, Foster City, California). Polymerase chain reactions were 
performed in 10µL reaction volumes in 48-well plates and contained 10 ng of 
DNA. Thermal cycler conditions were 95 °C for 10 min and then 40 cycles of 95 
°C for 15 s and 60 °C for 1 min. The SDS 2.2 software (Applied Biosystems) was 
used for allelic discrimination. For quality control, 10.0% of the samples were 
randomly chosen and genotyped as duplicates across and within a 48-well plate. 
All genotyping was performed by technicians blind to other study data. 
  
  
Figure 3.1. Schematic diagram of the human 
are represented by lines. The location of the rs4680 
et al., 1986). 
 
 
COMT gene. Exon positions are indicated by solid black blocks and introns 
val158met polymorphism in exon 4 is indicated
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 (adapted from Brahe 
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3.2.2 Behaviour and childhood stress measures 
Similar to Chapter 2, we used the child’s primary caregiver reports on the Child 
Behavior Checklist (CBCL; Achenbach, 2000). The stress task used to illicit children’s 
cortisol responses to stress was described on page 54. As described in Chapter 2 (p. 
58), the overall life stress aggregate score was used as a measure of stress during 
childhood in all analyses in this chapter and will be referred to as CS (i.e., childhood 
stress). 
3.2.3 Data Analyses 
To test the hypothesis that COMT val158met genotype moderated the influence 
of CS on emerging symptoms of anxiety and depression, I analyzed the interaction 
between life stress and genotypes using a macro for PASW developed by Hayes (2013) 
with parent reports of children’s anxious and depressive symptoms as the dependent 
variables. This macro uses a regression-based framework for testing two-way 
interactions in moderation models along with simple slopes. All predictor values were 
centered as needed.  This same macro was used to test the hypothesis that HPA axis 
reactivity mediates the link between COMT genotype and emerging symptoms. This 
method uses a bootstrapping procedure which yields mean direct and indirect 
(mediated) effects. The test also generates confidence intervals (CIs) for the means. 
The estimated effect is only significant at a p-value less than 0.05, when CIs do not 
contain a ‘zero’ within them. For further details on this method, see Hayes (2013). All 
analyses were performed using the PASW 20 (IBM Inc., USA). All statistical tests were 
two-tailed with alpha set at p = 0.05.   
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Finally, I tested the integrated pathway in Figure 1.3 using a path analysis 
framework using Mplus software. Path analysis is a form of structural equation 
modeling, which takes a confirmatory (i.e., hypothesis testing) approach to the 
multivariate analysis of a structural model (Byrne, 1998). Using this method, the causal 
associations under investigation are represented by a series of structural (i.e., 
regression) equations, and these structural equations are modeled pictorially (Byrne, 
1998). The chi-square statistic is used as a measure of fit between the sample 
covariance and fitted covariance matrices (Byrne, 1998). The higher the probability 
associated with chi-square, the closer the fit between the hypothesized model and 
perfect fit. In addition, other indices are used to assess the appropriateness of the 
proposed model to the sample data. These indices include the goodness of fit index, the 
non-normed fit index, and the comparative fit index. Values for these indices, in the mid 
.90 range and above, are indicative of optimal fit (e.g., Hu & Bentler, 1995; Schumaker 
& Lomax, 1996). Furthermore, the Root Mean Square of Approximation (RMSEA) is yet 
another fit index which takes into account the error of approximation in the population 
(Byrne, 1998). Values less than .05 indicate good fit, and values of .08 or less indicate 
acceptable fit (Byrne, 1998), whereas values of .08 to .10 indicate mediocre fit, and 
values above .10 indicate poor fit (MacCullum, Browne, & Sugawara, 1996). 
3.3 Results 
3.3.1 Associations between COMT val158met polymorphism and major study variables 
The genotype frequencies were as follows: 118 children (29.4%) were val 
homozygous, 190 (46.3%) were heterozygous, and 93 (23.2%) children were 
homozygous for the met substitution. This distribution was in Hardy-Weinberg 
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equilibrium (χ21, 400 = 0.95, p = 0.33). Demographic variables such as child gender and 
family income were not associated with child genotype (all ps > 0.22). However, positive 
associations existed between child gender and symptoms of depression (F1, 369 = 17.89, 
p < 0.01) and anxiety (F1, 369 = 13.50, p = 0.01); therefore, child sex was used a 
covariate in subsequent analyses. No associations existed between COMT genotypes 
and child gender (χ24, 380 = 1.73, p = 0.23) or family income (F1, 368 =.005, p = 0.94). No 
evidence for associations existed between COMT genotype and child depressive 
symptoms (mean difference: 0.13, t = 1.22, p = 0.31), but there was a significant 
association between COMT genotype and child anxious symptoms (mean difference: 
0.25, t = 6.74, p < .05). Specifically, children homozygous for the val allele had 
significantly lower symptoms of anxiety when compared to children with at least one 
copy of the met allele. 
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Table 3.1 Demographic and study variables by child COMT val158met genotype.  
COMT genotypes 
val/val (N = 113) val/met + met/met (N = 287) 
 Variable Mean  SD N Mean  SD  N 
Sex (N, boys) 61 134 
PPVT 111.94 12.87 112.04 14.59 
Family income 3.69 1.19 3.75 1.12 
Cortisol response [peak – baseline]* 0.05 0.01 0.03 0.01 
AUCi† 0.06 0.13 0.04 0.09 
AUCg 0.20 0.16 0.18 0.12 
Depressive symptoms 1.38 1.62 1.25 1.62 
Anxious symptoms* 1.40 1.69     1.15 1.29   
Note: AUC = area under curve; PPVT = Peabody picture vocabulary test; val = valine; met = methionine. Family income 
coded as 1 = < $20,000, 2 = $20,001 – $40000, 3 = $40,001 - $70,000, 4 = $70,001 – $100,000, 5 = >$ 100, 001. 
†p ≤ .10, *p < .05. 
 
 
  
  
Figure 3.2 shows the analysis of stress reactivity as a function of 
genotype. I found significant group differences in individual cortisol change scores [peak 
cortisol response – baseline cortisol], such that children homozygous for the 
had significantly higher cortisol reactivity compared to the children with at least one
copy of the met allele (F1, 356 = 3.80, 
the level of a trend (p = .08) when AUC
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3.3.2 HPA axis reactivity mediates the link between COMT val158met polymorphism 
and child clinical symptoms 
I also conducted mediation analyses to examine whether links between COMT 
genotype and emerging symptoms of depression or anxiety were mediated by child 
cortisol reactivity. As a precondition for testing mediation, associations must be present 
between the predictor and the outcome, the predictor and the hypothesized mediator, 
and the hypothesized mediator and the outcome (Baron and Kenny, 1986). Table 3.1 
shows the associations between COMT genotype and anxiety symptoms, and COMT 
genotype and cortisol reactivity measured via baseline to peak cortisol change. After 
confirming the significant association between cortisol reactivity and anxiety symptoms 
(r = 0.13, p < 0.01), I proceeded with the mediation analysis. The bootstrapping 
procedure showed a significant estimate of the indirect effect of COMT genotype on 
anxiety symptoms mediated via child cortisol reactivity (B= -0.06, 95% CI: -0.17 to -
0.01). The analysis also showed that the direct association between COMT genotype 
and anxiety symptoms was also significant, indicating that the genotype-symptoms link 
was only partially mediated by child cortisol reactivity (Figure 3.3).3   
                                                        
3
 I also modeled child depressive symptoms as the dependent variable in my mediation pathway 
but analysis showed that this model was not significant suggesting that the link between COMT genotype 
and depressive symptoms was not mediated by cortisol response to stress. 
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Figure 3.3. Cortisol reactivity in early childhood mediates the link between the COMT gene and anxious symptoms. * p < 
0.05, ** p < 0.01.  
Note: Child COMT val158met genotype coded as 0 = val/val genotype, 1 = val/met or met/met genotype; cortisol reactivity 
was measured via cortisol reactivity [baseline – peak cortisol post-stress task]; c = coefficient for direct path between child 
COMT genotype and anxious symptoms; c’ = coefficient for path between child COMT genotype and anxious symptoms, 
mediated by cortisol reactivity. 
  
Cortisol 
reactivity 
-0.08 (0.04)* 0.55 (0.22)** 
COMT  
val158met 
Anxious symptoms 
c’ = -0.10(0.17)* 
c = -0.04 (0.04)* 
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3.3.3 COMT val158met polymorphism and childhood life stress interact to predict 
emerging symptoms of anxiety but not depression 
In an effort to replicate and extend findings where an interaction between COMT 
val158met and CS was associated with adult internalizing symptoms (Ramsey et al., 
2013), I tested this interaction in this sample of preschoolers. The interaction term for 
COMT genotype and CS did not predict child depressive symptoms (β = 0.54, se = 
1.03, p = 0.73), but the interaction term was significant for child anxiety symptoms (β = 
4.38, se = 1.98, p = 0.03). Analyses showed that children homozygous for the val allele 
exhibited higher symptoms of anxiety with increasing life stress (β = 3.30, se = 1.14, p < 
0.01), but the interaction between genotype and life stress was nonsignificant in the met 
allele carriers (β = -1.08, se = 1.62, p = 0.51; Figure 3.4).  
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3.3.4 Path analyses 
Figure 3.5A shows the results of our path analyses, which aimed to test the 
integrated model of psychological risk based on Figure 1.3. CS was positively 
associated with baseline to peak cortisol change (β = 0.28, p = 0.001), and significant 
associations were found between genotype and cortisol response (β = -0.06, p < 0.05). 
Child cortisol reactivity was also positively associated with symptoms of anxiety (β = 
0.61, p < 0.01). The overall model fit was very good as indexed by chi-square (χ2 = 
25.61, df = 7, p < 0.001), as well as the root mean square error of approximation 
(RMSEA=.00) and the normed fit index, which was 1.00. 
In the next path analysis (Figure 3.5B), we modeled AUCi as an index of total 
cortisol produced post-stress task. Analysis showed that CS was positively associated 
with AUCi (β = 0.19, p = 0.03), although nonsignificant associations were found between 
genotype and this index of cortisol response (i.e., AUCi, β = -0.05, p = 0.30). Child AUCi 
was positively correlated with symptoms of anxiety (β = 0.12, p = 0.01). The overall 
model fit was very good as indexed by chi-square (χ2 = 20.46, df = 7, p < 0.001), as well 
as the root mean square error of approximation (RMSEA=.00) and the normed fit index, 
which was 1.00. 
In our third model (Figure 3.5C), we modeled AUCg as an index of total cortisol 
produced post-stress task. Childhood life stress was positively associated with AUCg (β 
= 0.11, p = 0.001) and positive associations were also found between genotype and 
cortisol response measured via AUCg (β = -0.04, p < 0.05). Child cortisol reactivity was 
also positively correlated with emerging symptoms of anxiety (β = 0.13, p = 0.01). The 
overall model fit was very good as indexed by chi-square (χ2 = 23.70, df = 7, p < 0.001), 
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as well as the root mean square error of approximation (RMSEA=.00) and the normed 
fit index, which was 1.00.4 
 
  
                                                        
4
 We also modeled parent reports on child depressive symptoms as a dependent variable in our 
path analysis. However, the overall fit for these models were poor when baseline to peak cortisol change 
(RMSEA = 0.14, fit index = 0.31), AUCi (RMSEA = 0.10, fit index = 0.55) and AUCg (RMSEA = 0.11, fit 
index = 0.53) were used in the path analyses. 
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Figure 3.5. Pathway analysis. The path shows interaction between COMT val158met genotype and early life stress as 
predictor of child anxious symptoms via baseline to peak cortisol change (A), AUCi (B) and AUCg (C). Child anxious 
symptoms are based on parent reports from the Child Behavior Checklist (Achenbach et al., 1991). Standardized β-
weights are shown for each path. †p ≤ 0.10, *p < 0.05, **p < 0.01, ***p <0.001. 
Note: val, valine; met, methionine; AUCg, Area under curve with respect to ground.
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3.4 Discussion 
In this study, I examined whether the COMT val158met genotype and CS 
were linked to emerging symptoms, and whether cortisol reactivity in children 
played a role in this pathway. Based on previous literature linking 
neurotransmitter gene polymorphisms and cortisol reactivity to stress (Derijk et 
al., 2009; Wust et al., 2009), my first set of analyses examined whether the 
COMT val158met genotype predicted early childhood cortisol reactivity to stress. 
I found significant associations between the COMT val158met genotype and 
cortisol reactivity such that children with two copies of the val allele had 
significantly higher cortisol reactivity compared to children with at least one copy 
of the met allele. These findings are consistent with previous studies in adults 
that have found a link between the val allele and higher cortisol reactivity (Jabbi 
et al., 2007; Ramsey et al., 2013). However, a recent study in 8-12-year-olds 
found that the met allele was linked to higher cortisol reactivity to the Trier Social 
Stress Task or TSST (Armbruster et al., 2012). The inconsistency in findings 
could be due to a few reasons. The TSST-C is not only a social stressor but also 
a cognitive challenge compared to the stress task used in the current study, 
which is based on the social evaluative threat model (e.g., threat of social 
rejection and evaluation). Although speculative, it is possible that the nature of 
the stressor is differentially related to catecholamine activity. Supporting this 
notion, studies have documented that met allele carriers perform better at 
cognitive tasks compared to val allele carriers (Dumontheil et al., 2011; Egan et 
al., 2001; Mier et al., 2010). However, additional research is needed to clarify 
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whether associations between COMT val158met polymorphism differ depending 
on stressor paradigms. Also, when compared to previous studies such as 
Armbruster and colleagues (2012), additional factors such as the younger age of 
this sample and a larger sample size may have contributed towards the 
differences in findings.5   
In addition to the association between the COMT val158met polymorphism 
and cortisol reactivity in children, we also found evidence for mediation of links 
between COMT genotype and emerging anxious symptoms by cortisol reactivity. 
Extant literature is scarce on findings where HPA axis function is demonstrated 
to mediate the link between a dopamine gene functional polymorphism and 
emotional problems such as anxiety or depression. A recent study from Burghy 
and colleagues (2013) demonstrated that HPA axis function is linked to anxiety 
symptoms in adolescents via reduced activation of the amygdala-ventromedial 
prefrontal cortex (vmPFC) functional connectivity. Although speculative, its is 
possible that increased dopaminergic clearance in val allele carriers may be one 
of the causes of reduced amygdala-vmPFC activation, which in turn may lead to 
individual differences in evaluation of stress stimuli and HPA axis activation.  
I found evidence for a gene-environment interaction, such that COMT 
genotype moderated the association between childhood stress on child anxiety 
                                                        
5
  Based on previous work by Bouma and colleagues (2012) where girls with the val 
homozygous genotype had stronger cortisol responses than the met allele carrier girls, I also 
conducted these analyses in my sample based on gender, However, I did not find any 
associations between COMT val158met genotype and cortisol response when the sample was 
stratified by gender (p = 0.25). 
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symptoms. Specifically, my analysis showed that under high levels of life stress, 
val allele carriers had significantly more symptoms of anxiety. A number of 
studies have reported on interactions between monoaminergic gene variants and 
childhood maltreatment as predictors of mood disorders. In a large study of over 
5000 participants, significant interaction between COMT gene region haplotypes 
(including the val158met polymorphism) and high early CS predicted depressive 
symptoms during adulthood (Nyman et al., 2011). Similarly, in a study by Klauke 
and colleagues (2012), COMT genotype moderated the effect of childhood 
trauma on startle response, which is widely considered an endophenotype for 
anxiety disorders. Specifically, the val homozygotes showed a higher increase in 
startle response as a function of childhood traumatic events when compared to 
the met allele carriers. Additionally, in a study by Kolassa and colleagues (2010), 
an interaction between COMT genotype and recent traumatic events predicted 
an increased risk for posttraumatic stress disorder but only in val homozygotes. 
Thus, our findings are broadly consistent with research implicating the val allele 
in anxiety disorder risk.  
I did not find evidence for moderation of life stress by the val158met 
polymorphism on emerging depressive symptoms. Depressive symptoms are 
rare at preschool age and emerge during middle to late childhood (Kovacs, 
1996). Therefore, it is possible that any gene-environment effect on depressive 
symptoms may emerge in later childhood years when depressive symptoms are 
more common. Overall, my findings extend existing literature and show that the 
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moderation of CS by COMT genotype contributes to emerging anxiety symptoms 
from an early age.     
In order to understand the pathways by which COMT val158met genotype, 
life stress, and their interaction may be linked to emerging symptoms, and the 
possible role cortisol response may play in this pathway, we tested an integrated 
model of emerging risk (Figure 3.5). My analyses showed that the COMT 
genotype and CS are linked to emerging anxiety symptoms via early age cortisol 
response. A few studies have reported on links between the COMT val158met 
polymorphism and endophenotypes of anxiety. For example, carriers of the 
COMT val allele showed an allele-dose effect on increased left amygdala activity 
in response to fearful/angry facial stimuli (Domschke et al., 2012) and amygdala 
activity has been linked to increases in neuroendocrine reactivity to stress 
(Jankord & Herman, 2008). These findings compliment and extend this literature 
and present a biological pathway in which interaction between catecholamine 
metabolism and CS is linked to emergence of psychological risk. The path 
analysis also demonstrates that the individual differences in neuroendocrine 
stress response are an important part of this pathway and the interaction 
between genotype and childhood stress contributes to childhood anxious 
symptoms via physiological stress response. 
In conclusion, I found an important link between life stress during early 
childhood and emerging symptoms of anxiety in a community sample of 
preschoolers. My findings suggest that functional variant of the COMT gene 
moderated the link of life stress on emerging symptoms in early childhood and 
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that the components of HPA axis function play a mechanistic role in this pathway. 
To my knowledge this is the first study to demonstrate the role of these variables 
in a relatively large community sample of young children. Thus, these findings 
add to the knowledge of underlying pathways involved in emerging risk for 
emotional problems and aid in our understanding of the complex etiology of 
mood disorders.  
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Chapter 4 - Dopamine pathway gene variants and early-emerging 
internalizing symptoms:  The roles of childhood stress and 
psychophysiological reactivity  
 
4.1 Introduction 
 
As discussed in Chapter 1, dopamine (DA) receptors regulate a number of 
neurological processes including cognition, memory, learning, and motor control, 
as well as modulation of neuroendocrine signaling (Money & Stanwood, 2013); 
thus, individual differences in DA receptor density are potentially relevant to 
many psychiatric disorders (Nemoda, Szekely & Sasvari-Szekely, 2011). In 
particular, evidence suggests that the limbic DA system may be involved in a 
number of stress-related pathologies such as depression and anxiety (Willner, 
1991). For example, DA may shape behaviour in the context of "learned 
helplessness," a mental state in which an organism forced to endure aversive 
stimuli, or stimuli that are painful or otherwise unpleasant, becomes unable or 
unwilling to avoid subsequent encounters with those stimuli, even if they are 
escapable, presumably because it has learned that it cannot control the situation 
(Colelli et al., 2010). Animals trained in the learned helplessness paradigm 
commonly exhibit widespread DA depletion in stress-regulating regions such as 
the prefrontal cortex, the caudate nucleus, and the nucleus accumbens 
compared to control animals (Charney, 2004). Similarly, prior treatment with a 
DA agonist prevents the development of learned helplessness and associated 
DA depletion in the prefrontal cortex (Boyce-Rustay, Janos & Holmes, 2008; 
Colelli et al., 2010). Conversely, DA antagonists exacerbate learned 
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helplessness and reduce the improvement produced by antidepressant treatment 
(Mozhui et al., 2010).  
Behavioural despair, which is often assessed using the forced swim test in 
animals, is a model in which animals are forced to swim in a confined space. 
After initial attempts to escape they assume an immobile posture. Animals prone 
to high behavioural despair (i.e., those which do not attempt to escape or swim) 
also show significantly lower levels of DA in the limbic structures of the brain, 
regions commonly associated with stress regulation (Touma et al., 2008). Similar 
to their effects on behaviour during learned helplessness paradigms, 
antidepressants exert an anti-immobility effect whereas DA agonists augment the 
anti-immobility effect (Cabib & Puglisi-Allegra, 2012; Orsini et al., 2002). The 
most consistent finding in human studies is decreased turnover of DA in patients 
with depressive disorders. Homovanillic acid (HVA) is the major metabolite of 
DA, and almost all cerebrospinal fluid (CSF) HVA originates from the brain. Thus, 
CSF HVA reflects CNS DA turnover. Studies have used probenecid to block the 
transport of HVA from the CSF, to increase the validity of CSF HVA as a 
measure of CNS DA turnover (Mineur, Belzung & Crusio, 2007). Most studies 
have found a decrease in the CSF HVA of patients with depression (Nemeroff & 
Dunlop, 2007). In sum, based on animal and human literature there is evidence 
for an important role of DA in behaviours commonly related to depression and 
anxiety; some of this risk may emerge based on genetic variation that influences 
dopaminergic activity in the brain. DA pathway candidate genes commonly 
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implicated in cortisol function and psychopathology are discussed in the following 
sections.  
4.1.1 DRD4 
A number of dopaminergic candidate genes have been examined as 
candidates for depression and anxiety, although most research has focused on 
the major DA receptors and synaptic DA transporter (DRD2, DRD4 & DAT) due 
to their widespread expression in brain regions commonly linked to emotion and 
cognition. The human DA receptor D4 (DRD4) gene (Figure 4.1), located near 
the telomere of chromosome 11p, exhibits an unusual amount of variation, 
including single nucleotide polymorphisms (SNPs) and variable number tandem 
repeats (VNTR). One of the common DRD4 polymorphism implicated in 
psychiatric literature is a 48-bp VNTR in the third exon (Schoots & Van Tol, 
2003). The VNTR consists of 2-11 repeats, with the most common versions 
being 2 (2R), 4 (4R) and 7 (7R) repeats. Amongst these the 4R allele is the most 
common, whereas 2R and 7R allele frequencies vary widely in Caucasians 
(Zalsman et al., 2004). The 48-bp VNTR is part of the third cytoplasmic loop of 
the receptor protein and molecular genetics studies have shown to affect the 
function of the D4 receptor. Specifically, in vitro studies suggest that the 7R 
variant exhibits decreased signal transduction efficiency relative to the 4R variant 
(Asghari et al., 1995), and may have decreased RNA stability or translational 
efficiency (Schoots & Van Tol, 2003). Furthermore, there are robust differences 
between receptor variants in folding efficiency when shaping the final protein 
product, such that the mRNA transcript of the DRD4 2R allele folds more quickly 
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into a protein product than the transcripts of longer alleles, thus increasing DRD4 
transmission (van Craenenbroeck et al., 2005). Cumulatively, these effects are 
likely to have a significant impact on the signaling and functioning of neural 
circuits involved in stress regulation. 
Findings of main effects of DRD4 on internalizing problems are less 
consistent. One study reported an association between the 2R of DRD4 and 
unipolar depression (Leon et al., 2005). However, a recent study reported no 
association between the DRD4 VNTR genotype and depression (Kang et al., 
2008) or suicide attempts (Persson et al., 1999; Zalsman et al., 2004). A few 
studies have looked at GxE involving the DRD4 VNTR polymorphism and early 
adversity predicting cortisol response to stress and internalizing outcomes during 
adulthood. For example, Armbruster and colleagues (2011) found that 
adolescent carriers of the 7R allele exhibited lower cortisol stress responses in 
presence of early adversity such as parental loss. The DRD4 genotype also 
moderated associations between stressors during early childhood such as 
parental depression and depressive symptoms during adolescence and early 
adulthood (Adkins et al., 2012). However, conflicting results were published by 
Dragan and colleagues (2009), who reported that participants with at least 1 copy 
of the DRD4 7R allele had more intense post-traumatic stress disorder (PTSD) 
symptoms. Thus, although a number of studies have looked at the role of DRD4 
gene variation and psychopathological outcomes, further research is needed to 
clarify which DRD4 variant is associated with psychopathological symptoms. 
Additionally, it remains unknown whether DRD4 variants are associated with 
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early childhood cortisol response.  Finally, whether the environment moderates 
genetic influences on these outcomes merits further exploration.
  
Figure 4.1. Diagrammatic representation of the human 
and introns by lines. The location of the 48bp exon 3 variable number tandem repeat (VNTR) is indicated. The 2
11-repeat variants of the VNTR are indicated below exon 3
DRD4 gene. Exon positions are indicated by solid black blocks 
 (Adapted from Van Tol et al., 1992). 
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 4.1.2 DRD2 
The DRD2 gene, first described by Grandy et al. (1989), is on 11q22 (Figure 4.2), 
and consists of six exons spanning almost 14kb. The gene has a restriction fragment 
length polymorphism downstream of the 3’UTR, called Taq1A (rs1800497) with two 
alleles referred to as A1 and A2 (Eisenberg et al., 2007). Using radioactively labeled 
agonists to detect D2 ligand binding, autoradiography of the caudate, putamen, and 
nucleus accumbens in tissue from normal middle-aged and elderly individuals without 
histories of substance abuse, neurological disorders, or psychopathology, it was shown 
that one or two A1 alleles was associated with reduced receptor binding throughout the 
striatum, with decreases found in the ventral caudate and putamen, brain regions 
implicated in emotion regulation. This supports findings from a few studies linking the 
Taq1A polymorphism with stress-related mood disorders. For example, a study of 
Chinese participants with bipolar disorder reported an association with Taq1A 
polymorphism (Li et al., 1999). A European multicenter study (Massat et al., 2002) 
reported an association of the (AC)- repeat polymorphism and bipolar, but not unipolar 
disorder. Additionally, studies have implicated the DRD2 A1 allele in posttraumatic 
stress disorder or PTSD (Comings & Blum, 2000; Noble, 2000). The findings of one 
study (Broekman, Olff & Boer, 2007) studied Vietnam veterans who had been exposed 
to severe combat conditions. The authors examined the prevalence of the DRD2 TaqI 
A1 allele in those who developed PTSD versus veterans without PTSD. The prevalence 
of the A1 allele was 60% in those with PTSD compared to 5% in those without PTSD. 
These findings were replicated in Caucasians where the frequency of A1 allele was 
significantly higher in PTSD combat veterans than controls (Young et al., 2000). In 
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addition to PTSD, a recent study has linked the Taq1A polymorphism with major 
depressive disorders as well (Savitz et al., 2013). Additionally, research from our group 
shows an association between the A1 allele and higher emerging symptoms of 
depression and anxiety in preschoolers (Hayden et al., 2010), suggesting a role of this 
variant in young children’s symptoms.   
In addition to main effects on symptoms, a handful of studies have also examined 
gene-environment interaction involving the Taq1A polymorphism. For example, in a 
large study of almost 2500 participants, DRD2 Taq1A variants moderated the role of 
violent victimization experiences on depression (Vaske et al., 2009). The results 
suggest that females who carry the A1 allele of DRD2 may be more vulnerable to the 
negative effects of violent victimization than females who do not carry at least one copy 
of the A1 allele. Similarly, data from our laboratory shows that the interaction between 
Taq1A genotype and early negative parenting, such as parental intrusion, predicted 
children’s symptoms of depression and anxiety (Hayden et al., 2010). In sum, literature 
suggests that the DRD2 polymorphism could have implications for emerging symptoms 
and that this gene may act as moderator of the impact of early stress on negative 
outcomes. However, to date no research exists in literature that has examined links 
between the DRD2 Taq1A variant and cortisol responses to stress.  
Furthermore, a gap in knowledge still remains as to whether this variant also 
moderates the effect of normative aspects of early stress, which are much more 
common for a majority of children, as compared to extreme forms of stress such as 
violent victimization in adults. Exploring these questions is an important addition to 
research examining the role of this variant in the etiology of depression and anxiety. 
  
 
 
Figure 4.2. A schematic showing DRD2 gene structure, and physical location of the rs1800497 polymorphism.
indicated with solid black boxes and connecting black lines indicate introns. White boxes represent the 5’
untranslated regions (Adapted from Eubanks et al., 1992)
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4.1.3 DAT1 
The DA transporter (DAT1) gene (Figure 4.3), located on chromosome 5p15.3, is 
heavily expressed in the human striatum, where it acts as the primary means of DA re-
uptake (Sesack et al., 1998). The most studied polymorphism is a 40bp VNTR in the 3’ 
untranslated region (UTR) of the DAT1 gene (Mitchell et al., 2000). Alleles from 3–13 
repeats have been described, but alleles with 9- and 10- repeats are the most frequently 
reported (Mitchell et al., 2000). Since this VNTR is not in the coding region of the gene, 
it does not affect the protein sequence of the DA transporter. However, it is thought to 
have functional significance, with in vitro studies indicating altered expression of the 
transporter as a function of VNTR alleles (Fuke et al., 2001; Miller & Madras, 2002), 
such that carrying 1 or 2 copies of the 10-repeat (10R) allele is associated with 
increased DAT1 expression. In addition, adults who are 10/10 homozygotes have 
significantly reduced DA transporter binding in the striatum relative to those having at 
least one 9-repeat (9R) allele (Jacobsen et al., 2000). In this way, the DAT1 genotype is 
thought to effect DA levels indirectly by altering translational efficiency and the amount 
of protein expressed. 
Given the central role of DA in the regulation of mood, it is unsurprising that 
association studies of DAT1 have linked this gene to various stress-related psychiatric 
problems including depression (Dunlop & Nemeroff, 2007). Literature indicates links 
between DAT1 30bp VNTR and childhood disorders, such as attention-deficit 
hyperactivity disorder/ADHD (Cook et al., 1995; Durston et al., 2008) and conduct 
disorder (Lahey et al., 2011). There is also evidence for interactions between this 
genotype and psychosocial adversity predicts ADHD (Laucht et al., 2007; Neuman et 
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al., 2007). For example, adolescents homozygous for the 10R allele of the DAT1 40bp 
VNTR polymorphism who grew up in greater psychosocial adversity exhibited 
significantly more inattention and hyperactivity-impulsivity than adolescents with other 
genotypes or who lived in less adverse family conditions; a finding recently replicated by 
Li and colleagues (2013) in a sample of six- to nine-year-olds. Furthermore, DAT1 has 
also been implicated in the etiology of depression and anxiety more generally, with 
inconsistencies regarding which genotype confers risk. Some have implicated the 9R 
allele rather than the 10R allele as being the risk allele (Lee et al., 2007; Young et al., 
2002), while others have suggested that it is the 10R. Given this pattern of results from 
previous studies, I will examine links between the 9R and 10R allele and children’s 
cortisol responses and internalizing symptoms.  
Based on this brief review, it seems possible that the DA gene variants discussed 
in the sections above are linked to both cortisol response and stress-related disorders in 
adolescents and adults. However, a gap in knowledge remains concerning whether 
links are evident at an early age, which could have implications for early intervention. 
Therefore, I examined links between variants in DA candidate gene variants (DRD2, 
DRD4, DAT1) and both cortisol reactivity to stress and emerging symptoms of 
depression and anxiety in early childhood. Specifically, I examined the following 
questions: First, given the role of cortisol reactivity to stress in the etiology of stress-
related mood disorders, I examined links between DA gene variants and children’s 
cortisol responses. Second, I examined whether associations existed between DA gene 
variants and children’s symptoms of depression and anxiety. Third, given the evidence 
for moderation of early adversity by DA genes on physiological stress responses and 
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internalizing symptoms, I examined the evidence for gene-environment interaction in 
this community sample of preschoolers.  
 
  
 
 
Figure 4.3. Diagrammatic representation of the human 
and introns by lines. The location of the 30bp exon 14 variable number tandem repeat (VNTR) is indicated. The 7
repeat variants of the VNTR are indicated by dashed arrows
  
SLC6A3 (DAT1) gene. Exons are indicated by solid black blocks 
 (Vandenberg et al., 1992). 
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4.2 Methods 
Detailed sample demographic are provided in Chapter 2, pg. 44. Similar to 
Chapter 2, I used the child’s primary caregiver reports on the Child Behavior Checklist 
(CBCL; Achenbach, 2000). As described in Chapter 2, the overall life stress aggregate 
score was used as a measure of life stress in all analyses in this chapter. The AUCi, 
baseline to peak cortisol change, and AUCg were used as measures of cortisol 
response as previously described in detail on page 57. Finally, population stratification 
was minimized by restricting all analyses to include Caucasian participants (N = 371) 
only. 
4.2.1 Genotyping methods  
Participant DNA was extracted as described previously in Chapter 2. The 48-
base pair VNTR located in the third exon of the DRD4 gene was amplified using a 25 µl 
reaction containing 25 ng of genomic DNA template with forward primer 5’-
CGCGACTACGTGGTCTACTCG-3’ and reverse primer 5’-AGGACCCTCATGGCCTTG-
3’, and 1 U of NovaTaq polymerase (Novagen, Gibbstown, New Jersey, USA). The 
reaction also included 2 mM each of dATP, dCTP and dTTP, 1mM each of dGTP, dITP, 
with 10% DMSO and 1X PCR amplification buffer (20 mmol/l Tris-HCL pH 8.4, 50 
mmol/L KCL). PCR amplification was carried out in a GeneAmp PCR System 9700 (ABI 
Biosystems, Foster City, California, USA). Following an initial denaturation at 95°C for 5 
minutes, thirty cycles of amplification were run with each cycle consisting of 
denaturation at 95°C for 20 sec, annealing at 54°C for 20 sec, and extension at 72°C for 
40 sec, ending with a final extension step of 5 min at 72°C. The PCR amplicons were 
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then resolved on a 2% agarose gel, stained with ethidium bromide (Sigma, Oakville, 
Ontario, Canada) and documented on the Bio-Rad 1300 Gel documentation system 
(Mississauga, ON, Canada). Product sizes were determined against a 100 bp molecular 
weight standard (Invitrogen, Carlsbad, California, USA). 
The DAT1 exon 3 VNTR was genotyped using the primers: 5'-
TGTGGTGTAGGGAACGGCCTGAG-3' (forward) and 5'-CTTCCTGGAGGTCACGG 
CTCAAGG-3' (reverse).  The PCR conditions were as follows: 5 min initial denaturation 
at 95 °C and 30 cycles of 30 s initial denaturation at 94 °C, 45 s annealing at 67.5 °C, 
45 s extension at 72 °C, followed by 5 min of final extension at 72 °C.  The 9R and 10R 
products yield a 440 bp and 480 bp fragment, respectively.  
For the detection of the polymorphism in the Taq1A site, oligonucleotide primers 
5′-CACGGCTGGCCAAGTTGT CTA-3′ (forward) and 5′-
CACCTTCCTGAGTGTCATCAA-3′ (reverse) were used to amplify a 300-bp region 
comprising the Taq1A site (Grandy et al., 1993). The PCR conditions used were initial 
denaturation for 5 min at 95°C followed by 30 cycles of 30 s denaturation at 94°C, 30 s 
annealing at 58°C, and a 30 s extension at 72°C, followed by a 5 min final extension at 
72°C. The 300 bp PCR product was digested overnight with 1U of TaqαI restriction 
enzyme (New England BioLabs, Massachusetts, USA). 
4.2.2 Data Analysis 
To test the hypothesis that DA candidate gene variants moderated the influence 
of childhood stress (CS) on emerging symptoms of anxiety and depression, similar to 
Chapters 2 and 3 I analyzed the interaction between life stress and genotypes using a 
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macro for PASW developed by Hayes (2013) with parent reports of children’s anxious 
and depressive symptoms as the dependent variables. This macro uses a regression-
based path analytical framework for estimating direct and indirect effects in simple and 
multiple mediator models, along with simple slopes for probing interactions. All predictor 
values were centered as needed. Additionally, I once again tested the integrated 
pathway in Figure 1.3 using a path analysis framework. Details of the path analysis and 
guidelines for model interpretation are provided in Chapter 3, page 120.  
4.3 Results 
The DRD4 VNTR polymorphism, like other VNTRs, has many possible variants 
(Wang et al., 2004), ranging from 2- to 11-repeat copies reported in the literature to 
date. In our sample, the following variants were present: 2/2 (N = 10, 2.4%), 2/4 (N = 
67,16.3%), 2/5 (N = 1, 0.2%), 2/7 (N = 8, 2.0%), 2/8 (N = 2, .5%), 3/3 (N = 3, .7%), 3/4 
(N = 9, 2.2%), 3/5 (N = 7, 1.7%), 3/7 (N = 2, .5%), 3/11 (N = 1, .2%), 4/4 (N = 157, 
38.3%), 4/5 (N = 4, 1.0%), 4/7 (N = 96, 23.4%), 4/8 (N = 3, .7%), 5/5 (N =1, .2%), 7/7 (N 
= 21, 5.1%), and 7/11 (N = 1, .2%). This distribution is not consistent with Hardy-
Weinberg equilibrium (Pearson X2 (45) = 163.31, p < 0.05), but is comparable to 
recently reported frequencies (Ding et al., 2002). Consistent with the majority of 
published research (e.g., Faraone et al., 2001; Sheese et al., 2007), groups for data 
analysis were formed based on whether children had (N = 128) or did not have (N = 
266) a 7R allele. 
Although genotypes were successfully obtained for 371 children, for the 
purposes of our analyses, six participants with rare variants of the DAT1 were excluded. 
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The genotypes of the remaining 365 children were distributed as follows: 177 (48%) 
children had the 10/10 genotype, 153 (42%) had the 9/10 genotype, and 35 (10%) had 
the 9/9 genotype. This distribution is in Hardy-Weinberg equilibrium, X2 = 0.05, p = 0.82. 
For the DRD2 Taq1A polymorphism, 369 children were genotyped successfully and the 
distributed as follows: 12 (3.2%) children had the A1A1 genotype, 114 (30.7%) had the 
A1A2 genotype, and 243 (65.5%) had the A2A2 genotype.  This distribution is in Hardy-
Weinberg equilibrium, X2 = 0.10, p = 0.76. 
4.3.1 Main effects 
Table 4.1 shows associations between study variables and DA pathway gene 
polymorphisms stratified by genotypes. One-way analysis of variance revealed no 
associations existed between DA gene polymorphisms and symptoms of anxiety and 
depression measured via the CBCL. I also did not find any associations between DA 
gene variants and our three indices of cortisol reactivity. The DA gene polymorphisms 
were also not associated with either the child’s gender or ethnicity (all ps > 0.21).  
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Table 4.1. Study variables stratified by DA pathway gene polymorphism genotypes. 
                                 Genotype 
DRD2 DRD4 DAT1 
Variable 
A1A1+A1A2 
(N=143) A2A2 (N=260) 
<7-repeat 
(N=262) 
≥7-repeat 
(N=136) 
9/9 + 9/10  
(N=207) 10/10 (N=183) 
Sex (N, boys) 64 134 125 69 98 94 
Family income 3.67 (1.18) 3.77 (1.12) 3.69 (1.13) 3.80 (1.17) 3.60 (1.16) 3.84 (1.11) 
PPVT 110.35 (15.11) 112.96 (13.45) 112.2 (14.21) 111.70 (13.69) 112.36 (13.68) 111.41 (14.57) 
Baseline to peak 
cortisol change -1.11 (0.35) -1.08 (0.37) -1.09 (0.37) -1.09 (0.36) -1.11 (0.38) -1.06 (0.35) 
AUCi 0.05 (0.09) 0.05 (0.11) 0.05 (0.09) 0.06 (0.10) 0.05 (0.08) 0.05 (0.12) 
AUCg 0.18 (0.13) 0.18 (0.13) 0.18 (0.13) 0.19 (0.15) 0.18 (0.13) 0.18 (0.13) 
CBCL Depression 1.35 (1.46) 1.24 (1.62) 1.39 (1.64) 1.16 (1.58) 1.25 (1.42) 1.37 (1.82) 
CBCL Anxiety  1.17 (1.27) 1.40 (1.71) 1.36 (1.61) 1.25 (1.50) 1.39 (1.51) 1.26 (1.65) 
Note: DRD2, DA receptor-D2; DRD4, DA receptor-D4; DAT1, DA Transporter-1; AUCi, Area Under Curve with respect to 
baseline; AUCg, Area Under Curve with respect to ground; CBCL, Child Behavior Checklist; Family income was coded as 
1 = < $20,000; 2= $20,000-$40,000; 3= $40,001-$70,000; 4 = $70,001-$100,000; 5 = > $100,001.  
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4.3.2 Moderation analyses 
Based on a large body of literature implicating DA pathway genes in gene-
environment interactions, I tested whether DA gene variants moderated the effect of life 
stress on symptoms of depression and anxiety. Details for moderation analyses have 
been discussed in Chapters 2 & 3. 
4.3.2.1 DRD2 
Multiple regression analysis showed evidence for moderation of the association 
between CS and children’s cortisol responses, measured via AUCi by DRD2 genotype 
(β = 0.04, se = 0.21, p = 0.03).6 Analyses showed that children carrying at least one 
copy of the A1 allele exhibited higher cortisol reactivity as function of increasing CS  (β 
= 1.03, se = 0.09, p = 0.001), but for children homozygous for the A2 allele, CS was not 
associated with cortisol response  (β = -0.03, se = 0.13, p = 0.77; Figure 4.4A). 
Similarly, the interaction term predicting AUCg was significant as well (β = 0.04, se = 
0.02, p = 0.03).  Analyses showed that children carrying at least one copy of the A1 
allele exhibited higher AUCg as function of increasing CS (β = 1.05, se = 0.13, p < 
0.001), but for children homozygous for the A2 allele, CS was not associated with 
cortisol response (β = 0.00, se = 0.18, p = 0.86; Figure 4.4B). There was no evidence 
                                                        
6
 Since AUCi and change score analyses yielded virtually identical results, only analyses 
predicting AUCi are reported here. However, the interaction term between DRD2 genotype and CS also 
predicted cortisol response measured via baseline to peak cortisol change (p = 0.02). As both baseline to 
peak cortisol change and AUCi represent the intensity of cortisol response after stress, only one of these 
DVs is reported.   
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for interaction between DRD2 genotype and CS in predicting children’s symptoms of 
depression (β = 0.03, se = 0.27, p = 0.89) or anxiety (β = -0.03, se = 0.26, p = 0.92). 
  
 
 
Figure 4.4. Relationship between childhood
groups.
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4.3.2.2 DRD4 
Although I found no main effects of DRD4 genotype on either cortisol response or 
emerging anxious and depressive symptoms, based on previous reports of evidence for 
GxE involving this genotype (Adkins et al., 2012), I proceeded to conduct interaction 
analyses to explore the possibility of GxE in this sample. Using multiple regression 
analyses, I examined whether the DRD4 genotype moderated the effect of early stress 
on cortisol response. The interaction terms were nonsignificant for AUCi (β = -0.03, se = 
0.02, p = 0.08) and AUCg (β = -0.04, se = 0.03, p = 0.10).7 Similarly, in the next set of 
analyses, I examined whether the DRD4 genotype moderated the effect of early stress 
on emerging symptoms of depression or anxiety. Once again, the interaction term for 
DRD4 genotype and CS did not predict child depressive symptoms (β = 0.02, se = 0.28, 
p = 0.93) or child anxiety symptoms (β = -0.14, se = 0.27, p = 0.61).  
4.3.2.3 DAT1 
Once again, multiple regression analyses showed that the interaction between 
DAT1 genotype and CS did not predict AUCi (β = 0.00, se = 0.16, p = 0.87) and AUCg 
(β = -0.02, se = 0.02, p = 0.42). However, the interaction term for DAT1 genotype and 
CS was a significant predictor of children’s depressive symptoms (β = 1.04, se = 0.26, p 
< 0.001). Analyses showed that children homozygous for the 10R allele exhibited higher 
symptoms of depression as a function of CS (β = 1.29, se = 0.20, p = 0.001). However, 
                                                        
7
 The interaction term between DRD4 genotype and CS did not predict cortisol response 
measured via baseline to peak cortisol change or internalizing symptoms (all ps > 0.05). 
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CS was not associated with childhood depressive symptoms in children who had at 
least one copy of the DAT1 9R allele  (β = 0.25, se = 0.16, p = 0.13; Figure 4.5A).  
Similarly, the interaction between DAT1 genotype and CS also predicted child 
anxiety symptoms (β = 0.59, se = 0.26, p = 0.02). Analyses showed that children 
homozygous for the 10R allele exhibited higher symptoms of depression with increasing 
life stress  (β = 0.74, se = 0.20, p < 0.001), but CS was not associated with anxious 
symptoms in children with at least one copy of the 9R allele (β = 0.14, se = 0.16, p = 
0.36; Figure 4.5B). 
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Figure 4.5. Relationship between childhood stress
allelic groups. 
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4.3.3 Path analyses 
 In previous sections, I examined associations between DA genetic variants and 
children’s cortisol responses to stress. Second, I examined the moderating role of DA 
gene polymorphisms on the association between CS and children’s depressive and 
anxious symptoms. In the final set of analyses, I examined an integrative model where I 
tested the moderating role of cortisol response on the effect DA gene polymorphisms 
and CS on emerging symptoms of depression and anxiety in a combined analytical 
framework.  
Figure 4.6A shows the results of the path analyses. The CS measure was 
positively associated with cortisol responses to stress (β = 0.22, p = 0.01), but the 
associations between genotype and cortisol were non-significant (β = 0.06, p = 0.21). 
Child cortisol reactivity, AUCi, was also positively correlated with emerging symptoms of 
anxiety (β = 0.14, p < 0.01). The DRD2-CS interaction path predicting AUCi was also 
non-significant (β = -0.04, p = 0.67). The overall model fit was very good (χ2 = 26.28, df 
= 7, p < 0.001; root mean square error of approximation [RMSEA]= 0.02; normed fit 
index = 0.97 (guidelines for interpreting path analyses are provided on page 118).    
Figure 4.6B shows the results of the path analyses. The CS measure was 
positively associated with cortisol responses to stress (β = 0.18, p < 0.01), but the 
associations between genotype and cortisol were non-significant (β = 0.01 p = 0.87). 
Child cortisol reactivity, AUCi, was also positively correlated with emerging symptoms of 
anxiety (β = 0.14, p < 0.01). The DRD4-CS interaction path predicting AUCi was also 
non-significant (β = -0.04, p = 0.67). The overall model fit was very good (χ2 = 21.25, df 
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= 7, p < 0.01; root mean square error of approximation [RMSEA]= 0.00; normed fit index 
= 1.00. 
Figure 4.6C shows the results of the path analyses. CS was positively associated 
with cortisol responses to stress (β = 0.13, p = 0.04), but the associations between 
genotype and cortisol were non-significant (β = 0.07 p = 0.25). Child cortisol reactivity, 
AUCi, was also positively correlated with emerging symptoms of anxiety (β = 0.14, p < 
0.01). The DAT1-CS interaction path predicting AUCi was also non-significant (β = -
0.04, p = 0.04). However, the overall model fit was mediocre as indexed by the RMSEA 
and normed fit index analyses (χ2 = 28.39, df = 7, p < 0.001; root mean square error of 
approximation [RMSEA]= 0.08; normed fit index = 0.65).8 
 
 
  
                                                        
8
 Similar to AUCi, I also conducted pathway analyses where AUCg was modeled as an index of 
total cortisol produced. The results of these analyses were identical to the models presented in section 
4.3.4 (all ps < 0.001). Therefore, these pathways were not included in the main text.  
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Figure 4.6. Pathway analysis. The path shows interaction between DRD2 rs1804973 genotype and childhood stress as 
predictor of child anxious symptoms via AUCi (A) and AUCg (B). Child anxious symptoms are based on parent reports 
from the Child Behavior Checklist (Achenbach et al., 2000). Standardized β-weights are shown for each path. *p < 0.05, 
**p < 0.01, ***p <0.001.  
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4.4 Discussion 
In this chapter, I conducted an analysis of the links between dopaminergic 
gene variants, cortisol reactivity and emerging symptoms of depression and 
anxiety in preschoolers. In the first set of analyses, I found that the DRD2 
rs1800473 SNP was associated with children’s internalizing symptoms. Analyses 
did not show associations between this gene variant and either emerging 
symptoms of depression and anxiety or cortisol reactivity to stress in 
preschoolers. These findings are consistent with a number of studies that have 
also reported no associations between DRD2 Taq1A variant and symptoms (Rot, 
Mathew & Charney, 2009). However, a few studies have reported positive 
associations between DA receptor genes and internalizing problems, including a 
previous study from our group that reported an association between the DRD2 
genotype and symptoms of depression and anxiety (Hayden et al., 2010; Lucht et 
al., 2006). Similarly, there were no associations between the DRD2 genotype 
and cortisol reactivity. However, the interaction between the DRD2 Taq1A 
polymorphism and CS predicted both cortisol intensity (AUCi) and total cortisol 
response over time (AUCg). Specifically, the cortisol response increased as a 
function of CS in carriers with at least one copy of the A1 allele, while childhood 
stress was not associated with cortisol response in A2 homozygous children. My 
findings are the first to report moderation of the association between CS and 
cortisol reactivity by this polymorphism.  
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There was also evidence for moderation of the association between CS 
and symptoms of anxiety and depression by the DAT1 VNTR polymorphism. 
Specifically, the 9R allele carriers had increasing symptoms as a function of CS, 
whereas no association between CS and symptoms was present in children with 
at least one copy of the 10R allele. Previous work from our lab and others has 
shown that genetic influences on children’s psychopathology risk may be 
moderated by contextual factors (Hayden et al., 2013). Other studies have 
reported that interactions between DAT1 and life stress predicted the 
development of conduct disorder and attention-deficit hyperactivity disorder in 
children (Bidwell et al., 2011; Lahey et al., 2011). Specifically, the children 
carriers for the DAT1 9R allele had higher risk as a function of increasing 
negative early life contexts such as negative parenting. My findings complement 
this literature by showing that interaction between CS and DAT1 genotype may 
also contribute to early symptoms of depression and anxiety.  
I also conducted path analyses in which I examined the role of DA gene 
variants, CS and cortisol reactivity in predicting children’s symptoms of 
depression and anxiety. Analyses showed that the path models were only 
significant for anxiety as an outcome. To my knowledge, no research in literature 
to date has explored these variables in a path analysis framework, although 
some research has linked contextual risk exposure to differential DA secretion in 
brain’s limbic regions. Specifically, excessive mesocortical DA released upon 
exposure to varying levels of stressful life events (such as childhood 
maltreatment) may increase vulnerability to depression through an inhibition of 
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subcortical DA transmission (Ventura et al., 2002; Cabib et al., 2002). While 
directly establishing that regional DA levels are different in children exposed 
varying levels of stress is not possible, the analyses in this chapter point to a 
positive link between functional DA gene polymorphisms, levels of CS and 
emerging symptoms of anxiety.   
Taken together, the analyses presented in this chapter suggest that the 
DRD2 and DAT1 gene polymorphisms contribute to emerging risk for anxiety in 
young children. However, there were no associations between DRD4 VNTR and 
cortisol reactivity and emerging symptoms of depression and anxiety. Current 
GxE research involving the DRD4 gene polymorphism suggests that adults with 
the 7R allele are more likely to be affected by life stress than are those with 
carriers of less than 7R allele. Additionally, a large amount of GxE literature 
involving DRD4 comes from cohorts suffering from substance abuse disorders 
where carriers the 2R and 4R allele did not relapse back to drug use when they 
experienced high levels of life stress when compared to 7R carriers, suggesting 
some implication for this gene in stress resilience. Due to the role of DA circuits 
in reward processing in the brain, it is plausible to assume that some of the DA 
receptor polymorphisms may be linked to individual differences towards stress 
contexts. However, future research should examine the role of the DRD4 
polymorphism in contextual processes at various levels of analysis (family, peer, 
school, or neighborhood) over middle and late childhood.  
Some limitations of the research in this chapter should be noted. Only one 
genetic polymorphism for each gene was examined; this does not represent all of 
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the genetic variation important to shaping cortisol reactivity or emerging 
symptoms. As discussed previously, many genetic variants may alter risk, the 
expression of which may emerge only under particular contextual conditions. 
These limitations notwithstanding, the present chapter offers several novel points 
for stress research and examines common DA pathway candidate genes 
implicated in adult psychopathology. Analyses suggest that DA gene 
polymorphisms contribute to early childhood development and likely contribute to 
future behaviour outcomes.   
  
  175
4.5 References 
1. Achenbach TM, Rescorla LA. (2000) Manual for the ASEBA Preschool 
Form & Profiles. Burlington VT: University of Vermont Department of Psychiatry. 
2. Adkins DE, Wang V, Elder GH Jr. (2011) Structure and Stress: 
Trajectories of Depressive Symptoms across Adolescence and Young 
Adulthood. Soc Forces 88:31. 
3. Armbruster D, Mueller A, Strobel A, Lesch KP, Brocke B, Kirschbaum C. 
(2012) Children under stress - COMT genotype and stressful life events predict 
cortisol increase in an acute social stress paradigm Int J Neuropsychopharmacol 
15:1229-39. 
4. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. 
(1995) Modulation of intracellular cyclic AMP levels by different human dopamine 
D4 receptor variants. J Neurochem 65:1157-65. 
5. Boyce-Rustay JM, Janos AL, Holmes A. (2008) Effects of chronic swim 
stress on EtOH-related behaviours in C57BL/6J, DBA/2J and BALB/cByJ mice. 
Behav Brain Res 186:133-7. 
6. Broekman BF, Olff M, Boer F. (2007) The genetic background to PTSD. 
Neurosci Biobehav Rev 31:348-62.  
7. Cabib S, Puglisi-Allegra S (1996) Different effects of repeated stressful 
experiences on mesocortical and mesolimbic DA metabolism. Neuroscience 
73:375–380 
  176
8. Cabib S, Ventgura R, Puglisi-Allegra S (2002) Opposite imbalances 
between mesocortical and mesoaccumbens DA responses to stress by the same 
genotype depending on living conditions. Behav Brain Res 129:179–185 
9. Charney DS. (2004) Psychobiological mechanisms of resilience and 
vulnerability: implications for successful adaptation to extreme stress. Am J 
Psychiatry 161:195-216. 
10. Colelli V, Fiorenza MT, Conversi D, Orsini C, Cabib S. (2010) Strain-
specific proportion of the two isoforms of the dopamine D2 receptor in the mouse 
striatum: associated neural and behavioural phenotypes. Genes Brain Behav 
9:703-11. 
11. Comings DE, Blum K. (2000) Reward deficiency syndrome: genetic 
aspects of behavioural disorders. Prog Brain Res 126:325-41. 
12. Cook EH Jr., Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, 
Leventhal BL. (1995) Association of attention-deficit disorder and the dopamine 
transporter gene. Am J Hum Genet 56(4):993-8. 
13. de Leon J, Susce MT, Pan RM, Koch WH, Wedlund PJ. (2005) 
Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and 
dopamine D2 and D3 receptors and their association with tardive dyskinesia in 
severe mental illness. J Clin Psychopharmacol 25:448-56. 
14. Domschke K. (2013) Clinical and molecular genetics of psychotic 
depression. Schizophr Bull 39:766-75. 
  177
15. Ding YC, Chi HC, Grady DL, Morishima A, Kidd JR, Kidd KK, et al. (2002) 
Evidence of positive selection acting at the human dopamine receptor D4 gene 
locus. Proc Natl Acad Sci USA 99:309-14. 
16. Dragan WŁ, Oniszczenko W. (2009) The association between dopamine 
D4 receptor exon III polymorphism and intensity of PTSD symptoms among flood 
survivors. Anxiety Stress Coping 22:483-95. 
17. Durston S, Fossella JA, Mulder MJ, Casey BJ, Ziermans TB, Vessaz MN, 
Van Engeland H. (2008) Dopamine transporter genotype conveys familial risk of 
attention-deficit/hyperactivity disorder through striatal activation. J Am Acad Child 
Adolesc Psychiatry 47:61-7. 
18. Eisenberg DT, Campbell B, Mackillop J, Lum JK, Wilson DS. (2007) 
Season of birth and dopamine receptor gene associations with impulsivity, 
sensation seeking and reproductive behaviours. PLoS One 2:e1216. 
19. Eubanks JH, Djabali M, Selleri L, Grandy DK, Civelli O, McElligott DL, 
Evans GA. (1992) Structure and linkage of the D2 dopamine receptor and neural 
cell adhesion molecule genes on human chromosome 11q23. Genomics 14: 
1010-1018. 
20. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. (2001) The 
VNTR polymorphism of the human dopamine transporter (DAT1) gene affects 
gene expression. Pharmacogenomics 1:152-6. 
21. Goldstein LE, Rasmusson AM, Bunney BS, Roth RH (1996) Role of the 
amygdala in the coordination of behavioural, neuroendocrine, and prefrontal 
  178
cortical monoamine responses to psychological stress in the rat. J Neurosci 
16:4787–4798 
22. Grandy DK, Zhang Y, Civelli O. (1993) PCR detection of the TaqA RFLP 
at the DRD2 locus. Hum Mol Genet 2:2197. 
23. Hayden EP, Klein DN, Dougherty LR, Olino TM, Laptook RS, Dyson MW, 
Bufferd SJ, Durbin CE, Sheikh HI, Singh SM. (2010) The dopamine D2 receptor 
gene and depressive and anxious symptoms in childhood: associations and 
evidence for gene-environment correlation and gene-environment interaction. 
Psychiatr Genet 20:304-10. 
24. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, 
Gelernter J. (2000) Prediction of dopamine transporter binding availability by 
genotype: a preliminary report. Am J Psychiatry 157:1700-3. 
25. Kang JI, Namkoong K, Kim SJ. (2008) The association of 5-HTTLPR and 
DRD4 VNTR polymorphisms with affective temperamental traits in healthy 
volunteers. J Affect Disord 109:157-63. 
26. Laucht M, Skowronek MH, Becker K, Schmidt MH, Esser G, Schulze TG, 
Rietschel M. (2007) Interacting effects of the dopamine transporter gene and 
psychosocial adversity on attention-deficit/hyperactivity disorder symptoms 
among 15-year-olds from a high-risk community sample. Arch Gen Psychiatry 
64:585-90. 
27. Lee SH, Ham BJ, Cho YH, Lee SM, Shim SH. (2007) Association study of 
dopamine receptor D2 TaqI A polymorphism and reward-related personality traits 
in healthy Korean young females. Neuropsychobiology 56:146-51. 
  179
28. Li T, Liu X, Sham PC, Aitchison KJ, Cai G, Arranz MJ, et al. (1999) 
Association analysis between dopamine receptor genes and bipolar affective 
disorder. Psychiatry Res 86:193-201. 
29. Li JJ, Lee SS. (2013) Interaction of dopamine transporter gene and 
observed parenting behaviors on attention-deficit/hyperactivity disorder: a 
structural equation modeling approach. J Clin Child Adolesc Psychol 42:174-86. 
30. Massat I, Souery D, Del-Favero J, Van Gestel S, Serretti A, Macciardi F, 
et al. (2002) Positive association of dopamine D2 receptor polymorphism with 
bipolar affective disorder in a European Multicenter Association Study of affective 
disorders. Am J Med Genet 114:177-85. 
31. Morrow BA, Elsworth JD, Rasmusson AM, Roth RH. (1999) The role of 
mesoprefrontal DA neurons in the acquisition and expression of conditioned fear 
in the rat. Neuroscience 92:553–564 
32. Mitchell SN, Yee BK, Feldon J, Gray JA, Rawlins JN. (2000) Activation of 
the retrohippocampal region in the rat causes dopamine release in the nucleus 
accumbens: disruption by fornix section. Eur J Pharmacol 407:131-8. 
33. Miller GM, Madras BK. (2002) Polymorphisms in the 3'-untranslated region 
of human and monkey dopamine transporter genes affect reporter gene 
expression. Mol Psychiatry 7:44-55. 
34. Mineur YS, Belzung C, Crusio WE. (2007) Functional implications of 
decreases in neurogenesis following chronic mild stress in mice. Neuroscience 
150:251-9.  
  180
35. Money KM, Stanwood GD. (2013) Developmental origins of brain 
disorders: roles for dopamine. Front Cell Neurosci 7:260.  
36. Mozhui K, Karlsson RM, Kash TL, Ihne J, Norcross M, Patel S, et al. 2010 
Strain differences in stress responsivity are associated with divergent amygdala 
gene expression and glutamate-mediated neuronal excitability. J Neurosci 
30:5357-67. 
37. Natsuaki MN, Klimes-Dougan B, Ge X, Shirtcliff EA, Hastings PD, Zahn-
Waxler C. (2009) Early pubertal maturation and internalizing problems in 
adolescence: sex differences in the role of cortisol reactivity to interpersonal 
stress. J Clin Child Adolesc Psychol 38:513-24.  
38. Dunlop BW, Nemeroff CB. (2007) The role of dopamine in the 
pathophysiology of depression. Arch Gen Psychiatry 64:327-37. 
39. Nemoda Z, Szekely A, Sasvari-Szekely M. (2011) Psychopathological 
aspects of dopaminergic gene polymorphisms in adolescence and young 
adulthood. Neurosci Biobehav Rev 35:1665-86. 
40. Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD. 
(2007) Prenatal smoking exposure and dopaminergic genotypes interact to 
cause a severe ADHD subtype. Biol Psychiatry 61:1320-8. 
41. Noble EP. (2000) The DRD2 gene in psychiatric and neurological 
disorders and its phenotypes. Pharmacogenomics 1:309-33. 
42. Orsini C, Ventura R, Lucchese F, Puglisi-Allegra S, Cabib S. (2002) 
Predictable stress promotes place preference and low mesoaccumbens 
dopamine response. Physiol Behav 75:135-41. 
  181
43. Persson ML, Geijer T, Wasserman D, Rockah R, Frisch A, Michaelovsky 
E, Jönsson EG, Apter A, Weizman A. (1999) Lack of association between suicide 
attempt and a polymorphism at the dopamine receptor D4 locus. Psychiatr Genet 
9:97-100. 
44. Savitz J, Hodgkinson CA, Martin-Soelch C, Shen PH, Szczepanik J, 
Nugent AC, et al. (2013) DRD2/ANKK1 Taq1A polymorphism (rs1800497) has 
opposing effects on D2/3 receptor binding in healthy controls and patients with 
major depressive disorder. Int J Neuropsychopharmacol 16:2095-101. 
45. Sesack SR, Hawrylak VA, Melchitzky DS, Lewis DA. (1998) Dopamine 
innervation of a subclass of local circuit neurons in monkey prefrontal cortex: 
ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive 
structures. Cereb Cortex 8:614-22. 
46. Schoots O, Van Tol HH. (2003) The human dopamine D4 receptor repeat 
sequences modulate expression. Pharmacogenomics J 3:343-8. 
47. Touma C, Bunck M, Glasl L, Nussbaumer M, Palme R, Stein H, et al. 
(2008) Mice selected for high versus low stress reactivity: a new animal model for 
affective disorders. Psychoneuroendocrinology 33:839-62.  
48. Van Craenenbroeck K, Clark SD, Cox MJ, Oak JN, Liu F, Van Tol HH. 
(2005) Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. J 
Biol Chem 280:19350-7.  
49. Van Tol HHM, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, et al. 
(1992) Multiple dopamine D4 receptor variants in the human population. Nature 
358:149-152. 
  182
50. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl 
GR. (1992) Human dopamine transporter gene (DAT1) maps to chromosome 
5p15.3 and displays a VNTR. Genomics 14: 1104-1106. 
51. Vaske J, Makarios M, Boisvert D, Beaver KM, Wright JP. (2009) The 
interaction of DRD2 and violent victimization on depression: an analysis by 
gender and race. J Affect Disord 112(1-3):120-5. 
52. Ventura R, Cabib S, Puglisi-Allegra S. (2002) Genetic susceptibility of 
mesocortical DA to stress determines liability to inhibition of mesoaccumbens DA 
and to behavioural despair in a mouse model of depression. Neuroscience 
115:99–1007 
53. Wang Y, Goldman-Rakic PS. (2004) D2 receptor regulation of synaptic 
burst firing in prefrontal cortical pyramidal neurons. Proc Natl Acad Sci U S A 
101:5093-8.  
54. Young EA, Midgley AR, Carlson NE, Brown MB. (2000) Alteration in the 
hypothalamic-pituitary-ovarian axis in depressed women. Arch Gen Psychiatry 
57:1157-62. 
55. Young IR, Chan EC, Smith R, Chrousos GP, Veldhuis JD, Canny BJ. 
(2002) Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, 
on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal 
axis. Neuroendocrinology 76:47-54. 
56. Zalsman G, Frisch A, Lewis R, Michaelovsky E, Hermesh H, Sher L, et al. 
(2004) DRD4 receptor gene exon III polymorphism in inpatient suicidal 
adolescents. J Neural Transm 111:1593-603.  
  183
Chapter 5 - The serotonin candidate genes and emerging symptoms of 
psychopathology: The roles of cortisol reactivity and childhood stress  
Along with the dopamine pathway, the serotonin pathway has been widely 
implicated in shaping early neurodevelopment. Among the multiple 
neurochemical processes involved, reduced brain serotonin (5-HT) seems to be 
feature of depression and anxiety (Van Praag, 2004). Although there are 
questions about the exact role of 5-HT in the onset and course of depression, 5-
HT dysfunction is commonly found in depressed patients as captured by lower 
brain availability of tryptophan and 5-hydroxytryptophan (Agren & Reibring, 1994; 
Maes et al, 1990). Specifically, impaired reuptake and degradation in the 
synapse have been implicated in stress-related mood disorders such as 
depression (Arango et al. 2002; Markus & Firk, 2011; Malison et al, 1998; 
Sargent et al, 2000) and antidepressant drugs act by improving brain 5-HT 
function (van Praag, 2004). Candidate genes with functional effects on the 5-HT 
reuptake and its degradation, and their links to the stress response, are 
discussed in the following sections. 
5.1.1 5-Hydroxytryptophan transporter (SLC6A4) gene polymorphism 
Probably the most widely-studied and controversial candidate genes for 
depression is the serotonin transporter gene (5-HTT). The 5-HTT (SLC6A4) gene 
spans 31kb and contains 14 exons (Lesch et al., 1994). A common functional 
polymorphism has been described in the promoter region this gene known as the 
5-HTTLPR (Figure 5.1). Variants of the 5-HTTLPR consist of a long (L) allele, 
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comprised of 16 copies of an approximately 22 base pair (bp) repeat unit, and a 
short (S) allele, consisting of 14 copies (for a review, see Hariri & Holmes, 2006). 
Compared to the L allele, the S allele is associated with decreased transcriptional 
efficiency of the promoter (Lesch et al., 1994). Reduced density of the 5-HT 
transporter has been found in subjects with depression and in the postmortem 
brain tissue of suicide victims (Arango et al. 2002, Drevets et al., 1992). In 
addition to associations between 5-HTTLPR and psychopathology, a large body 
of research suggests that the 5-HTTLPR moderates the effects of adverse life 
experiences on the probability and severity of a diverse array of mental health 
related conditions and constructs, including depression (Taylor et al., 2006; 
Caspi et al., 2003), suicide (Roy et al., 2007; Retz et al., 2008) and anxiety 
(Gunthert et al., 2007; Stein et al., 2007). Across these diverse stress-related 
psychological disorders, the majority of studies associate the 5-HTTLPR S-allele, 
and particularly the S/S genotype, with greater psychological sensitivity to stress 
(Uher et al., 2007). However, there is variability in the success of replicating such 
findings as some meta-analysis studies have found no evidence that the 5-
HTTLPR genotype alone or in interaction with stressful life events is associated 
with elevated depression risk (Risch et al., 2009). However, these meta-analyses 
have been criticized on the grounds that they are heavily influenced by large 
studies that typically have the poorest measurement of life events (i.e., self-report 
checklists) and, as a consequence, are poorly equipped to detect conditional 
effects of the environment (Caspi et al., 2010; Karg et al., 2011). However, it is 
also possible that the 5-HTTLPR may be more closely associated with the 
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regulation of the hypothalamic-pituitary-adrenal (HPA) axis response to stress 
than it is with specific psychological states that are influenced by stress (Markus 
& Firk, 2011). Thus, the cortisol response to stressful life events may represent 
an intermediate phenotype between the 5-HTTLPR and psychological disorder. 
Literature shows that serotonin fibers activate the hypothalamic CRH neurons 
(Heisler et al., 2007; Liposits, Phelix & Paul, 1987) that initiate the hormonal 
cascade leading to cortisol release. The S/S genotype of the 5-HTTLPR is 
associated with greater cortisol reactivity to psychosocial stress in adults (Way & 
Taylor, 2010). Additionally, a study by Wust and colleagues (2009) linked this 
polymorphism to basal cortisol secretion over the course of the day, showing a 
link between HPA axis function and this gene. However, two recent independent 
studies in adults have failed to find positive associations between this 
polymorphism and cortisol reactivity in adults (Markus & Firk, 2009; Vinberg et 
al., 2010). Taken together, the present literature suggests a need for further 
research to ascertain the relationship between this polymorphism and cortisol 
responses to stress, as well as links to emerging symptoms of depression and 
anxiety.  
  
  186
 
 
Figure 5.1. Diagrammatic representation of the human SLC6A4 (5-HTT) gene. Exons are indicated by solid black blocks 
and introns by lines. The location of the 44bp promoter region variable number tandem repeat (VNTR) are indicated. The 
16-repeats (Long) and 14-repeats (Short) variants of the VNTR are indicated by dashed arrows (Adapted from Lesch et 
al., 1996). 
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5.1.2 Monoamine Oxidase-A 
Along with the 5-HTTLPR and its possible role in the etiology of mood disorders, 
the MAOA enzyme also regulates availability of serotonin in the synaptic cleft and 
therefore regulates serotonergic tone in response to external stimuli (Jacob et al., 
2005). MAOA is an enzyme involved in the metabolism of biological amines, including 
the monoaminergic neurotransmitters serotonin and norepinephrine (Jacob et al., 2005). 
MAO contributes to controlling amine availability by oxidative deamination of neuronal 
serotonin (Shih et al., 1999). MAOA enzyme expression is dependent on the MAOA 
gene (Gene ID: 4128), which is located on chromosome Xp11.3 and contains 16 exons, 
spanning 60 kilobases (Figure 5.2). A naturally occurring sequence polymorphism exists 
in the MAOA promoter region with functional effects on MAOA transcription. This VNTR 
polymorphism consists of 30-bp repeat elements with 3, 3.5, 4, 5 or 6 copies (Sabol et 
al., 1998). Relative to the longer alleles, the 3-repeat allele results in a significantly 
decreased expression of MAOA gene, and is therefore commonly referred to as the low 
activity variant compared to the longer or high activity alleles (Deckert et al., 1999). The 
latter allelic variant also results in higher cerebrospinal fluid (CSF) homovanillic acid 
levels, a byproduct of catecholamine catabolysis, indicating functional effects of this 
polymorphism in humans (Zalsman et al, 2005). As the MAOA gene is X linked, males 
(XY) carry only a single copy of the MAOA allele, whereas females (XX) carry two, one 
of which is subject to random X-chromosome inactivation in the cell. Thus, high activity 
boys have a single long or “high activity” allele, whereas girls must have the high/high 
genotype in order to be unequivocally established as having the high activity allele for 
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the purposes of research, as one copy will be randomly inactivated due to X-linked 
inactivation (Deckert et al., 1999). 
Given the functional nature of MAOA VNTR and its effect on serotonin signaling 
(or serotonergic tone) in the brain, it is plausible that this polymorphism may be linked to 
individual differences in cortisol response to stress. Only a single study so far has 
examined associations between the MAOA VNTR polymorphism and cortisol reactivity, 
and found a positive association between the low activity MAOA allele and elevated 
cortisol reactivity to psychosocial stress task (Bouma et al., 2012). In addition to this 
recent study, a few studies have also examined the main effects of MAOA genotype on  
stress-related disorders such as depression and anxiety, but the findings in this 
literature have been mixed. Some have found positive links between the MAOA VNTR 
polymorphism and anxiety (Gutierrez et al., 2004; Tochigi et al., 2006) but others have 
failed to replicate such findings (Arbelle et al., 2003; Eley et al., 2003; Jacob et al., 
2005; Syaglio et al., 2001), suggesting a need for further work to clarify the link between 
this polymorphism and anxiety. There are similar mixed results for associations with 
depression, with depression associated with MAOA VNTR in some studies (Tochigi et 
al., 2006) and not in others (Gutierrez et al., 2004).  
In addition to main effects, this gene has been implicated in GxE. For example, 
GxE has been found for MAOA and adversity (Prom-Wormley et al., 2009), life trauma 
(Frazzetto et al., 2007), and childhood maltreatment (Taylor & Kim-Cohen, 2007) in 
predicting both internalizing and externalizing outcomes. More complex interactions 
have also been noted, with high MAOA activity buffering the effects of early adversity on 
later antisocial behaviour in Caucasian participants (Widom & Brzustowicz, 2006). 
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Similarly, Cicchetti and colleagues (2007) found that depressive symptoms were 
elevated in maltreated children only if they had the low-activity MAOA variant. These 
findings were also replicated in adults by Kinnally and colleagues (2009), who reported 
that adults having lower activity MAOA and exposed to early family stressors showed 
higher impulsivity/aggression than girls with good parental care. Other data (Kim-Cohen 
et al., 2006) indicate that adolescents with the low MAOA activity allele who were 
exposed to physical abuse had more mental health problems. Taken together, these 
studies suggest that MAOA plays a role in moderating the effects of the early 
environment on psychopathology.  
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Figure 5.2. Diagrammatic representation of the human MAOA gene. Exons are indicated by solid black blocks and introns 
by lines. The location of the 30bp promoter region variable number tandem repeat (VNTR) are indicated. The approximate 
location of 3-5 repeats VNTR is indicated by dashed arrows (Adapted from Sabol et al., 1998). 
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In addition to gene-environment interaction in influencing symptoms of 
depression and anxiety, a limited literature has also examined the effect of interaction 
between MAOA and 5-HTTLPR gene polymorphisms (gene-gene interaction; GxG) on 
symptoms of anxiety and depression. For example, interactions between MAOA VNTR 
and 5-HTTLPR have been linked to cognitive performance in a large, population-based 
sample of 6000 children (Barnett et al., 2011). Specifically, an epistatic interaction 
between the two loci was associated with better working memory in children with the 
long alleles of both MAOA and SLC6A4 genes. However, studies to date have not 
reported epistasis between the MAOA and 5-HTTLPR loci in predicting risk for 
psychopathology in humans. In additions to GxG, a report by Eley and colleagues 
(2004) reported that the interaction between MAOA and 5-HTTLPR moderated the 
effect of life stress on anxious and depressive symptoms. Specifically, adults 
homozygous for the low activity alleles of MAOA and 5-HTTLPR VNTR polymorphisms 
interacted with low socio-economic status to predict higher number of anxious and 
depressive symptoms. Taken together, this limited literature suggests GxG are linked to 
emotional problems in adults. However, whether GxG predicts emerging symptoms of 
depression or anxiety remains unexplored.  
  In sum, the aim of this chapter is to explore main effects of 5-HTTLPR and 
MAOA polymorphisms on children’s cortisol responses to stress and emerging 
symptoms of depression and anxiety. Based on research reporting positive associations 
between cortisol function and 5-HTTLPR and MAOA genes (Bouma et al., 2012; Way & 
Taylor, 2010), and the possible role of cortisol reactivity as a vulnerability marker for 
later psychopathology, I examined these links in a community sample of preschoolers. 
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Second, based on previous evidence for moderation of early environment risk contexts 
by serotonin genes on symptoms of internalizing psychopathology risk, I predicted that 
these links would also exist at an early age as well. The final set of analyses in this 
chapter would aim to examine and extend the evidence for epistasis as moderator of 
childhood stress (CS) on cortisol response and emerging symptoms.  
5.2  Methods 
 Participant DNA was extracted as described previously in chapter 2. Also, as 
described in Chapters 2 and 3, parent reports on the Child Behavior Checklist 
(Achenbach et al., 2000) were used to ascertain levels of depression and anxiety. AUCi, 
baseline to cortisol change, and AUCg were used as measures of cortisol response as 
previously described in detail on page 54. Finally, details of the CS variable are detailed 
in Chapter 2 as well. 
5.5.1 Genotyping 
The 5-HTTLPR polymorphisms were assayed using methods described by 
Chorbov et al. (2007). Briefly, the forward primer was 5-
GGCGTTGCCGCTCTGAATGC-3’, and the reverse primer was 5- 
GAGGGACTGAGCTGGACAACCAC-3, which yielded 486-bp (short) and 529-bp (long) 
amplicons. Polymerase chain reaction (PCR) was performed in a total volume of 25µl, 
containing 100 ng of DNA, 160 nM of each primer, 1mM Tris-HCL (pH 8.3), 5mM KCl, 
1.5 mM MgCl2, 2% DMSO (v/v), 2.5 U AmpliTaq Gold DNA polymerase (Applied 
Biosystems, Foster City, CA), 200 µM of dATP, dCTP, dTTP, and 100 µM of dGTP, and 
7-deaza-2-dGTP. After an initial denaturation at 94°C for 5 min, 35 cycles of 
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denaturation (94°C for 30 sec), annealing (63°C for 30 sec), and extension (72°C for 1 
min) was performed followed by a final extension at 72°C for 20 min. Amplicons were 
separated on 6% polyacrylamide gels, visualized using SYBR-Green and documented 
using the Bio-Rad 2000 gel documentation system (Bio-Rad Laboratories, Mississauga, 
ON, Canada).  
MAOA promoter VNTR was amplified using the primer sequences forward 5’-
CCCAGGCTGCTCCAGAAACATG-3’ and reverse 5’-
GTTCGGGACCTGGGCAGTTGTG-3’. Conditions used for amplification were one cycle 
at 94°C for 5 min followed by 30 cycles of 94°C for 15 s, 60°C for 15 s, 72°C for 30s, 
and a final 7 min extension at 72°C (Sabol et al., 1998). To improve reaction fidelity, we 
used the Invitrogen PCRx Enhancer (Invitrogen, Carlsbad, CA, USA) as an adjuvant in 
PCR amplifications. Amplicons were separated on 6% polyacrylamide gels, visualized 
using SYBR-Green and documented using the Bio-Rad 2000 gel documentation system 
(Bio-Rad Laboratories, Mississauga, ON, Canada).  
5.3  Results 
5.3.1 Main effects 
In this sample, 119 children (32.1%) were homozygous for the long (L) allele of 
the 5-HTTLPR, 171 (46.1%) were heterozygous, and 76 (20.5%) were homozygous for 
the short (S) allele. I was unable to genotype five children due to non-specificity of PCR 
amplification. This distribution is in Hardy-Weinberg equilibrium, χ2 = 0.31, p > 0.52. 
Analysis of variance was used to test the associations between genotype and study 
variables including cortisol response and behaviour measures (Table 5.1). The 5-
  
HTTLPR polymorphism was not associated with child gender (
family income (χ2 = 41.25, p =
polymorphism on emerging anxiety symptoms such that children with at least one copy 
of the S-allele had higher symptoms of anxiety compared to their L
(365)= 2.14, p = 0.03). 
Figure 5.3. Relationship between the 5HTTLPR 44bp VNTR polymorphism and 
symptoms of anxiety in preschoolers
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Table 5.1. Demographic and study variables by child 5-HTTLPR 44bp VNTR genotype. 
5-HTTLPR genotype     
s/s + s/l  
(short allele) 
(N=241) 
l/l  
(long allele) 
(N=114) 
Variable M SD N M SD N 
Sex (N, boys) 114 69 
Family income 3.80 1.05 3.70 1.2 
PPVT 112.19 13.80 111.22 14.89 
Baseline to peak change -1.10 0.35 -1.06 0.36 
AUCi 0.05 0.10 0.05 0.08 
AUCg 0.17 0.12 0.18 0.12 
CBCL Depression 1.36 1.62 1.22 1.48 
CBCL Anxiety* 1.32 1.09 1.00 1.33 
Note: PPVT = Peabody Picture Vocabulary Test; Family income coded as 1 = < $20,000; 2= $20,000-$40,000; 3= $40,001-$70,000; 
4 = $70,001-$100,000; 5 = > $100,001; AUCi, Area Under Curve with respect to increase; AUCg, Area Under Curve with respect to 
ground; CBCL, Child Behavior Checklist. 
* p < 0.05 †p < 0.10.  
  196
I was unable to genotype three children for the MAOA polymorphism due to lack 
of PCR amplification. For boys, the MAOA hemizygous frequencies were: 3R (N = 74, 
19.8%), 3.5R (N = 8, 2.2%), 4R (N = 101, 27.2%) and 5R (N = 4, 1.1%). MAOA 
genotypes in girls were, 3/3 (N = 54, 13.7%), 3.5/4 (N = 1, 0.3%), 3/4 (N = 52, 14.0%), 
3/5 (N = 4, 1.1%), 4/4 (N = 65, 17.5%) and 4/5 (N = 5, 1.1%). This distribution is not in 
Hardy-Weinberg equilibrium (Pearson X2 (38) = 91.02, p < 0.05), but is comparable to 
recently reported frequencies (Sabol et al., 1998). Consistent with the majority of 
published research (e.g., Zalsman et al., 2005; Ducci et al., 2006), groups for data 
analysis were formed based on whether children had 3R polymorphism (N = 183) or did 
not have (N = 185) a 3R allele. Following previous studies (Zalsman et al., 2005), 
heterozygous females (N = 62) were excluded from analyses, as it is not possible to 
know which X-chromosome escaped inactivation. Furthermore, four boys homozygous 
for the MAOA 5R allele were excluded from analyses as the literature is unclear with 
respect to functionality of the translated protein associated with this allele. This meant 
that the final sample size available for analyses in the chapter was 301. 
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Table 5.2. Demographic and study variables by child MAOA 30bp VNTR repeat status. 
 
Child MAOA genotypes 
  3-repeats (N = 131) ≥ 3.5 repeats (N = 171) 
Variable M SD N M SD N 
Sex (N, boys) 80 100 
Family income 3.73 1.11 3.8 1.11 
PPVT 113.11 15.46 111.01 13.03 
Baseline to peak change -1.12 0.38 -1.07 0.35 
AUCi 0.05 0.08 0.05 0.10 
AUCg 0.18 0.13 0.18 0.13 
CBCL Depressive symptoms 1.19 1.45 1.25 1.48 
CBCL Anxious symptoms 1.14 1.27 1.22 1.46 
 
Note: PPVT = Peabody Picture Vocabulary Test; Family income coded as 1 = < $20,000; 2= $20,000-$40,000; 3= $40,001-$70,000; 
4 = $70,001-$100,000; 5 = > $100,001; AUCi, Area Under Curve with respect to baseline; AUCg, Area Under Curve with respect to 
ground; CBCL, Child Behavior Checklist; ODD, Oppositional Defiance Disorder; ADHD, Attention-Deficit Hyperactivity Disorder. 
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5.3.2  Moderation analyses 
5.3.2.1 5-HTTLPR 
Using multiple regression, in my next set of analyses I examined whether GxE 
predicted children’s cortisol response and symptoms of depression and anxiety. 
Analyses showed no evidence for moderation of CS by 5-HTTLPR in predicting any 
index of cortisol reactivity or symptoms of depression and anxiety. More specifically, the 
interaction between CS and 5-HTTLPR did not predict baseline to peak cortisol change 
(β = -.03, se = 0.05, p = 0.58), AUCi (β = 0.01, se = 0.02, p = 0.77) or AUCg (β = -0.01, 
se = 0.03, p = 0.59). Similarly, there was no evidence for moderation by 5HTTLPR of 
CS association with emerging symptoms of depression (β = 0.03, se = 0.26, p = 0.88) 
and anxiety (β = 0.40, se = 0.30, p = 0.18).  
5.3.2.2 MAOA 
Similarly, I conducted GxE analysis with MAOA as a moderator variable. 
Regression analyses showed that the interaction between MAOA and CS did not predict 
individual baseline to peak cortisol change (β = 0.02, se = 0.05, p = 0.56), AUCi (β = 
0.01, se = 0.02, p = 0.72) or AUCg (β = 0.01, se = 0.02, p = 0.61). However, analyses 
showed significant moderation of CS by MAOA genotype on child anxious symptoms (β 
= 0.77, se = 0.27, p = 0.004). Further analysis showed that children without the 3-repeat 
allele exhibited higher anxiety symptoms as a function of increasing CS (β = 0.63, se = 
0.17, p = 0.001), but CS was not associated with symptoms of anxiety in children with 
the 3-repeat allele (β = -0.14, se = 0.20, p = 0.50; Figure 5.4). I did not find evidence of 
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5.3.3 Gene-Gene interactions 
 Previous literature has also implicated an interactive effect of the 5-
HTTLPR VNTR and MAOA VNTR on developmental risk for psychopathology 
(Barnett et al., 2011; Roiser et al., 2007). Therefore, I also investigated whether 
such a gene-gene interaction (GxG) also predicted symptoms of depression and 
anxiety in preschoolers. Analysis showed that the GxG terms were nonsignificant 
and did predict either cortisol response or emerging risk for internalizing 
problems (all ps > 0.16; figure not presented).   
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5.4  Discussion 
The aim of this chapter was to examine links between serotogenic gene 
functional polymorphisms and symptoms of depression and anxiety in 
preschoolers. The first finding was a positive association between the 5-HTTLPR 
polymorphism and child anxious symptoms. Specifically, children with at least 
one copy of the S-allele had higher levels of anxiety than children homozygous 
for the L-allele. This finding extends and compliments extant literature linking this 
polymorphism and internalizing symptoms. For example, literature has reported 
that the S-allele of the 5-HTTLPR was associated with anxiety traits (Katsuragi et 
al., 1999; Lesch et al., 1996; Ohara et al., 1998; Gonda et al., 2007) and with 
anxiety-related personality traits such as neuroticism and impulsivity (Gorwood, 
2004; Sen et al., 2004). The presence of associations between emerging anxiety 
symptoms in three-year-olds and this polymorphism is a novel finding and 
suggests a possible role of this variant in the early development of anxiety 
vulnerability. Along with anxiety traits, research has also linked this 
polymorphism with depression in adults (Arya et al., 2009), but such associations 
did not exist in this sample. The lack of associations could be due to a few 
possibilities including the young age and the non-clinical nature of this sample. 
As discussed in Chapter 3 and 4, depressive symptoms are rare during 
preschool years; it is possible that associations between this gene and 
depressive symptoms may emerge later when such symptoms are more 
common and variable across children. A number of prior studies have detected 
an interaction between 5-HTTLPR and stressful life experiences such as 
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childhood abuse (Caspi et al. 2003; Araya et al., 2009) in predicting depressive 
symptoms. However, I did not find evidence for such an interaction in this 
sample. As discussed in earlier chapters, the lack of an extreme stressor context 
could be one of the reasons for the lack of replication in this sample (see this 
discussion in Chapter 4). Additionally, a reason for the failure to find a significant 
association between 5-HTTLPR and emerging symptoms (and cortisol reactivity) 
may reflect insufficient power to detect such associations. 
In addition to 5HTTLPR polymorphism, previous research on GxE in 
adults has implicated the MAOA 30bp VNTR in moderating the effect of 
childhood maltreatment on psychiatric symptoms (Kraft et al., 2006; Wendland et 
al., 2006); therefore, I tested this model in the current sample. My analyses 
complemented this earlier literature in adults by showing that the interaction 
between MAOA genotype and CS predicts children’s anxious symptoms. In 
addition to anxiety problems, previous GxE studies in literature have linked 
MAOA VNTR polymorphism with other psychiatric phenotypes in the presence of 
early adversity. For example, in their seminal work, Caspi et al. (2002) found that 
individuals possessing the 3-repeat genotype of MAOA showed increased risk for 
antisocial behaviour, but only if they had experienced an adverse early 
environment. Other studies have found similar interactions between MAOA gene 
polymorphism and early maltreatment for behaviours reflecting conduct disorder 
(Foley et al., 2004), antisocial behaviour (Kim-Cohen et al., 2006), antisocial 
alcoholism (Ducci et al., 2007), and physical aggression (Frazzetto et al., 2007). 
These findings add to this literature by showing the moderation of symptoms by 
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MAOA VNTR genotype in the presence of more subtle forms of life stress. As 
most research has reported the moderation effect of this genotype on extreme 
forms of adverse experience (such as physical and sexual abuse), the findings in 
this chapter suggests that this variant may moderate a broad contexts of early life 
stressors, and is a novel finding in literature with implications on early childhood 
development.  
In my final set of analyses, I looked at the effect of MAOA and SLC6A4 (5-
HTTLPR) on either cortisol response or emerging symptoms at preschool age 
and found no evidence for GxG. My analyses did not support literature from 
previous adult studies, which reported that GxG predicted symptoms of 
psychopathology (Roiser et al., 2007). However, my findings are in line with 
literature from young samples such as adolescents, which show that the 
interaction between MAOA and 5HTTLPR variants did not predict symptoms of 
anxiety (Armbruster et al., 2011). Although speculative, these findings suggest 
that the interaction between these two variants may be evident at a later age 
rather than in early childhood.  
In sum, I present evidence that functional polymorphisms in 5-HTTLPR 
and MAOA, two gene involved in the functional deactivation of serotonin, are 
linked to emerging symptoms of anxiety in young children. While neither gene 
has been unquestionably linked to psychiatric symptoms, the data in this chapter 
suggests that serotonergic polymorphisms linked to normal variation in brain 
function are at play in influencing early-emerging symptoms of depression and 
anxiety in the presence of life stress. The lack of links between these genes and 
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cortisol reactivity suggests that such links may possible be influenced by other 
hormone and/or components of the HPA axis pathway or more evident at a later 
age.   
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Chapter 6 - Discussion 
The current thesis is an examination of genetic markers of children’s 
cortisol responses to stress and their possible role in contributing to emerging 
internalizing disorder symptoms. The implications of my findings for our 
understanding of the biological and environmental bases of children’s 
internalizing disorders risk are discussed in the following sections.  
6.1  Context of study findings 
6.1.1 Chapter 2 – The CRH system genes 
Chapter 2 expanded on the hypothesis that variation of the CRH system 
genes would be linked to individual differences in cortisol responses to stress. 
Specifically, single nucleotide polymorphisms (SNPs) spanning the coding and 
regulatory regions of CRH, CRHR1 and CRHBP genes were examined. I 
identified significant main effects of gene variants of CRHR1 and CRHBP coding 
regions on childhood cortisol reactivity. In addition to main effects, I identified 
GxE with multiple individual SNPs, as well as with common variants of the 
CRHR1 and CRHBP locus, that were associated with children’s internalizing 
symptoms in the presence of stress (Figures 2.7 & 2.9). The associations 
between SNPs of the CRHR1 and CRHBP coding region and cortisol reactivity 
are the first reported in the literature. Additionally, the GxEs I found are an 
extension of previous work suggesting that CRH system gene variant SNPs 
moderate the effect of early adversity on future psychopathology (Bradley et al., 
2008). The SNP variants involved in these studies were the same as those 
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described previously in two separate studies by Bradley and colleagues (2008) 
and Polanczyk and colleagues (2009). However, the stress contexts in the 
present study and previous studies by Bradley and colleagues (2008) were 
different. Specifically, the CS variable used in this study included family income, 
dyadic adjustment and family stressors such as illness, job loss, etc. over the 
past 12 months, and were in some cases less extreme forms of stress than those 
typically examined in the field. For example, Bradley and colleagues (2008) 
examined severe or extreme forms of stressors such as physical and sexual 
abuse. Taken together, findings in Chapter 2 and previous findings (Bradley et 
al., 2008; Cicchetti et al., 2009; Heim et al., 2009; Polancyzk et al., 2009) 
suggest that the CRH gene variants interact with a broad range of forms of early 
adversity to influence adjustment in childhood and later in life. 
6.1.2  Chapter 3 - The Catechol-O-Methyltransferase (COMT) gene  
As an important regulator of dopaminergic signaling in the prefrontal and 
limbic systems of the brain, the functional polymorphism of the COMT gene 
(val158met) has been extensively studied in psychiatric literature (Meyer-
Lindenberg & Weinberger, 2006). Based on previous findings in animal models 
where COMT gene knockouts exhibited abnormal HPA axis function, I examined 
the association between the val158met polymorphism and cortisol reactivity in 
preschoolers. The analyses showed a main effect of the val158met 
polymorphism on children’s cortisol reactivity, supporting previous work by Jabbi 
and colleagues (2005), who showed that adolescents who were val homozygotes 
showed heightened cortisol responses to psychosocial stress tasks.  
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In addition to evidence for direct associations, I also investigated GxE. 
Analyses showed that the val158met polymorphism moderated the link between 
CS and emerging symptoms of anxiety; expanding on recent work by Klauke and 
colleagues (2012) who found that COMT genotype moderated the effect of 
childhood trauma on startle response, which is considered an endophenotype for 
anxiety disorders. Additionally, in a study by Kolassa and colleagues (2010), the 
interaction between COMT genotype and recent traumatic events predicted an 
increased risk for posttraumatic stress disorder, such that val homozygotes who 
experienced trauma were more likely to develop posttraumatic stress disorder. In 
sum, analyses in Chapter 3 along with recent studies in the literature suggest 
that val homozygous carriers are especially vulnerable to stress during early 
childhood.  
6.1.3  Chapter 4 - The dopamine pathway candidate genes 
 In Chapter 4 of this dissertation, I looked at common variants of the 
dopamine (DA) pathway and their links to cortisol reactivity to stress and 
children’s symptoms of depression and anxiety. Analyses did not yield evidence 
for main effects of DA candidate genes on any of these outcomes; however, I did 
find evidence for GxE in my analyses. Specifically, the DRD2 genotype 
moderated the effect of CS on children’s cortisol responses to stress. Although 
this is the first study to report such an effect, these findings expand on a previous 
study from our group that reported a positive association between the DRD2 
genotype and symptoms of depression and anxiety (Hayden et al., 2010). In 
Chapter 4, I also reported evidence for moderation of the association between 
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CS and symptoms of anxiety and depression in preschoolers by the DAT1 VNTR 
polymorphism. Specifically, the 9R allele carriers had increasing symptoms as a 
function of CS, whereas there was no significant association between CS and 
symptoms in children with at least one copy of the 10R allele. These findings 
extend previous work from our lab showing that genetic influences on children’s 
psychopathology risk were moderated by contextual factors (Hayden et al., 
2013). Other studies have reported an interaction between DAT1 and life stress 
in shaping the development of conduct disorder and attention-deficit hyperactivity 
disorder in children (Bidwell et al., 2011; Lahey et al., 2011). Specifically, the 
children carriers for the DAT1 9R allele had higher risk as a function of increasing 
negative early life contexts such as negative parenting. Taken together, these 
studies combined with my findings suggest that this polymorphisms may play a 
role in etiology of mood and emotion problems. 
I did not find associations between the DRD4 VNTR genotype and cortisol 
reactivity or internalizing symptoms. The lack of associations could be due to 
several factors. Recent work from our lab suggests that DRD4 genotype 
moderated the association between parenting and child effortful control, a 
temperament trait associated with both internalizing and externalizing 
psychopathology (Smith et al., 2013). Specifically, the association between 
children’s effortful control and positive parenting was moderated by children’s 
DRD4 7R status, such that children with at least one 7R allele displayed both 
better and worse effortful control than children without this allele, depending on 
the degree of positive parenting. These findings suggest that this gene may be 
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linked to other endophenotypes, such as child temperament, rather than 
children’s psychophysiological stress responses.  
6.1.4  Chapter 5 - The serotonin pathway candidate genes 
 In Chapter 5, I reported analyses examining links between serotonin 
pathway candidate gene variants and cortisol reactivity. There was no evidence 
for associations between MAOA and 5-HTTLPR and measures of children’s 
cortisol responses to stress. However, I did find evidence for a main effect of 5-
HTTLPR genotype on symptoms of anxiety in preschoolers. This finding extends 
previous work showing that the S-allele of the 5-HTTLPR is associated with 
anxiety traits (Katsuragi et al., 1999; Lesch et al., 1996; Ohara et al., 1998; 
Gonda et al., 2007) and with anxiety traits such as neuroticism and impulsivity 
(Gorwood, 2004; Sen et al., 2004). In addition to main effects, I also tested gene-
environment interactions and found significant evidence for moderation of the 
effect of CS on child anxiety symptoms by MAOA genotype. Specifically, children 
without the 3-repeat allele exhibited higher anxious symptoms as a function of 
increasing CS. These results extended previous findings where MAOA genotype 
moderated the link between childhood adversity and risk for conduct disorder and 
antisocial behaviour (Foley et al., 2004; Kim-Cohen et al., 2006), although this 
report of GxE predicting symptoms of anxiety in preschoolers is the first to be 
reported, to my knowledge.  
   In addition to GxE, literature has suggested that interactions between 
these serotonin candidate gene variants may also moderate the effect of life 
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stress on psychopathology in adults (Roiser et al., 2007). My analyses extended 
the work by Roiser and colleagues (2007) and recent work by Barnett and 
colleagues (2013), suggesting that interaction between MAOA and 5-HTTLPR 
moderated the effect of childhood stress also predicted symptoms of anxiety. 
6.2 Implications for risk and resilience 
Epidemiological and clinical research studies have consistently identified 
early exposure to stress as a major risk factor for mood and anxiety disorders 
(Chapman et al., 2004; Dube et al., 2001; Felitti et al., 1998; Gladstone et al., 
2004). The parallel study of individuals who emerge from such adverse 
environments without significant mood or anxiety disorder (Rutter, 2006) has 
resulted in the identification of psychosocial and biological variables associated 
with psychological resilience (Feder et al., 2009). As with environmental 
variables, predisposing genetic factors also influence vulnerability (Stein et al., 
2002; Sullivan, Neale & Kendler, 2000) and resilience (Rijsdijk et al., 2003) in 
terms of risk for mood and anxiety disorders. However, the relationship between 
individual genetic variability and exposure to various forms of early life stress and 
how these interactions translate to early risk remains largely unclear and was the 
main focus of this dissertation. 
Analyses in this thesis show the importance of gene-environment 
interactions in predicting cortisol reactivity and symptoms of depression and 
anxiety. More specifically, in Chapters 2, 3 and 4, I report findings that confirm 
gene-environment interactions as predictors of depressive and anxious 
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symptoms. These findings extend a literature which has documented the role of 
gene-environment interaction in conferring risk. This line of work started over a 
decade ago with the publication of seminal studies by Caspi and colleagues 
(2002a, 2002b), where gene-environment interaction, predict risk for conduct 
disorders and risk for depression. In both studies, specific risk alleles drawn from 
prior biological research on candidate genes were shown to predict behaviour 
problems, but only under specific environmental contexts, such as childhood 
maltreatment. Caspi and colleagues (2010) recently provided a cogent review of 
studies based on their initial discovery that variation in the promoter region of the 
serotonin transporter gene (5-HTT/SLC6A4) moderated the link between 
stressful life events and depression. The present work may not have replicated 
the exact finding for this variant, but my analyses nonetheless point to the 
importance of functional monoaminergic variation in moderating the role of more 
subtle contexts of stress faced by a vast majority of children during early 
development.  
Taken together, what’s especially interesting from these studies is that 
some gene variants contribute to vulnerability by virtue of direct and indirect 
pathways. Moreover, the data confirm and extend Caspi and colleagues (2010) 
assertion that risk alleles may carry risk for behavioural disorders because they 
moderate reactions to the environment. The implication, then, is that specific 
gene markers are influential but only in combination with environmental triggers, 
not as main effects on behavioural dimensions and disorders.  
6.3 Methodological considerations 
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6.3.1 Study strengths 
The study had a number of strengths. First, I chose to examine genes that 
are an integral part of the HPA axis pathways activation and inhibition. The gene 
and pathway-based association analysis considers a gene or a pathway as the 
basic unit of analysis, and aim to study simultaneously the association of a group 
of genetic variants in the same biological pathway, in this case, the CRH system 
pathway (Neale & Sham, 2004). This can help unravel the complex genetic 
structure of phenotypes in order to gain insight into the biological processes and 
developmental mechanisms (Curtis, Oresic & Vidal-Puig, 2005). Additionally, in 
case of the CRH system genes (CRH, CRHR1 and CRHBP) the haplotyping of 
tag-SNPs captured entire genetic variation in the coding and regulatory regions 
of these genes, making the analyses comprehensive. Similarly, monoaminergic 
candidate genes polymorphisms examined in this thesis were also functional in 
nature, with well-documented functional effects on brain neurotransmitter 
systems. Furthermore, in Chapter 2, I also controlled for Type I error by using 
permutation-based procedures (Schmidt et al., 2002, 2003) that randomly 
assigned the sample AUCi scores to subjects (sampled without replacement) 
while holding each subject’s genotype fixed. This permutation method is 
preferred as it accounts for linkage disequilibrium among SNPs in a haplotype 
block; therefore conserving power compared to commonly used correction 
techniques such as the Bonferroni method (Schmidt et al., 2003). Moreover, I 
tried to keep population stratification to a minimum by conducting all analyses in 
Caucasians only.  
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In addition to precautions taken during data analyses, conducting this 
research in a young sample should be considered a major strength. Specifically, 
as mood disorders are rare in preschoolers, our data was not confounded by 
previous or current psychopathology. Additionally, literature has linked sex 
hormone status such as estrogen during the menstrual cycle with cortisol 
reactivity to stress. However, sex hormones are not a confounder in my study 
due the young nature of this sample. Similarly, precautions were taken during 
cortisol sampling as well to obtain an accurate index of children’s stress 
reactivity. For example, the stress task was conducted during the same time of 
the day to control for diurnal variance of cortisol in humans (Gunnar, Talge & 
Herrera), and parents were instructed not to feed their children immediately prior 
to cortisol sampling to address the influence of certain foods on cortisol levels 
(Gunnar, Talge & Herrera). The stress task was conducted after an 
acclimatization period of 30 minutes to capture normalized baseline cortisol and 
was conducted by trained study personnel. Additionally, all cortisol samples were 
measured in duplicates in a single batch for a given participant usually within 24 
hours of sample collection. All measurements were repeated if cortisol variance 
within the duplicates or even different plates exceeded >5-6 % variance, a very 
stringent criteria for ELISA assays. Furthermore, 10 % of all genotyping was 
repeated and all probes were sequenced for accuracy. Of the ~13000 genotypes, 
99.8 % were in concordance.  
6.3.2 Limitations 
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 Some limitations of this thesis should be considered as well. Even though 
the sample size of this study was relatively large compared other studies in 
developmental literature, it is small for a genetic study. However, it may be 
logistically challenging and not financially viable to perform stress tasks for 
cortisol assessment on a very large sample. Additionally, due to the sample size, 
all the variants in this thesis are common genetic variants in the Caucasian 
population. Biological interactions that involve rare genetic variants or rare 
environment exposures are unlikely to detect as significant statistical interactions 
(Uher, 2008). In this case, therefore, even a very large sample size will only be 
powerful enough to detect moderately strong GXE. Therefore, replication of 
findings in independent samples is very important.  For some studies, I examined 
a limited number of markers at each gene, and I did not correct for multiple 
statistical tests in some analyses due to the hypothesis-driven nature of the work. 
The study also used parent-reported measures of child behaviour. The 
difference between objective interview and self-report or parent-report measures 
of behaviour is a question of specificity and objective validity (Monroe, 2008). For 
example, parental psychopathology may “color” descriptions of child problems as 
may occur when abusive or depressed mothers provide negative or exaggerated 
descriptions of their children (Gotlib & Hammen, 1992). Similarly, 
dismissive/avoidant adult informants deny the presence of emotional problems at 
the same time that professionals observe a high level of symptoms (Dozier & 
Lee, 1995), or parents downplay the importance of a given behaviour or 
sometimes individuals simply try to avoid thinking of past traumatic events (Uher 
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et al., 2011). In some cases, some parents take the instruction too literally, which 
may lead to omission of data that could otherwise be an important stressful life 
event. Additionally, parents could misunderstand and misinterpret questions; the 
opportunity to clarify symptoms is an important asset of interview measures. 
However, it should be noted that, due to the young age of the sample, parent-
reports were more logistically feasible. Further, the CBCL is the most widely-
used measure of children’s symptoms, and has been shown to be a reliable 
indicator of current symptomatology.  
In addition to the limitations described above, I conducted most analyses 
in candidate genes previously described in psychopathology research. However, 
one of the limitation of the current analyses is that I did not utilize the current 
knowledge from ENCODE or HaploReg databases to predict a possible 
regulatory effect of polymorphisms genotyped in this study on remote genes. It is 
likely that some of the variants genotyped in this study may code for DNA 
regulatory elements with functional effects on genes not investigated here but 
may be linked to early risk for psychopathology. Additionally, complex traits being 
polygenic in nature are also influenced by other gene variants and extant 
literature has documented their associations with stress-related problems such 
as depressive and anxious symptoms. Of importance amongst these are the 
glucocorticoid receptor complex genes such as NR3C1 and FKBP5 (Binder et al., 
2009; Roy et al., 2012). Also widely implicated are the oxytocin receptor gene 
and the brain neurotrophins, which directly influence synaptic plasticity and 
therefore regulate the effects of stress and HPA axis response at the neuronal 
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level (Zheng et al., 2014). Below, some of the current knowledge is discussed to 
add to our understanding of the complex underpinning of the developmental risk.  
6.3.2.1 The glucocorticoid complex genes 
The regulating effects of cortisol on brain and behaviour are mediated by 
binding of the hormone to specific receptors. Glucocorticoid receptors (GR) are 
widely distributed throughout the PFC, amygdala, hippocampus, and brainstem, 
and are critical to regulating responses during conditions of elevated cortisol 
secretion or stress (Myers, McKlveen & Herman, 2014; Timmermans et al., 
2013). Relative GR resistance is a core feature of depression, perhaps leading to 
disinhibition of central CRH secretion and HPA axis hyperactivity (Silverman & 
Sternberg, 2012). For example, Bet and colleagues (2009) demonstrated that, in 
a longitudinal aging study, SNPs in the GR gene interacted with adverse life 
events during youth, including war experiences, sexual abuse, parental loss, or 
physical illness in the prediction of major depressive disorder (MDD). 
However, the sensitivity of the GR is fine-tuned by a co-chaperone 
chaperone protein, FKBP5. When bound to the GR complex, FKBP5 decreases 
GR affinity for cortisol and prevents translocation of the GR to the nucleus 
(Binder et al., 2009). Given the important role of GR in regulating stress 
responses and the evidence for GR resistance in depression, variation of the 
FKBP5 gene likely is a critical modulator of the relationship between childhood 
maltreatment and depression (Binder et al., 2009). In a recent population-
representative sample of more than 2000 Caucasians, Appel et al., (2011) 
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reported an interaction between the rs1360780 of the FKBP5 gene and 
maltreatment in predicting both depressive symptoms and diagnoses of 
depression. Another recent study in 884 adolescent and young adult individuals 
confirmed an interaction of different FKBP5 variants and traumatic life events in 
predicting the onset of MDD (Zimmermann et al., 2011). These results, taken 
together, strongly implicate the GR and related pathway gene variants in the 
pathogenesis of stress-related depression. My future work will investigate the 
role of these genes and emerging symptoms to inform whether these variants are 
involved in developmental risk pathways. 
6.3.2.2 Oxytocin Receptor 
The human oxytocin (OXT) system mediates social attachment, including 
mother–infant bonding, and demonstrated to buffer emotional and physiological 
responses to stress (Meyer-Lindenberg et al., 2011). For example, in patients 
with MDD, plasma oxytocin concentrations are inversely correlated with symptom 
severity (Scantamburlo et al., 2007). Additionally, women reporting exposure to 
childhood maltreatment exhibit deceases in cerebrospinal fluid oxytocin 
concentrations, which in turn were associated with increased anxiety (Heim et al., 
2009). Similarly, interaction of between oxytocin receptor gene (OXTR) SNP 
rs2254298 and adverse parental environment predicted symptoms of depression 
in 9–14 years old girls (Thompson et al., 2011). Other studies have also reported 
interactions between OXTR variants and childhood stress predicting cortisol 
reactivity in adults (Chen et al., 2011). Future work from our group will investigate 
these links in our sample as well.  
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6.3.2.3 Brain-Derived Neurotrophic Factor 
Brain-derived neurotrophic factor (BDNF) is a widely expressed 
neurotrophin in the brain that is implicated in neuronal growth, synaptic plasticity, 
and neuronal survival. In animal models, prolonged stress exposure and elevated 
glucocorticoid levels down-regulate BDNF expression, whereas administration of 
antidepressant drugs induces BDNF expression; antidepressant treatment 
normalizes hippocampal volume in depressed patients (Nestler et al., 2002). The 
BDNF gene contains a functional polymorphism (rs6265), which is associated 
with a valine to methionine substitution (val66met) and leads to reduced BDNF 
expression in the brain. Literature reports on interaction between this 
polymorphism and childhood sexual abuse in the prediction of adult depression 
(Aguilera et al., 2009). A report from our group demonstrated found that BDNF 
val66met polymorphism moderated the interactive effects between 5-HTTLPR 
and stress on HPA axis reactivity in a sample of preschool children (Dougherty et 
al., 2010). Furthermore, the BDNF val66met × 5-HTTLPR × childhood 
maltreatment interaction also predicted depression (Wichers et al., 2008).  
In addition to DNA sequence variants that may contribute to risk for later 
psychopathology, structural DNA variation also regulates gene expression in 
response to external stress stimuli. The biology of gene regulation via DNA 
structural variation is the emerging field of epigenetics that may provide a 
promising avenue of research, which may aid in our understanding of biological 
bases of psychopathology and briefly discussed in this section. The influence of 
genetic variations in the DNA sequences of HPA axis related genes on mood 
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disorders is clear, but may only be one of the many factors contributing to our 
understanding of mood disorders. One of the most promising pathways of future 
research is the investigation of epigenetic processes modulating the relationship 
between Gene × CS interactions and depression. Epigenetic changes are 
changes in gene expression, which remain stable during cell divisions but do not 
affect the DNA sequence itself. Such changes are heritable and can be caused 
by changes such as those found in DNA methylation, the modeling of chromatin, 
and the deacetylation of histones in the DNA (Spijker & van Rossum, 2012). 
Epigenetic control of gene regulation has been implicated as influencing early 
development. For example, quality of maternal care was found to influence HPA 
function in rats through epigenetic programing of GR expression (Meaney, 2001). 
Poor quality of maternal care was associated with changes in the promoter 
region methylation of the GR gene. These rodents also exhibited enhanced 
hormonal and anxiety-like behavioural responses to stress, suggesting a role of 
epigenetic status in early neurodevelopment. In humans, recent work showed 
that the brain tissue of human suicide victims who were also exposed to 
childhood abuse had considerably higher methylation in the promoter region of 
the GR gene when compared to controls (McGowan et al., 2009). Additionally 
poor maternal rearing conditions led to differential DNA methylation in the 
prefrontal cortex glial cells of rhesus macaques (Provencal et al., 2012). In a 
recent study by Klengel and colleagues (2013), methylation pattern differences 
were observed in FKBP5 gene following childhood trauma. However, a large gap 
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in knowledge still remains when it comes to epigenetic mechanisms that play a 
role in early childhood. 
6.5 Future directions 
6.5.1 Additional stress contexts that contribute to risk: The role of parenting  
Due to the complexity and multifactorial nature of depressive and anxious 
disorders, this thesis focused on well-studied dimensions of life stress such as 
family income, dyadic adjustment and stressful life events in the child’s family in 
the past 12 months. However, along with genetic factors which may be at play 
and described in the previous sections, an equally important contextual risk in the 
child’s life is parenting. Parental effects on children’s emotional development are 
hypothesized to be due, in part, to the influence of early childhood parental care 
on stress reactivity (Leuken et al., 2004; Loman & Gunnar, 2010). In addition, by 
shaping the nature of the response to stress and challenge, such an influence is 
also likely to determine the impact a broad range of environmental factors across 
development (Ellis & Boyce, 2008) and have a broad and lasting influence across 
time. However, despite the importance of the hypothesis that early parenting 
influences stress reactivity, support for this notion is indirect. For example, animal 
research has demonstrated lasting effects of parenting on stress reactivity later in 
life. In rodents, the offspring of mothers who exhibit high levels of licking, 
grooming and arched-back nursing (which facilitates pups’ access to milk) show 
increased hippocampal glucocorticoid receptor expression, enhanced negative 
feedback regulation, decreased hypothalamic CRH expression, more modest 
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HPA-axis responses to stress, and less fearful behaviour (Levine, 2005; Zhang et 
al., 2006; Zhang & Meaney, 2010).  
In addition to the research in rodents, studies in nonhuman primates 
demonstrate that in the presence of low maternal caregiving led to higher levels 
of plasma CRH in the offspring (Coplan et al., 2001). Parenting behaviours may 
alter cortisol levels, potentially representing a link in the overall pathway by which 
low income and cumulative risk eventually disrupts children's cortisol levels. 
Research has examined the relation of parenting to HPA axis functioning both in 
high-risk samples, such as low maternal education and high maternal stress, and 
low risk samples. In general, parenting that is lower in sensitivity, higher in 
intrusiveness and harshness is associated with lower morning cortisol levels 
(Roisman et al., 2009), flatter diurnal slope (Papp, Pendry & Adam, 2009), 
greater reactivity (Bugental et al., 2003), and slower cortisol recovery after a 
stressor (Albers et al., 2008). Studies typically examine one or two parenting 
variables at a time, with more emphasis on affective (i.e. sensitivity, harshness) 
parenting behaviours compared to control-related parenting behaviours (i.e. limit 
setting). This study sought to examine several parenting behaviours 
simultaneously to see which specific parenting behaviours, if any, accounted for 
the relations of income and cumulative family risk to disrupted cortisol patterns. 
Parenting has been posited to mediate the relationship between other 
early risks and child cortisol levels. Specifically, two studies have examined 
environmental risk and parenting as mediators of the relation between poverty 
and disruptions to children's cortisol. In a sample of preschool-aged children 
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representing the full range of income, there was a trend toward an association 
between maternal negative affect and children's diurnal cortisol pattern, with 
negative affect trending toward mediating the relation between poverty status 
and a low, flat diurnal pattern (Zalewski et al., 2012). Another study found that 
positive parenting, but not negative parenting, explained a small but significant 
portion of higher basal cortisol levels in young children, over and above 
environmental risk factors (Blair et al., 2011). These two studies point to the 
possibility that parenting may mediate the relations of poverty and cumulative risk 
to disruptions in children's cortisol levels. In sum, a large amount of literature has 
suggested the importance of parenting in shaping neuroendocrine responsivity to 
childhood stress and will be a focus of future research from our group. 
6.5.2 Differential susceptibility to the environment  
The GxE model described above has historical roots in diathesis-stress 
models of psychopathology. Diathesis-stress models propose that clinically 
relevant phenotypes are the product of both high-risk genes and high-risk 
environments typically to lead to a psychological disorder (Caspi et al., 2010). 
Some of the data in this thesis supports this model by showing risk alleles 
interaction with high early life stressor to predict either high cortisol response to 
stress or higher depressive and/or anxious symptoms. However, my analyses 
also suggest that in some cases the supposed “risk allele” was associated with 
either lower cortisol response to stress or lower symptoms when compares to the 
advantageous or “resilience” gene in the presence of low life stress. For 
example, in Figure 3.4 the COMT val-allele carriers had lower anxiety symptoms 
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than their met-allele counterparts under low stress conditions, even though val-
allele is widely considered the risk allele. This finding, along with other examples 
in this thesis (Figure 5.6B), may not entirely fit the notion that risk alleles only 
lend to vulnerability traits and specifically under high environmental stress. Based 
on similar findings in extant literature, theorists have posited that the “risk” alleles 
may also confer a particular ability to respond positively to environment based on 
the context. The key idea is that specific genes do not confer only vulnerability in 
the face of environmental adversity but they may also sensitize individuals to 
positive experiences and influences. This notion of dual action of a given allele is 
now commonly known as “differential susceptibility” to the environment (Belsky & 
Pluess, 2009; Ellis & Boyce, 2008).  
Theorists suggest that specific genes may function more like “plasticity 
factors” rather than “vulnerability factors.” Data from our group and others 
support this concept. For example, Hankin and colleagues (2011) examined 
interactions between 5-HTTLPR genotype and degree of positive and supportive 
parenting (ranging from low to high) in adolescents and young adults. Other 
studies replicate these findings and show the same effect, that youth 
homozygous for the short allele of 5-HTTLPR were more responsive to 
parenting, whether it was positive or negative. Youth at high genetic risk, or 
homozygous for the short allele, had low-levels of positive affect if their parents 
were unsupportive. However, the same group also had high levels of positive 
affect if their parents were supportive. Thus, the short allele group was not only 
vulnerable to negative parenting but also benefited from positive parenting as 
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well. In sum, based on these findings, the ontogenetic origins of differential 
susceptibility and, more specifically, identifying specific genetic variants linked to 
heightened susceptibility to environmental influence, need further attention in the 
future. 
6.5.3 Beyond GxE: The role of gene-environment correlations  
In large part, studies of gene–environment interplay (including this thesis) 
have been motivated by the search for gene–environment interactions, following 
recent demonstrations of genetic sensitivity to environmental effects on human 
phenotypes. By the late 1970s, behavioural geneticists had amassed a large 
body of research on twins and adoptees that attested to the importance of 
genetic influences on individual differences in personality, cognitive abilities and 
liability to disease (Plomin et al., 1994). These studies demonstrated that genetic 
factors influencing an individual's exposure to particular environments could 
make those environments themselves heritable. This phenomenon is referred to 
as gene-environment correlation, or rGE (Plomin, DeFries & Eaves, 1977).  
rGEs reflect genetic differences in exposure to particular environments 
(Kendler & Eaves, 1986). Three separate types of rGE have been described: 
passive, evocative/ reactive, and active (Plomin, DeFries & Fulker, 1977). In 
passive rGE, parents pass on genes and also provide an environment, both of 
which influence the child’s development. For example, depressed parents may 
pass on depressogenic genes to their children, and also provide low levels of 
warmth and emotional support. These correlated genetic and environmental 
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influences increase the risk of depressive symptoms in the child. In evocative 
rGE, heritable traits influence the reaction of others and hence the environment 
provided by others. For example, a shy child may be perceived as less fun by 
other children, making other children less likely to spend time with him or her. In 
active rGE, a child’s heritable traits influence his or her choice of environment. 
For example, a shy child may have reduced motivation to engage with peers. 
This reduced exposure to positive environments may increase depressive 
symptoms. The presence of significant correlation between genetic and 
environmental factors can make interpretation of results difficult, because it is 
difficult to distinguish whether it is the genes, the environment, or both that 
influence an outcome of interest (Jaffee & Price, 2013). 
Developmental studies looking at evidence for rGE are rare (only 5 
publications), but some studies from our group (Hayden et al., 2010, 2013) and 
others (Dick et al., 2006; Lucht et al., 2006) reported rGE in community samples. 
For example, Lucht et al. (2006) reported an association between perceived 
negative paternal parenting (reported retrospectively by adult offspring) and 
offspring variants of both DRD2 and GABRA6. Similarly, DAT1 9-repeat variant 
was associated with child negative affect expressed toward the parent during 
parent-child interactions, and parents of children with a DAT1 9-repeat allele 
exhibited more hostility and lower guidance/engagement during the tasks than 
parents of children without a copy of the DAT1 9-repeat polymorphism. These 
gene-environment associations were partially mediated by child negative affect 
toward the parent, suggesting that evocative associations play a role in elevating 
  235
children’s psychopathology risk (Hayden et al., 2013). Even though examining 
rGEs was beyond the scope of this thesis, the implications of this phenomenon 
on emerging risk for mood and anxiety disorders will receive further attention in 
my future research. 
6.6 Conclusions 
This thesis set out to examine the role of neurotransmitter systems 
commonly implicated in stress reactivity and pathogenesis of stress-related 
disorders. The findings support a role for CRH system gene variants in early age 
cortisol response and internalizing symptoms. Along with direct associations, 
common variants of CRH and monoaminergic system genes also acted as 
moderators of early environment’s effect on developmental risk in young 
preschool age children. This research further supports a large body of GxE 
literature implicating the role of both genes and environment in etiology of mood 
disorders. Identifying the genetic underpinnings of stress response and emerging 
risk may ultimately aid in public health prevention efforts and help identifying at-
risk individuals or subgroups of the population. This knowledge could eventually 
guide intervention efforts and may help to reduce the effects of chronic life stress 
on at-risk children. Since many of the genes studied here are targets of drug 
development for stress-related disorders, it may be possible to pharmacologically 
treat intermediate phenotypes that share genetic etiology with internalizing 
problems. In closing, the better understanding of nature and nurture will help 
reduce the tremendous toll mental health disorders exact of individuals and 
society. 
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